BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Levine A, Griffiths A, Markowitz J, Wilson DC, Turner D, Russell RK, Fell J, Ruemmele FM, Walters T, Sherlock M, Dubinsky M, Hyams JS. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis. 2011;17:1314-1321. [PMID: 21560194 DOI: 10.1002/ibd.21493] [Cited by in Crossref: 889] [Cited by in F6Publishing: 799] [Article Influence: 74.1] [Reference Citation Analysis]
Number Citing Articles
1 Lv Y, Lou Y, Yang G, Luo Y, Lou J, Cheng Q, Yu J, Fang Y, Zhao H, Peng K, Chen J, M'koma A. Outcomes of Pediatric Patients with Crohn’s Disease Received Infliximab or Exclusive Enteral Nutrition during Induction Remission. Gastroenterology Research and Practice 2022;2022:1-9. [DOI: 10.1155/2022/3813915] [Reference Citation Analysis]
2 Aloi M, D'Arcangelo G, Rossetti D, Bucherini S, Felici E, Romano C, Martinelli M, Dipasquale V, Lionetti P, Oliva S. Occurrence and Clinical Impact of Eosinophilic Esophagitis in a Large Cohort of Children With Inflammatory Bowel Disease. Inflamm Bowel Dis 2022:izac172. [PMID: 35942651 DOI: 10.1093/ibd/izac172] [Reference Citation Analysis]
3 Dipasquale V, Romano C. Genes vs environment in inflammatory bowel disease: an update. Expert Rev Clin Immunol 2022. [PMID: 35912838 DOI: 10.1080/1744666X.2022.2108407] [Reference Citation Analysis]
4 El Koofy NM, Moawad EMI, Yassin NA, Almohammady MN, Ibrahim GS, El Mougy FA, El Ayadi AA, Tarek S. Basic anthropometry, micronutrients status and growth velocity of patients with early-onset inflammatory bowel disease: A prospective cohort study. Arab J Gastroenterol 2022:S1687-1979(22)00056-9. [PMID: 35918289 DOI: 10.1016/j.ajg.2022.06.004] [Reference Citation Analysis]
5 Kwon Y, Kim ES, Choe YH, Kim MJ. How has the disease course of pediatric ulcerative colitis changed throughout the biologics era? A comparison with the IBSEN study. World J Gastroenterol 2022; 28(28): 3666-3681 [DOI: 10.3748/wjg.v28.i28.3666] [Reference Citation Analysis]
6 Choi SY, Kim ES, Jeon TY, Lee YM, Lee SM, Choe B, Choe YH, Kang B. Transmural healing evaluated by magnetic resonance enterography in paediatric patients with Crohn's disease receiving maintenance treatment with biologics. Aliment Pharmacol Ther. [DOI: 10.1111/apt.17161] [Reference Citation Analysis]
7 Dipasquale V, Pellegrino S, Ventimiglia M, Cucinotta U, Citrano M, Graziano F, Cappello M, Busacca A, Orlando A, Accomando S, Romano C; Sicilian Network for Inflammatory Bowel Disease. Real-life experience of infliximab biosimilar in pediatric-onset inflammatory bowel disease: data from the Sicilian Network for Inflammatory Bowel Disease. Eur J Gastroenterol Hepatol 2022. [PMID: 35830365 DOI: 10.1097/MEG.0000000000002408] [Reference Citation Analysis]
8 Choe YJ, Han K, Shim JO. Treatment patterns of anti‐tumour necrosis factor‐alpha and prognosis of paediatric and adult‐onset inflammatory bowel disease in Korea: a nationwide population‐based study. Aliment Pharmacol Ther. [DOI: 10.1111/apt.17125] [Reference Citation Analysis]
9 Constant BD, de Zoeten EF, Weinman JP, Albenberg L, Scott FI. Early Anti-Tumor-Necrosis-Factor Therapy for Crohn's Disease-Related Abdominal Abscesses and Phlegmon in Children. Dig Dis Sci 2022. [PMID: 35790702 DOI: 10.1007/s10620-022-07604-7] [Reference Citation Analysis]
10 Klomberg RCW, Aardoom MA, Kemos P, Rizopoulos D, Ruemmele FM, Croft NM, de Ridder L, Neyt M; PIBD-SET Quality consortium. High Impact of Pediatric Inflammatory Bowel Disease on Caregivers' Work Productivity and Daily Activities: An International Prospective Study. J Pediatr 2022;246:95-102.e4. [PMID: 35429506 DOI: 10.1016/j.jpeds.2022.04.014] [Reference Citation Analysis]
11 Attauabi M, Madsen GR, Bendtsen F, Wewer AV, Wilkens R, Ilvemark J, Vladimirova N, Jensen AB, Jensen FK, Hansen SB, Siebner HR, Nielsen YJW, Møller JM, Thomsen HS, Thomsen SF, Ingels HAS, Theede K, Boysen T, Bjerrum JT, Jakobsen C, Dorn-Rasmussen M, Jansson S, Yao Y, Burian EA, Møller FT, Fana V, Wiell C, Terslev L, Østergaard M, Bertl K, Stavropoulos A, Seidelin JB, Burisch J. Influence of Genetics, Immunity and the Microbiome on the Prognosis of Inflammatory Bowel Disease (IBD Prognosis Study): the protocol for a Copenhagen IBD Inception Cohort Study. BMJ Open 2022;12:e055779. [PMID: 35760545 DOI: 10.1136/bmjopen-2021-055779] [Reference Citation Analysis]
12 Atia O, Pujol-Muncunill G, Navas-López VM, Orlanski-Meyer E, Ledder O, Lev-Tzion R, Focht G, Shteyer E, Stein R, Aloi M, Russell RK, Martin-de-Carpi J, Turner D. Children included in randomised controlled trials of biologics in inflammatory bowel diseases do not represent the real-world patient-mix. Aliment Pharmacol Ther 2022. [PMID: 35735987 DOI: 10.1111/apt.17092] [Reference Citation Analysis]
13 van Unen V, Ouboter LF, Li N, Schreurs M, Abdelaal T, Kooy-winkelaar Y, Beyrend G, Höllt T, Maljaars PWJ, Mearin ML, Mahfouz A, Witte AMC, Clemens CHM, Abraham S, Escher JC, Lelieveldt BPF, Pascutti MF, van der Meulen – de Jong AE, Koning F. Identification of a Disease-Associated Network of Intestinal Immune Cells in Treatment-Naive Inflammatory Bowel Disease. Front Immunol 2022;13:893803. [DOI: 10.3389/fimmu.2022.893803] [Reference Citation Analysis]
14 Olbjørn C, Småstuen MC, Moen AEF. Targeted Analysis of the Gut Microbiome for Diagnosis, Prognosis and Treatment Individualization in Pediatric Inflammatory Bowel Disease. Microorganisms 2022;10:1273. [DOI: 10.3390/microorganisms10071273] [Reference Citation Analysis]
15 Gordon RJ, Pappa HM, Vajapeyam S, Mulkern R, Ecklund K, Snapper SB, Gordon CM. Bone marrow adiposity in pediatric Crohn's disease. Bone 2022. [DOI: 10.1016/j.bone.2022.116453] [Reference Citation Analysis]
16 Krawiec P, Opoka-winiarska V, Pac-kożuchowska E. Is It Inflammatory Bowel Disease Flare or Pediatric Inflammatory Multisystem Syndrome Temporally Associated with COVID-19? JCM 2022;11:2765. [DOI: 10.3390/jcm11102765] [Reference Citation Analysis]
17 Huang JG, Wong YKY, Chew KS, Tanpowpong P, Calixto Mercado KS, Reodica A, Rajindrajith S, Chang KC, Ni YH, Treepongkaruna S, Lee WS, Aw MM. Epidemiological characteristics of Asian children with inflammatory bowel disease at diagnosis: Insights from an Asian-Pacific multi-centre registry network. World J Gastroenterol 2022; 28(17): 1830-1844 [PMID: 35633913 DOI: 10.3748/wjg.v28.i17.1830] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Mouratidou N, Malmborg P, Järås J, Sigurdsson V, Sandström O, Fagerberg UL, Bröms G, Ludvigsson JF, Olén O; SWIBREG Study Group. Identification of Childhood-Onset Inflammatory Bowel Disease in Swedish Healthcare Registers: A Validation Study. Clin Epidemiol 2022;14:591-600. [PMID: 35520278 DOI: 10.2147/CLEP.S358031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Arcucci MS, Contreras MB, Gallo J, Antoniska MA, Busoni V, Tennina C, D'Agostino D, Kakisu MH, Weyersberg C, Orsi M. Pediatric Inflammatory Bowel Disease: A Multicenter Study of Changing Trends in Argentina Over the Past 30 Years. Pediatr Gastroenterol Hepatol Nutr 2022;25:218-27. [PMID: 35611373 DOI: 10.5223/pghn.2022.25.3.218] [Reference Citation Analysis]
20 Matar M, Levi R, Zvuloni M, Shamir R, Assa A. Pediatric inflammatory bowel disease: Fecal calprotectin response to Anti-tumor necrosis factor alpha. Pediatr Res 2022. [PMID: 35379929 DOI: 10.1038/s41390-022-02045-4] [Reference Citation Analysis]
21 Albayrak NE, Polydorides AD. Characteristics and Outcomes of Left-sided Ulcerative Colitis With a Cecal/Periappendiceal Patch of Inflammation. Am J Surg Pathol 2022. [PMID: 35354161 DOI: 10.1097/PAS.0000000000001883] [Reference Citation Analysis]
22 Gerenli N, Sozeri B, Kalin S, Kirmizibekmez H, Celtik C. Sacroiliac joint involvement in children with inflammatory bowel diseases. North Clin Istanb 2022;9:57-63. [PMID: 35340318 DOI: 10.14744/nci.2021.24572] [Reference Citation Analysis]
23 Sturm A, Atreya R, Bettenworth D, Bokemeyer B, Dignaß A, Ehehalt R, Germer C, Grunert PC, Helwig U, Herrlinger K, Kienle P, Kreis ME, Kucharzik T, Langhorst J, Maaser C, Ockenga J, Ott C, Siegmund B, Zeißig S, Stallmach A; Collaborators:. Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – August 2021 – AWMF-Registernummer: 021-004. Z Gastroenterol 2022;60:332-418. [PMID: 35263784 DOI: 10.1055/a-1713-3941] [Reference Citation Analysis]
24 Rinawi F, Popalis C, Tersigni C, Frost K, Muise A, Church PC, Walters TD, Ricciuto A, Griffiths AM. Long-Term Outcomes With Adalimumab Therapy in Pediatric Crohn Disease: Associations With Adalimumab Exposure. J Pediatr Gastroenterol Nutr 2022;74:389-95. [PMID: 35226647 DOI: 10.1097/MPG.0000000000003366] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Śledzińska K, Landowski P, Żmijewski MA, Kamińska B, Kowalski K, Liberek A. Diet, Sun, Physical Activity and Vitamin D Status in Children with Inflammatory Bowel Disease. Nutrients 2022;14:1029. [PMID: 35268001 DOI: 10.3390/nu14051029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
26 Tegtmeyer D, Flemming G, Klemann C. Chronisch-entzündliche Darmerkrankung: Die Nadel im Heuhaufen: Wann steckt ein angeborener Immundefekt dahinter? Monatsschr Kinderheilkd. [DOI: 10.1007/s00112-022-01425-8] [Reference Citation Analysis]
27 Kuloglu Z, Çetin F, Urgancı N, Önal Z, Sarı S, Yüksekkaya H, Çaltepe G, Kutluk G, Dumlupinar E; Turkish Inflammatory Bowel Disease Study Group. Nutritional characteristic of children with inflammatory bowel disease in the nationwide inflammatory bowel disease registry from the Mediterranean region. Eur J Clin Nutr 2022. [PMID: 35173290 DOI: 10.1038/s41430-022-01094-6] [Reference Citation Analysis]
28 Bosa L, Di Chiara C, Gaio P, Cosma C, Padoan A, Cozzani S, Perilongo G, Plebani M, Giaquinto C, Donà D, Cananzi M. Protective SARS-CoV-2 Antibody Response in Children With Inflammatory Bowel Disease. Front Pediatr 2022;10:815857. [DOI: 10.3389/fped.2022.815857] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Alvisi P, Labriola F, Scarallo L, Gandullia P, Knafelz D, Bramuzzo M, Zuin G, Pastore MR, Illiceto MT, Miele E, Graziano F, Romano C, Bartoletti D, Oliva S, Arrigo S, Bracci F, Renzo S, Agrusti A, Aloi M, Lionetti P; SIGENP IBD Working Group. Epidemiological trends of pediatric IBD in Italy: A 10-year analysis of the Italian society of pediatric gastroenterology, hepatology and nutrition registry. Dig Liver Dis 2022:S1590-8658(22)00001-9. [PMID: 35125313 DOI: 10.1016/j.dld.2021.12.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
30 Derfalvi B, Boros KK, Szabo D, Bozsaki G, Cseh A, Rudas G, Muller KE, Veres G. Joint involvement, disease activity and quality of life in pediatric Crohn’s disease – a cross-sectional study. Pediatr Rheumatol 2022;20. [DOI: 10.1186/s12969-022-00664-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Wasilewska A, Ponanta-gawron K, Burtan B, Stephen Chandra Sagaran C, Duplaga M, Kowalska-duplaga K. Exclusive Enteral Nutrition Remission Induction Treatment Influence on Transient Hypertransaminasemia in Children with Newly Onset Crohn's Disease. Journal of Medicinal Food. [DOI: 10.1089/jmf.2021.0069] [Reference Citation Analysis]
32 Labriola F, Marcato C, Zarbo C, Betti L, Catelli A, Valerii MC, Spisni E, Alvisi P. Dietary Habits of a Group of Children with Crohn’s Disease Compared to Healthy Subjects: Assessment of Risk of Nutritional Deficiencies through a Bromatological Analysis. Nutrients 2022;14:499. [DOI: 10.3390/nu14030499] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Choe JY, Choi S, Song KH, Jang HJ, Choi KH, Yi DY, Hong SJ, Hwang JH, Cho SM, Kim YJ, Choe BH, Kang B. Incidence and Prevalence Trends of Pediatric Inflammatory Bowel Disease in the Daegu-Kyungpook Province From 2017 to 2020. Front Pediatr 2021;9:810173. [PMID: 35059365 DOI: 10.3389/fped.2021.810173] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Singh A, Wall C, Levine A, Midha V, Mahajan R, Sood A. Nutritional screening and assessment in inflammatory bowel disease. Indian J Gastroenterol 2022. [PMID: 35031977 DOI: 10.1007/s12664-021-01223-2] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
35 Jeong TJ, Kim ES, Kwon Y, Kim S, Seo SW, Choe YH, Kim MJ. Discontinuation of Azathioprine could be considered in pediatric patients with Crohn's disease who have sustained clinical and deep remission. Sci Rep 2022;12:507. [PMID: 35017546 DOI: 10.1038/s41598-021-04304-6] [Reference Citation Analysis]
36 Kuenzig ME, Fung SG, Marderfeld L, Mak JWY, Kaplan GG, Ng SC, Wilson DC, Cameron F, Henderson P, Kotze PG, Bhatti J, Fang V, Gerber S, Guay E, Kotteduwa Jayawarden S, Kadota L, Maldonado D F, Osei JA, Sandarage R, Stanton A, Wan M, Benchimol EI; InsightScope Pediatric IBD Epidemiology Group. Twenty-first Century Trends in the Global Epidemiology of Pediatric-Onset Inflammatory Bowel Disease: Systematic Review. Gastroenterology 2022;162:1147-1159.e4. [PMID: 34995526 DOI: 10.1053/j.gastro.2021.12.282] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 19.0] [Reference Citation Analysis]
37 D'Arcangelo G, Abi Nader E, Charbit-Henrion F, Talbotec C, Goulet O, Ruemmele FM, Pigneur B. Increased Use of Anti-Tumor Necrosis Factor Following the Implementation of the ECCO-ESPGHAN Guidelines and its Impact on the Outcome of Pediatric Crohn's Disease: A Retrospective Single-Center Study. J Pediatr Gastroenterol Nutr 2022;74:79-84. [PMID: 34962501 DOI: 10.1097/MPG.0000000000003301] [Reference Citation Analysis]
38 Jongsma MME, Aardoom MA, Cozijnsen MA, van Pieterson M, de Meij T, Groeneweg M, Norbruis OF, Wolters VM, van Wering HM, Hojsak I, Kolho KL, Hummel T, Stapelbroek J, van der Feen C, van Rheenen PF, van Wijk MP, Teklenburg-Roord STA, Schreurs MWJ, Rizopoulos D, Doukas M, Escher JC, Samsom JN, de Ridder L. First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn's disease: an open-label multicentre randomised controlled trial. Gut 2022;71:34-42. [PMID: 33384335 DOI: 10.1136/gutjnl-2020-322339] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 17.0] [Reference Citation Analysis]
39 Burgess CJ, Clark C, Khedim CA, Armstrong K, Henderson P, Wilson DC. Recognising and Treating Complicated Fissuring Perianal Crohn Disease: A South-East Scotland Cohort Study. J Pediatr Gastroenterol Nutr 2022;74:68-71. [PMID: 34962500 DOI: 10.1097/MPG.0000000000003285] [Reference Citation Analysis]
40 Hu W, Feng Y, Ye Z, Tang Z, Qian L, Wang Y, Huang Y. The Association Between Genetic Variants, Pharmacokinetics, and Infliximab Efficacy in Pediatric Patients With Crohn's Disease in China. Front Pediatr 2021;9:744599. [PMID: 34966700 DOI: 10.3389/fped.2021.744599] [Reference Citation Analysis]
41 Adler J, Eder SJ, Gebremariam A, Moran CJ, Bass LM, Moses J, Lewis JD, Singer AAM, Morhardt TL, Picoraro JA, Cardenas V, Zacur GM, Colletti RB. Quantification of Mucosal Activity from Colonoscopy Reports via the Simplified Endoscopic Mucosal Assessment for Crohn's Disease. Inflamm Bowel Dis 2021:izab315. [PMID: 34964861 DOI: 10.1093/ibd/izab315] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Sassine S, Zekhnine S, Qaddouri M, Djani L, Cambron-Asselin C, Savoie-Robichaud M, Lin YF, Grzywacz K, Groleau V, Dirks M, Drouin É, Halac U, Marchand V, Girard C, Courbette O, Patey N, Dal Soglio D, Deslandres C, Jantchou P. Factors associated with time to clinical remission in pediatric luminal Crohn's disease: A retrospective cohort study. JGH Open 2021;5:1373-81. [PMID: 34950781 DOI: 10.1002/jgh3.12684] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Colman RJ, Xiong Y, Mizuno T, Hyams JS, Noe JD, Boyle B, D'Haens GR, van Limbergen J, Chun K, Yang J, Rosen MJ, Denson LA, Vinks AA, Minar P. Antibodies-to-infliximab accelerate clearance while dose intensification reverses immunogenicity and recaptures clinical response in paediatric Crohn's disease. Aliment Pharmacol Ther 2021. [PMID: 34935161 DOI: 10.1111/apt.16733] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Gkikas K, Logan M, Nichols B, Ijaz UZ, Clark CM, Svolos V, Gervais L, Duncan H, Garrick V, Curtis L, Buchanan E, Cardigan T, Armstrong L, Delahunty C, Flynn DM, Barclay AR, Tayler R, Milling S, Hansen R, Russell RK, Gerasimidis K. Dietary triggers of gut inflammation following exclusive enteral nutrition in children with Crohn's disease: a pilot study. BMC Gastroenterol 2021;21:454. [PMID: 34861829 DOI: 10.1186/s12876-021-02029-4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
45 Bayrak NA, Polat E, Erdogan F. Cytomegalovirus Colitis in Immunocompetent and Immunocompromised Children: A 2-Center Study. Pediatr Infect Dis J 2021;40:1101-7. [PMID: 34609104 DOI: 10.1097/INF.0000000000003339] [Reference Citation Analysis]
46 Herman R, Dumnicka P, Pieczarkowski S, Fyderek K. Induction of Remission in Pediatric Crohn's Disease Patients Assessed by the Mucosal Inflammation Noninvasive Index. J Clin Med 2021;10:5613. [PMID: 34884315 DOI: 10.3390/jcm10235613] [Reference Citation Analysis]
47 Schwarz J, Vecka M, Stožický F, Pomahačová R, Staňková B, Tvrzická E, Kreslová M, Zahálková R, Sýkora J. The assessment of plasma fatty acid profiles in newly diagnosed treatment-naive paediatric Crohn's disease. Physiol Res 2021;70:799-808. [PMID: 34505533 DOI: 10.33549/physiolres.934665] [Reference Citation Analysis]
48 Um SH, Lee SW, Song KH, Lee SM, Choe BH, Lee YM, Kang B. Incidentally Detected Asymptomatic Perianal Abscess in an Adolescent during Crohn's Disease Diagnosis: Is Routine Pelvic Imaging Required in Korean Pediatric Patients at Diagnosis? Pediatr Gastroenterol Hepatol Nutr 2021;24:564-70. [PMID: 34796101 DOI: 10.5223/pghn.2021.24.6.564] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 Yoon H. Another Piece of Evidence for Early Administration of Biologics in Children with Crohn's Disease Who Start as an Inflammatory Phenotype. Gut Liver 2021;15:791-2. [PMID: 34782486 DOI: 10.5009/gnl210508] [Reference Citation Analysis]
50 Jang HJ, Suh HR, Choi S, Hong SJ, Cho SM, Choi KH, Choe BH, Kang B; Crohn's and Colitis Association in Daegu-Gyeongbuk (CCAiD). Severe Disease Activity Based on the Paris Classification Is Associated with the Development of Extraintestinal Manifestations in Korean Children and Adolescents with Ulcerative Colitis. J Korean Med Sci 2021;36:e278. [PMID: 34783212 DOI: 10.3346/jkms.2021.36.e278] [Reference Citation Analysis]
51 Jagt JZ, Struys EA, Ayada I, Bakkali A, Jansen EEW, Claesen J, van Limbergen JE, Benninga MA, de Boer NKH, de Meij TGJ. Fecal Amino Acid Analysis in Newly Diagnosed Pediatric Inflammatory Bowel Disease: A Multicenter Case-Control Study. Inflamm Bowel Dis 2021:izab256. [PMID: 34757415 DOI: 10.1093/ibd/izab256] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
52 Sandy NS, Marega LF, Bechara GD, Riccetto AGL, Bonfim C, Vilela MMDS, Ribeiro AF, Servidoni MF, Lomazi EA. Elevated IgA and IL-10 levels in very-early-onset inflammatory bowel disease secondary to IL-10 receptor deficiency. Rev Paul Pediatr 2021;40:e2020434. [PMID: 34730757 DOI: 10.1590/1984-0462/2022/40/2020434] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Kim FS, Patel PV, Stekol E, Ali S, Hamandi H, Heyman MB, Verstraete SG. Experience Using Ustekinumab in Pediatric Patients With Medically Refractory Crohn Disease. J Pediatr Gastroenterol Nutr 2021;73:610-4. [PMID: 34415711 DOI: 10.1097/MPG.0000000000003230] [Reference Citation Analysis]
54 Sassine S, Savoie Robichaud M, Lin YF, Djani L, Cambron-Asselin C, Qaddouri M, Zekhnine S, Grzywacz K, Groleau V, Dirks M, Drouin É, Halac U, Marchand V, Girard C, Courbette O, Patey N, Dal Soglio D, Deslandres C, Jantchou P. Changes in the clinical phenotype and behavior of pediatric luminal Crohn's disease at diagnosis in the last decade. Dig Liver Dis 2021:S1590-8658(21)00783-0. [PMID: 34756526 DOI: 10.1016/j.dld.2021.09.012] [Reference Citation Analysis]
55 Salvador-Martín S, Melgarejo-Ortuño A, López-Fernández LA. Biomarkers for Optimization and Personalization of Anti-TNFs in Pediatric Inflammatory Bowel Disease. Pharmaceutics 2021;13:1786. [PMID: 34834201 DOI: 10.3390/pharmaceutics13111786] [Reference Citation Analysis]
56 Spencer EA, Klang E, Dolinger M, Pittman N, Dubinsky MC. Seroconversion Following SARS-CoV-2 Infection or Vaccination in Pediatric IBD Patients. Inflamm Bowel Dis 2021;27:1862-4. [PMID: 34427638 DOI: 10.1093/ibd/izab194] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
57 Müller KE, Dezsőfi A, Cseh Á, Szűcs D, Vass N, Nemes É, Kadenczki O, Tárnok A, Szakos E, Guthy I, Kovács M, Karoliny A, Czelecz J, Tokodi I, Tomsits E, Veres G. Adherence to the Porto Criteria Based on the Hungarian Nationwide Pediatric Inflammatory Bowel Disease Registry (HUPIR). Front Pediatr 2021;9:710631. [PMID: 34631616 DOI: 10.3389/fped.2021.710631] [Reference Citation Analysis]
58 Sherlock ME, Zachos M, Issenman RM, Mulder DJ. Clinical and Laboratory Characteristics Are Associated With Biologic Therapy Use in Pediatric Inflammatory Bowel Disease: A Retrospective Cohort Study. J Can Assoc Gastroenterol 2021;4:e92-e100. [PMID: 34617006 DOI: 10.1093/jcag/gwaa033] [Reference Citation Analysis]
59 Sulkanen E, Repo M, Huhtala H, Hiltunen P, Kurppa K. Impact of diagnostic delay to the clinical presentation and associated factors in pediatric inflammatory bowel disease: a retrospective study. BMC Gastroenterol 2021;21:364. [PMID: 34620103 DOI: 10.1186/s12876-021-01938-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
60 El Amrousy D, El Ashry H, Hodeib H, Hassan S. Vitamin D in Children With Inflammatory Bowel Disease: A Randomized Controlled Clinical Trial. J Clin Gastroenterol 2021;55:815-20. [PMID: 33060436 DOI: 10.1097/MCG.0000000000001443] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
61 Shentova-eneva R, Kofinova D, Hadzhiyski P, Yaneva P, Lazarova E, Baycheva M. Anemia in Newly Diagnosed Pediatric Patients with Inflammatory Bowel Disease. Gastroenterology Insights 2021;12:376-83. [DOI: 10.3390/gastroent12040036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Hellmann J, Andersen H, Fei L, Linn A, Bezold R, Lake K, Jackson K, Meyer D, Dirksing K, Bonkowski E, Ollberding NJ, Haslam DB, Denson L. Microbial Shifts and Shorter Time to Bowel Resection Surgery Associated with C. difficile in Pediatric Crohn's Disease. Inflamm Bowel Dis 2020;26:1212-21. [PMID: 31725875 DOI: 10.1093/ibd/izz263] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
63 Lehtomäki J, Nikkonen A, Merras-Salmio L, Hiltunen P, Kolho KL. Therapy outcome related to adalimumab trough levels in pediatric patients with inflammatory bowel disease. Scand J Gastroenterol 2021;:1-6. [PMID: 34546843 DOI: 10.1080/00365521.2021.1977843] [Reference Citation Analysis]
64 Kamel S, Sakr M, Hamed W, Eltabbakh M, Sherief A, Rashad H, Elghamrini Y, Elbaz A. Characterization of Crohn's disease patients in Egypt: Risk factors for postoperative recurrence (A cohort study). Ann Med Surg (Lond) 2021;69:102781. [PMID: 34527234 DOI: 10.1016/j.amsu.2021.102781] [Reference Citation Analysis]
65 Kim MJ, Kim E, Kang B, Lee Y, Kang ES, Choe YH. Anti-Saccharomyces cerevisiae Antibody in Pediatric Crohn's Disease Patients without Mucosal Healing Is a Useful Marker of Mucosal Damage. Gut Liver 2021;15:763-70. [PMID: 33376230 DOI: 10.5009/gnl20212] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Jones CMA, Connors J, Dunn KA, Bielawski JP, Comeau AM, Langille MGI, Van Limbergen J. Bacterial Taxa and Functions Are Predictive of Sustained Remission Following Exclusive Enteral Nutrition in Pediatric Crohn's Disease. Inflamm Bowel Dis 2020;26:1026-37. [PMID: 31961432 DOI: 10.1093/ibd/izaa001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 17.0] [Reference Citation Analysis]
67 Liang G, Conrad MA, Kelsen JR, Kessler LR, Breton J, Albenberg LG, Marakos S, Galgano A, Devas N, Erlichman J, Zhang H, Mattei L, Bittinger K, Baldassano RN, Bushman FD. Dynamics of the Stool Virome in Very Early-Onset Inflammatory Bowel Disease. J Crohns Colitis 2020;14:1600-10. [PMID: 32406906 DOI: 10.1093/ecco-jcc/jjaa094] [Cited by in Crossref: 7] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
68 van Hoeve K, Seyed Tabib NS, Dreesen E, Tops S, Hoffman I, Gils A, Ferrante M, Vermeire S. Infliximab Concentrations during Induction Are Predictive for Endoscopic Remission in Pediatric Patients with Inflammatory Bowel Disease under Combination Therapy. J Pediatr 2022;240:150-157.e4. [PMID: 34481805 DOI: 10.1016/j.jpeds.2021.08.079] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
69 Starr AE, Deeke SA, Ning Z, de Nanassy J, Singleton R, Benchimol EI, Mack DR, Stintzi A, Figeys D. Associations between Cellular Energy and Pediatric Inflammatory Bowel Disease Patient Response to Treatment. J Proteome Res 2021;20:4393-404. [PMID: 34424714 DOI: 10.1021/acs.jproteome.1c00341] [Reference Citation Analysis]
70 Kandavel P, Eder SJ, Adler J; ImproveCareNow Network Pediatric IBD Learning Health System. Reduced Systemic Corticosteroid Use among Pediatric Patients With Inflammatory Bowel Disease in a Large Learning Health System. J Pediatr Gastroenterol Nutr 2021;73:345-51. [PMID: 34415262 DOI: 10.1097/MPG.0000000000003182] [Reference Citation Analysis]
71 Kim ES, Song JS, Ki CS, Choe YH, Kang B. Development of Crohn's Disease in a Child With SLC26A3-related Congenital Chloride Diarrhea: Report of the First Case in East Asia and a Novel Missense Variant. Ann Lab Med 2021;41:255-7. [PMID: 33063691 DOI: 10.3343/alm.2021.41.2.255] [Reference Citation Analysis]
72 Napolitano M, Munari AM, Di Leo G, Panarisi NAR, Zuin G, Fava G, Vecchi M, Sardanelli F, Zuccotti GV. MR enterography grading of pediatric ileocolonic Crohn disease activity based on a single bowel segment. Radiol Med 2021;126:1396-406. [PMID: 34414550 DOI: 10.1007/s11547-021-01409-w] [Reference Citation Analysis]
73 Sainz E, Zabana Y, Miguel I, Fernández-Clotet A, Beltrán B, Núñez L, García MJ, Martín-Arranz MD, Iglesias E, Cañete F, Gutiérrez A, Piqueras M, Pérez-Martínez I, Bujanda L, Rodríguez-Lago I, Casanova MJ, Navarro P, Vicente R, Merino O, Algaba A, Rodríguez C, Huguet JM, Fernández-Bañares F, Domènech E, Esteve M; ENEIDA registry of GETECCU. Clinical features, therapeutic requirements and evolution of patients with Crohn's disease and upper gastrointestinal involvement (CROHNEX study). Aliment Pharmacol Ther 2021;54:1041-51. [PMID: 34406676 DOI: 10.1111/apt.16547] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
74 Dhaliwal J, Carroll MW, deBruyn JC, Ricciuto A, Benchimol EI, Lawrence S, Sherlock M, El-Matary W, Brill H, Church P, Wine E, Carman N, Muise A, Huynh H, Mack D, Walters TD, Griffiths AM, Jacobson K. The phenotypic spectrum of new onset IBD in Canadian children of South Asian ethnicity: A prospective multi-centre comparative study. J Crohns Colitis 2021:jjab143. [PMID: 34379117 DOI: 10.1093/ecco-jcc/jjab143] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
75 deBruyn JCC, Jacobson K, El-Matary W, Wine E, Carroll MW, Goedhart C, Panaccione R, Wrobel IT, Huynh HQ. Early Serum Infliximab Levels in Pediatric Ulcerative Colitis. Front Pediatr 2021;9:668978. [PMID: 34395336 DOI: 10.3389/fped.2021.668978] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
76 Steell L, Johnston BA, Dewantoro D, Foster JE, Gaya DR, Macdonald J, McMillan M, Russell RK, Seenan JP, Ahmed SF, Gray SR, Wong SC. Muscle deficits with normal bone microarchitecture and geometry in young adults with well-controlled childhood-onset Crohn's disease. Eur J Gastroenterol Hepatol 2020;32:1497-506. [PMID: 32675776 DOI: 10.1097/MEG.0000000000001838] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Jasielska M, Grzybowska-Chlebowczyk U. Hypocalcemia and Vitamin D Deficiency in Children with Inflammatory Bowel Diseases and Lactose Intolerance. Nutrients 2021;13:2583. [PMID: 34444743 DOI: 10.3390/nu13082583] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
78 Saez A, Gomez-Bris R, Herrero-Fernandez B, Mingorance C, Rius C, Gonzalez-Granado JM. Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease. Int J Mol Sci 2021;22:7618. [PMID: 34299236 DOI: 10.3390/ijms22147618] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 15.0] [Reference Citation Analysis]
79 Rashidian A, Dejban P, Karami Fard K, Abdollahi A, Chamanara M, Dehpour A, Hasanvand A. Bupropion Ameliorates Acetic Acid-Induced Colitis in Rat: the Involvement of the TLR4/NF-kB Signaling Pathway. Inflammation 2020;43:1999-2009. [PMID: 32594336 DOI: 10.1007/s10753-020-01273-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
80 Kelsen JR, Conrad MA, Dawany N, Patel T, Shraim R, Merz A, Maurer K, Sullivan KE, Devoto M. The Unique Disease Course of Children with Very Early onset-Inflammatory Bowel Disease. Inflamm Bowel Dis 2020;26:909-18. [PMID: 31560377 DOI: 10.1093/ibd/izz214] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
81 Ouahed J, Spencer E, Kotlarz D, Shouval DS, Kowalik M, Peng K, Field M, Grushkin-Lerner L, Pai SY, Bousvaros A, Cho J, Argmann C, Schadt E, Mcgovern DPB, Mokry M, Nieuwenhuis E, Clevers H, Powrie F, Uhlig H, Klein C, Muise A, Dubinsky M, Snapper SB. Very Early Onset Inflammatory Bowel Disease: A Clinical Approach With a Focus on the Role of Genetics and Underlying Immune Deficiencies. Inflamm Bowel Dis 2020;26:820-42. [PMID: 31833544 DOI: 10.1093/ibd/izz259] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 44.0] [Reference Citation Analysis]
82 Steien DB, Dillman JR, Lopez MJ, Ehrlich P, Adler J. Morphometric Changes in Children With Small Bowel Crohn Disease During Induction of Therapy: A Pilot Study. J Pediatr Gastroenterol Nutr 2021;72:603-9. [PMID: 33264183 DOI: 10.1097/MPG.0000000000003009] [Reference Citation Analysis]
83 Hizarcioglu-Gulsen H, Kaplan JL, Moran CJ, Israel EJ, Lee H, Winter H. The Impact of Vitamin D on Response to Anti-tumor Necrosis Factor-α Therapy in Children With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2021;72:e125-31. [PMID: 33847289 DOI: 10.1097/MPG.0000000000003064] [Reference Citation Analysis]
84 Scarallo L, Alvisi P, Bolasco G, Di Toma M, Lanari M, Cangiari A, Paci M, Naldini S, Renzo S, Barp J, De Masi S, Lionetti P. Mucosal and Histologic Healing in Children With Inflammatory Bowel Disease Treated With Antitumor Necrosis Factor-Alpha. J Pediatr Gastroenterol Nutr 2021;72:728-35. [PMID: 33399329 DOI: 10.1097/MPG.0000000000003043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
85 Kim MJ, Kim E, Kang B, Choe YH. Therapeutic Drug Monitoring of Adalimumab During Long-term Follow-up in Paediatric Patients With Crohn Disease. J Pediatr Gastroenterol Nutr 2021;72:870-6. [PMID: 33908743 DOI: 10.1097/MPG.0000000000003070] [Reference Citation Analysis]
86 Mitchel EB, Rosenbaum S, Gaeta C, Huang J, Raffini LJ, Baldassano RN, Denburg MR, Albenberg L. Venous Thromboembolism in Pediatric Inflammatory Bowel Disease: A Case-Control Study. J Pediatr Gastroenterol Nutr 2021;72:742-7. [PMID: 33605670 DOI: 10.1097/MPG.0000000000003078] [Reference Citation Analysis]
87 Atlan L, Cohen S, Shiran S, Sira LB, Pratt LT, Yerushalmy-Feler A. Sarcopenia is a Predictor for Adverse Clinical Outcome in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2021;72:883-8. [PMID: 33720095 DOI: 10.1097/MPG.0000000000003091] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 Ito N, Takeuchi I, Kyodo R, Hirano Y, Sato T, Usami M, Shimizu H, Shimizu T, Arai K. Features and Outcomes of Children with Ulcerative Colitis who Undergo a Diagnostic Change: A Single-Center Experience. Pediatr Gastroenterol Hepatol Nutr 2021;24:357-65. [PMID: 34316470 DOI: 10.5223/pghn.2021.24.4.357] [Reference Citation Analysis]
89 Ludvigsson JF, Sachs MC, Järås J, Malmborg P, Olén O. Serious Infections in Pediatric Inflammatory Bowel Disease 2002-2017-A Nationwide Cohort Study. J Pediatr 2021:S0022-3476(21)00658-2. [PMID: 34216628 DOI: 10.1016/j.jpeds.2021.06.076] [Reference Citation Analysis]
90 Halligan S, Boone D, Archer L, Ahmad T, Bloom S, Rodriguez-Justo M, Taylor SA, Mallett S. Prognostic biomarkers to identify patients likely to develop severe Crohn's disease: a systematic review. Health Technol Assess 2021;25:1-66. [PMID: 34225839 DOI: 10.3310/hta25450] [Reference Citation Analysis]
91 Cananzi M, Wohler E, Marzollo A, Colavito D, You J, Jing H, Bresolin S, Gaio P, Martin R, Mescoli C, Bade S, Posey JE, Dalle Carbonare M, Tung W, Jhangiani SN, Bosa L, Zhang Y, Filho JS, Gabelli M, Kellermayer R, Kader HA, Oliva-Hemker M, Perilongo G, Lupski JR, Biffi A, Valle D, Leon A, de Macena Sobreira NL, Su HC, Guerrerio AL. IFIH1 loss-of-function variants contribute to very early-onset inflammatory bowel disease. Hum Genet 2021;140:1299-312. [PMID: 34185153 DOI: 10.1007/s00439-021-02300-4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
92 Kim MJ, Kim E, Kang B, Choe YH. Infliximab Therapy for Children with Moderate to Severe Ulcerative Colitis: A Step-Up versus a Top-Down Strategy. Yonsei Med J 2021;62:608-14. [PMID: 34164958 DOI: 10.3349/ymj.2021.62.7.608] [Reference Citation Analysis]
93 Stallard L, Hussey S. Endoscopic and Histologic Predictors of Outcomes in Pediatric Ulcerative Colitis-Caveat Emptor. Front Pediatr 2021;9:678132. [PMID: 34249815 DOI: 10.3389/fped.2021.678132] [Reference Citation Analysis]
94 McGillis L, Bronte-Tinkew DM, Dang F, Capurro M, Prashar A, Ricciuto A, Greenfield L, Lozano-Ruf A, Siddiqui I, Hsieh A, Church P, Walters T, Roth DE, Griffiths A, Philpott D, Jones NL. Vitamin D deficiency enhances expression of autophagy-regulating miR-142-3p in mouse and "involved" IBD patient intestinal tissues. Am J Physiol Gastrointest Liver Physiol 2021;321:G171-84. [PMID: 34159811 DOI: 10.1152/ajpgi.00398.2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
95 Grandmougin A, D'Amico F, Remen T, Danese S, Bonneton M, Galloy MA, Peyrin-Biroulet L, Laurent V. Role of Cross-Sectional Imaging in Pediatric Inflammatory Bowel Disease. Dig Dis Sci 2021. [PMID: 34159487 DOI: 10.1007/s10620-021-07016-z] [Reference Citation Analysis]
96 Choshen S, Turner D, Pratt LT, Precel R, Greer ML, Castro DA, Assa A, Martínez-León MI, Herman-Sucharska I, Coppenrath E, Konen O, Davila J, Bekhit E, Alsabban Z, Focht G, Gavish M, Griffiths A, Cytter-Kuint R. Development and Validation of a Pediatric MRI-Based Perianal Crohn Disease (PEMPAC) Index-A Report from the ImageKids Study. Inflamm Bowel Dis 2021:izab147. [PMID: 34151950 DOI: 10.1093/ibd/izab147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Bosch S, El Manouni El Hassani S, Brizzio Brentar M, Ayada I, Bakkali A, Jansen EEW, Struys EA, Benninga MA, de Boer NKH, de Meij TGJ. Fecal Amino Acid Profiles Exceed Accuracy of Serum Amino Acids in Diagnosing Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2020;71:371-5. [PMID: 32404754 DOI: 10.1097/MPG.0000000000002770] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
98 Ronel N, Tzion RL, Orlanski-Meyer E, Shteyer E, Guz-Mark A, Assa A, Strich D, Turner D, Ledder O. Clinical Criteria Can Identify Children With Osteopenia in Newly Diagnosed Crohn Disease. J Pediatr Gastroenterol Nutr 2021;72:270-5. [PMID: 32810035 DOI: 10.1097/MPG.0000000000002911] [Reference Citation Analysis]
99 Uhlig HH, Charbit-Henrion F, Kotlarz D, Shouval DS, Schwerd T, Strisciuglio C, de Ridder L, van Limbergen J, Macchi M, Snapper SB, Ruemmele FM, Wilson DC, Travis SPL, Griffiths AM, Turner D, Klein C, Muise AM, Russell RK; Paediatric IBD Porto group of ESPGHAN. Clinical Genomics for the Diagnosis of Monogenic Forms of Inflammatory Bowel Disease: A Position Paper From the Paediatric IBD Porto Group of European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2021;72:456-73. [PMID: 33346580 DOI: 10.1097/MPG.0000000000003017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
100 D'Arcangelo G, Distante M, Raso T, Rossetti D, Catassi G, Aloi M. Safety of Biological Therapy in Children With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2021;72:736-41. [PMID: 33416268 DOI: 10.1097/MPG.0000000000003044] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
101 Jabandziev P, Pinkasova T, Kunovsky L, Papez J, Jouza M, Karlinova B, Novackova M, Urik M, Aulicka S, Slaby O, Bohosova J, Bajerova K, Bajer M, Goel A. Regional Incidence of Inflammatory Bowel Disease in a Czech Pediatric Population: 16 Years of Experience (2002-2017). J Pediatr Gastroenterol Nutr 2020;70:586-92. [PMID: 32058417 DOI: 10.1097/MPG.0000000000002660] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
102 Bramuzzo M, De Carlo C, Arrigo S, Pavanello PM, Canaletti C, Giudici F, Agrusti A, Martelossi S, Di Leo G, Barbi E. Parental Psychological Factors and Quality of Life of Children With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2020;70:211-7. [PMID: 31978019 DOI: 10.1097/MPG.0000000000002548] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
103 Rees WD, Stahl M, Jacobson K, Bressler B, Sly LM, Vallance BA, Steiner TS. Enteroids Derived From Inflammatory Bowel Disease Patients Display Dysregulated Endoplasmic Reticulum Stress Pathways, Leading to Differential Inflammatory Responses and Dendritic Cell Maturation. J Crohns Colitis 2020;14:948-61. [PMID: 31796949 DOI: 10.1093/ecco-jcc/jjz194] [Cited by in Crossref: 11] [Cited by in F6Publishing: 19] [Article Influence: 11.0] [Reference Citation Analysis]
104 Wędrychowicz A, Tomasik P, Kowalska-Duplaga K, Pieczarkowski S, Fyderek K. Plasma elafin, cathelicidin, and α-defensins are increased in paediatric inflammatory Crohn's disease and reflect disease location. Arch Med Sci 2021;17:1114-7. [PMID: 34336040 DOI: 10.5114/aoms/138349] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
105 Ezirike Ladipo J, He Z, Chikwava K, Robbins K, Beri J, Molle-Rios Z. Oncostatin-M Does Not Predict Treatment Response in Inflammatory Bowel Disease in a Pediatric Cohort. J Pediatr Gastroenterol Nutr 2021;73:352-7. [PMID: 34117193 DOI: 10.1097/MPG.0000000000003201] [Reference Citation Analysis]
106 Hung HH, Lee HC, Yeung CY, Wang NL, Tang TY, Winter HS, Kelsen JR, Jiang CB. Importance of early detection of infantile inflammatory bowel disease with defective IL-10 pathway: A case report. Medicine (Baltimore) 2021;100:e25868. [PMID: 34032699 DOI: 10.1097/MD.0000000000025868] [Reference Citation Analysis]
107 Liles E, Irving SA, Dandamudi P, Belongia EA, Daley MF, DeStefano F, Jackson LA, Jacobsen SJ, Kharbanda E, Klein NP, Weintraub E, Naleway AL. Incidence of pediatric inflammatory bowel disease within the Vaccine Safety Datalink network and evaluation of association with rotavirus vaccination. Vaccine 2021;39:3614-20. [PMID: 34052066 DOI: 10.1016/j.vaccine.2021.05.032] [Reference Citation Analysis]
108 Choi S, Moon W. [Pediatric-onset Inflammatory Bowel Disease: What Are Different from Adult in the Treatment?]. Korean J Gastroenterol 2021;77:220-6. [PMID: 34035199 DOI: 10.4166/kjg.2021.067] [Reference Citation Analysis]
109 Dheri AK, Kuenzig ME, Mack DR, Murthy SK, Kaplan GG, Donelle J, Smith G, Benchimol EI. Shifting health care use from hospitalizations and surgeries to outpatient visits in children with inflammatory bowel disease: a population-based cohort study from Ontario, Canada. J Crohns Colitis 2021:jjab095. [PMID: 34019625 DOI: 10.1093/ecco-jcc/jjab095] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
110 Ye X, Wu J, Li J, Wang H. Anterior Gradient Protein 2 Promotes Mucosal Repair in Pediatric Ulcerative Colitis. Biomed Res Int 2021;2021:6483860. [PMID: 34055987 DOI: 10.1155/2021/6483860] [Reference Citation Analysis]
111 Lawrence LS, Heider A, Singer AAM, Neef HC, Adler J. Granulomas in Diagnostic Biopsies Associated With High Risk of Crohn's Complications-But May Be Preventable. Inflamm Bowel Dis 2021:izab109. [PMID: 33999198 DOI: 10.1093/ibd/izab109] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
112 Benchimol EI, Afif W, Plamondon S, Newhook D, Nicholls SG, Lévesque D. Medical Summary Template for the Transfer of Patients with Inflammatory Bowel Disease from Pediatric to Adult Care. Journal of the Canadian Association of Gastroenterology 2022;5:3-11. [DOI: 10.1093/jcag/gwab009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
113 Somineni HK, Weitzner JH, Venkateswaran S, Dodd A, Prince J, Karikaran A, Sauer CG, Abramowicz S, Zwick ME, Cutler DJ, Okou DT, Chopra P, Kugathasan S. Site- and Taxa-Specific Disease-Associated Oral Microbial Structures Distinguish Inflammatory Bowel Diseases. Inflamm Bowel Dis 2021:izab082. [PMID: 34002220 DOI: 10.1093/ibd/izab082] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
114 Chien MM, Chang MH, Chang KC, Chiu YC, Chen HL, Hsu HY, Wu JF. The characteristics of pediatric ulcerative colitis with primary sclerosing cholangitis: A single-center study in Taiwan. Pediatr Neonatol 2021;62:483-90. [PMID: 34074613 DOI: 10.1016/j.pedneo.2021.05.001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
115 Lucafò M, Curci D, Bramuzzo M, Alvisi P, Martelossi S, Silvestri T, Guastalla V, Labriola F, Stocco G, Decorti G. Serum Adalimumab Levels After Induction Are Associated With Long-Term Remission in Children With Inflammatory Bowel Disease. Front Pediatr 2021;9:646671. [PMID: 34017806 DOI: 10.3389/fped.2021.646671] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
116 Corrêa FF, Sdepanian VL. BODY IRON STATUS INDICATORS AND INFLAMMATION INDICATORS DURING INFLAMMATORY BOWEL DISEASE THERAPY IN CHILDREN AND ADOLESCENTES. Arq Gastroenterol 2021;58:48-54. [PMID: 33909796 DOI: 10.1590/S0004-2803.202100000-09] [Reference Citation Analysis]
117 Dhaliwal J, McKay HE, Deslandres C, Debruyn J, Wine E, Wu A, Huynh H, Carman N, Crowley E, Church PC, Walters TD, Ricciuto A, Griffiths AM; Canadian Children IBD Network. One-year outcomes with ustekinumab therapy in infliximab-refractory paediatric ulcerative colitis: a multicentre prospective study. Aliment Pharmacol Ther 2021;53:1300-8. [PMID: 33909911 DOI: 10.1111/apt.16388] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
118 Hyams JS, Brimacombe M, Haberman Y, Walters T, Gibson G, Mo A, Mack D, Griffiths A, Boyle B, LeLeiko N, Markowitz J, Rosh J, Patel A, Shah S, Baldassano R, Pfefferkorn M, Sauer C, Dailey J, Venkateswaran S, Kugathasan S, Denson LA. Clinical and Host Biological Factors Predict Colectomy Risk in Children Newly Diagnosed With Ulcerative Colitis. Inflamm Bowel Dis 2021:izab061. [PMID: 33904583 DOI: 10.1093/ibd/izab061] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
119 Garcia-Romero R, Martinez de Zabarte Fernandez JM, Pujol-Muncunill G, Donat-Aliaga E, Segarra-Cantón O, Irastorza-Terradillos I, Medina-Benitez E, Ruiz-Hernández CJ, Carrillo-Palau M, Ros-Arnal I, Rodriguez-Martínez A, Escartin-Madurga L, Gutiérrez-Junquera C, Vicente-Santamaría S, Velasco Rodriguez-Belvis M, Fernández-Fernández S, Alberto-Alonso JR, Montraveta M, Torres-Peral R, Navalon-Rubio M, Navas-López VM, Martin de Carpi J. Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicentre Spanish study. Eur J Pediatr 2021;180:3029-38. [PMID: 33880650 DOI: 10.1007/s00431-021-04063-6] [Reference Citation Analysis]
120 Scarallo L, Bolasco G, Barp J, Bianconi M, di Paola M, Di Toma M, Naldini S, Paci M, Renzo S, Labriola F, De Masi S, Alvisi P, Lionetti P. Anti-Tumor Necrosis Factor-Alpha Withdrawal in Children With Inflammatory Bowel Disease in Endoscopic and Histologic Remission. Inflamm Bowel Dis 2021:izab046. [PMID: 33835155 DOI: 10.1093/ibd/izab046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
121 Lund K, Larsen MD, Knudsen T, Kjeldsen J, Nielsen RG, Mertz Nørgård B. Infliximab, Immunomodulators and Treatment Failures in Paediatric and Adolescent Patients with Crohn's Disease: a Nationwide Cohort Study. J Crohns Colitis 2021;15:575-82. [PMID: 32926166 DOI: 10.1093/ecco-jcc/jjaa188] [Reference Citation Analysis]
122 Ye Y, Manne S, Treem WR, Bennett D. Prevalence of Inflammatory Bowel Disease in Pediatric and Adult Populations: Recent Estimates From Large National Databases in the United States, 2007-2016. Inflamm Bowel Dis 2020;26:619-25. [PMID: 31504515 DOI: 10.1093/ibd/izz182] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 20.0] [Reference Citation Analysis]
123 Yu Y, Zhao H, Luo Y, Lou J, Chen J, Fang Y. Poor Concordance Between Clinical Activity and Endoscopic Severity in Pediatric Crohn's Disease: Before and After Induction Therapy. Dig Dis Sci. 2021;. [PMID: 33818661 DOI: 10.1007/s10620-021-06917-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
124 Norsa L, Berni Canani R, Duclaux-Loras R, Bequet E, Köglmeier J, Russell RK, Uhlig HH, Travis S, Hollis J, Koletzko S, Grimaldi G, Castaldo G, Rodrigues A, Deflandre J, Dembinski L, Shah N, Heinz-Erian P, Janecke A, Leskinen S, Wedenoja S, Koskela R, Lachaux A, Kolho KL, Ruemmele FM. Inflammatory bowel disease in patients with congenital chloride diarrhoea. J Crohns Colitis 2021:jjab056. [PMID: 33770165 DOI: 10.1093/ecco-jcc/jjab056] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
125 Jabandziev P, Kakisaka T, Bohosova J, Pinkasova T, Kunovsky L, Slaby O, Goel A. MicroRNAs in Colon Tissue of Pediatric Ulcerative Pancolitis Patients Allow Detection and Prognostic Stratification. J Clin Med 2021;10:1325. [PMID: 33806966 DOI: 10.3390/jcm10061325] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
126 Coelho T, Sonnenberg-Riethmacher E, Gao Y, Mossotto E, Khojanazarov A, Griffin A, Mukanova S, Ashimkhanova A, Haggarty R, Borissenko A, Ashton JJ, Stafford IS, Batra A, Afzal NA, Stanton MP, Vadgama B, Adrisova K, Beattie RM, Williams AP, Ennis S, Riethmacher D. Expression profile of the matricellular protein periostin in paediatric inflammatory bowel disease. Sci Rep 2021;11:6194. [PMID: 33737520 DOI: 10.1038/s41598-021-85096-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
127 Bosa L, Batura V, Colavito D, Fiedler K, Gaio P, Guo C, Li Q, Marzollo A, Mescoli C, Nambu R, Pan J, Perilongo G, Warner N, Zhang S, Kotlarz D, Klein C, Snapper SB, Walters TD, Leon A, Griffiths AM, Cananzi M, Muise AM. Novel CARMIL2 loss-of-function variants are associated with pediatric inflammatory bowel disease. Sci Rep 2021;11:5945. [PMID: 33723309 DOI: 10.1038/s41598-021-85399-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
128 Ormsby MJ, Johnson SA, Carpena N, Meikle LM, Goldstone RJ, McIntosh A, Wessel HM, Hulme HE, McConnachie CC, Connolly JPR, Roe AJ, Hasson C, Boyd J, Fitzgerald E, Gerasimidis K, Morrison D, Hold GL, Hansen R, Walker D, Smith DGE, Wall DM. Propionic Acid Promotes the Virulent Phenotype of Crohn's Disease-Associated Adherent-Invasive Escherichia coli. Cell Rep 2020;30:2297-2305.e5. [PMID: 32075765 DOI: 10.1016/j.celrep.2020.01.078] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
129 Aloi M, Bramuzzo M, Norsa L, Arrigo S, Distante M, Miele E, Romano C, Giobbi C, Panceri R, Cucchiara S, Alvisi P; SIGENP IBD Working Group. IBD Working group . Disease Activity Patterns in the First 5 Years After Diagnosis in Children With Ulcerative Colitis: A Population-Based Study. J Crohns Colitis 2021;15:367-74. [PMID: 33022055 DOI: 10.1093/ecco-jcc/jjaa203] [Reference Citation Analysis]
130 Ho SSC, Ross M, Keenan JI, Day AS. Fecal Calprotectin in Combination With Standard Blood Tests in the Diagnosis of Inflammatory Bowel Disease in Children. Front Pediatr 2020;8:609279. [PMID: 33748035 DOI: 10.3389/fped.2020.609279] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
131 Kitani T, Maddipatla SC, Madupuri R, Greco C, Hartmann J, Baraniuk JN, Vasudevan S. In Search of Newer Targets for Inflammatory Bowel Disease: A Systems and a Network Medicine Approach. Network and Systems Medicine 2021;4:74-87. [DOI: 10.1089/nsm.2020.0012] [Reference Citation Analysis]
132 Dhaliwal J, Walters TD, Mack DR, Huynh HQ, Jacobson K, Otley AR, Debruyn J, El-Matary W, Deslandres C, Sherlock ME, Critch JN, Bax K, Seidman E, Jantchou P, Ricciuto A, Rashid M, Muise AM, Wine E, Carroll M, Lawrence S, Van Limbergen J, Benchimol EI, Church P, Griffiths AM. Phenotypic Variation in Paediatric Inflammatory Bowel Disease by Age: A Multicentre Prospective Inception Cohort Study of the Canadian Children IBD Network. J Crohns Colitis 2020;14:445-54. [PMID: 31136648 DOI: 10.1093/ecco-jcc/jjz106] [Cited by in Crossref: 7] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
133 Colman RJ, Dhaliwal J, Rosen MJ. Predicting Therapeutic Response in Pediatric Ulcerative Colitis-A Journey Towards Precision Medicine. Front Pediatr 2021;9:634739. [PMID: 33681110 DOI: 10.3389/fped.2021.634739] [Reference Citation Analysis]
134 Berkovitch G, Cohen S, Lubetzky R, Singer D, Yerushalmy-Feler A. Biologic therapy is associated with a mild decrease in the rate of hospitalizations in pediatric IBD. BMC Pediatr 2021;21:63. [PMID: 33541320 DOI: 10.1186/s12887-021-02526-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
135 Jagt JZ, Pothof CD, Buiter HJC, van Limbergen JE, van Wijk MP, Benninga MA, de Boer NKH, de Meij TGJ. Adverse Events of Thiopurine Therapy in Pediatric Inflammatory Bowel Disease and Correlations with Metabolites: A Cohort Study. Dig Dis Sci 2021. [PMID: 33532972 DOI: 10.1007/s10620-021-06836-3] [Reference Citation Analysis]
136 Pichler J, Memaran N, Huber WD, Aufricht C, Bidmon-Fliegenschnee B. Golimumab in adolescents with Crohn's disease refractory to previous tumour necrosis factor antibody. Acta Paediatr 2021;110:661-7. [PMID: 32781480 DOI: 10.1111/apa.15522] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
137 Shimizu H, Arai K, Takeuchi I, Minowa K, Hosoi K, Sato M, Oka I, Kaburaki Y, Shimizu T. Long-Term Durability of Infliximab for Pediatric Ulcerative Colitis: A Retrospective Data Review in a Tertiary Children's Hospital in Japan. Pediatr Gastroenterol Hepatol Nutr 2021;24:7-18. [PMID: 33505889 DOI: 10.5223/pghn.2021.24.1.7] [Reference Citation Analysis]
138 Neville JJ, Macdonald A, Fell J, Choudhry M, Haddad M. Therapeutic strategies for stricturing Crohn's disease in childhood: a systematic review. Pediatr Surg Int 2021;37:569-77. [PMID: 33492462 DOI: 10.1007/s00383-020-04848-0] [Reference Citation Analysis]
139 Krawiec P, Pac-Kożuchowska E. Cathelicidin - A Novel Potential Marker of Pediatric Inflammatory Bowel Disease. J Inflamm Res 2021;14:163-74. [PMID: 33519224 DOI: 10.2147/JIR.S288742] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
140 Bramuzzo M, Lionetti P, Miele E, Romano C, Arrigo S, Cardile S, Di Nardo G, Illiceto MT, Pastore M, Felici E, Fuoti M, Banzato C, Citrano M, Congia M, Norsa L, Pozzi E, Zuin G, Agrusti A, Bianconi M, Grieco C, Giudici F, Aloi M, Alvisi P. Phenotype and Natural History of Children With Coexistent Inflammatory Bowel Disease and Celiac Disease. Inflamm Bowel Dis 2021:izaa360. [PMID: 33452803 DOI: 10.1093/ibd/izaa360] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
141 Rempel J, Grover K, El-Matary W. Micronutrient Deficiencies and Anemia in Children with Inflammatory Bowel Disease. Nutrients 2021;13:236. [PMID: 33467587 DOI: 10.3390/nu13010236] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
142 Kim PH, Kim SH, Cho YA, Yoon HM, Lee JS, Jung AY, Oh SH, Kim DY, Namgoong JM, Kim KM. Ability of Pelvic Magnetic Resonance Imaging to Predict Clinical Course of Perianal Fistula in Paediatric Crohn's Disease Patients. J Crohns Colitis 2021;15:1152-60. [PMID: 33411884 DOI: 10.1093/ecco-jcc/jjab004] [Reference Citation Analysis]
143 Wittmann Dayagi T, Werner L, Pinsker M, Salamon N, Barschak I, Weiss B, Shouval DS. Mucosal IL-10 and IL-10 receptor expression patterns in paediatric patients with ulcerative colitis. Int J Exp Pathol 2021;102:4-10. [PMID: 33405352 DOI: 10.1111/iep.12382] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
144 Kern I, Schoffer O, Kiess W, Henker J, Laaß MW, Winkler U, Quietzsch J, Wenzel O, Zurek M, Büttner K, Fischer P, de Laffolie J, Manuwald U, Stange T, Zenker R, Weidner J, Zimmer KP, Kunath H, Kugler J, Richter T, Rothe U. Incidence trends of pediatric onset inflammatory bowel disease in the years 2000-2009 in Saxony, Germany-first results of the Saxon Pediatric IBD Registry. PLoS One 2021;16:e0243774. [PMID: 33395450 DOI: 10.1371/journal.pone.0243774] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
145 Troelsen FS, Jick S. Antibiotic Use in Childhood and Adolescence and Risk of Inflammatory Bowel Disease: A Case-Control Study in the UK Clinical Practice Research Datalink. Inflamm Bowel Dis 2020;26:440-7. [PMID: 31265060 DOI: 10.1093/ibd/izz137] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
146 Goddard GR, Lim IIP, Cheng YC, Velazco CS, Jenkins T, Rosen NG, Kotagal M, Garrison AP, Falcone R, Rymeski B, Frischer JS. A child presents with perianal symptoms - how often is this Crohn's disease? J Pediatr Surg 2021;56:1618-22. [PMID: 33280851 DOI: 10.1016/j.jpedsurg.2020.11.016] [Reference Citation Analysis]
147 Ha C, Kim ES, Kwon Y, Choe YH, Kim MJ, Lee SY. The Identification of a Novel Thiopurine S-Methyltransferase Allele, TPMT*45, in Korean Patient with Crohn's Disease. Pharmgenomics Pers Med 2020;13:665-71. [PMID: 33273844 DOI: 10.2147/PGPM.S279446] [Reference Citation Analysis]
148 Alkhatry M, Al-Rifai A, Annese V, Georgopoulos F, Jazzar AN, Khassouan AM, Koutoubi Z, Nathwani R, Taha MS, Limdi JK. First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensus. World J Gastroenterol 2020; 26(43): 6710-6769 [PMID: 33268959 DOI: 10.3748/wjg.v26.i43.6710] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
149 Banerjee R, Pal P, Nabi Z, Shava U, Ganesh G, Reddy DN. Very early onset inflammatory bowel disease in a South Asian country where inflammatory bowel disease is emerging: a distinct clinical phenotype from later onset disease. Intest Res 2021;19:398-407. [PMID: 33207854 DOI: 10.5217/ir.2020.00107] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
150 Kalla R, Adams AT, Bergemalm D, Vatn S, Kennedy NA, Ricanek P, Lindstrom J, Ocklind A, Hjelm F, Ventham NT, Ho GT, Petren C, Repsilber D, Söderholm J, Pierik M, D'Amato M, Gomollón F, Olbjorn C, Jahnsen J, Vatn MH, Halfvarson J, Satsangi J. Serum proteomic profiling at diagnosis predicts clinical course, and need for intensification of treatment in inflammatory bowel disease. J Crohns Colitis 2021;15:699-708. [PMID: 33201212 DOI: 10.1093/ecco-jcc/jjaa230] [Cited by in Crossref: 5] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
151 Jiménez Treviño S, Pujol Muncunill G, Martín-Masot R, Rodríguez Martínez A, Segarra Cantón O, Peña Quintana L, Armas Ramos H, Eizaguirre Arocena FJ, Barrio Torres J, García Burriel JI, Ortigosa Castillo L, Donat Aliaga E, Crujeiras Martínez V, Barros García P, Botija Arcos G, Bartolomé Porro JM, Juste Ruiz M, Ochoa Sangrador C, García Casales Z, Galicia Poblet G, Oliver Goicolea P, Lorenzo Garrido H, García Romero R, La Orden Izquierdo E, Pérez Solis D, Navas-López VM, Díaz Martin JJ, Martín de Carpi J. Spanish Pediatric Inflammatory Bowel Disease Diagnostic Delay Registry: SPIDER Study From Sociedad Española de Gastroenterología, Hepatología y Nutrición Pediátrica. Front Pediatr 2020;8:584278. [PMID: 33178654 DOI: 10.3389/fped.2020.584278] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
152 Osiecki M, Kierkuś J, Pawłowska J, Woźniak M, Jankowska I, Teisseyre M, Dądalski M, Jarzębicka D, Stefanowicz M, Czubkowski P. The Course of Ulcerative Colitis After Pediatric Liver Transplantation for Sclerosing Cholangitis. Transplant Proc 2021;53:244-9. [PMID: 33162100 DOI: 10.1016/j.transproceed.2020.09.011] [Reference Citation Analysis]
153 Kim ES, Kwon Y, Choe YH, Kim MJ. Upper gastrointestinal tract involvement is more prevalent in Korean patients with pediatric Crohn's disease than in European patients. Sci Rep 2020;10:19032. [PMID: 33149222 DOI: 10.1038/s41598-020-75938-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
154 Mizuochi T, Arai K, Kudo T, Nambu R, Tajiri H, Aomatsu T, Abe N, Kakiuchi T, Hashimoto K, Sogo T, Takahashi M, Etani Y, Takaki Y, Konishi KI, Ishihara J, Obara H, Kakuma T, Kurei S, Yamashita Y, Mitsuyama K. Diagnostic accuracy of serum proteinase 3 antineutrophil cytoplasmic antibodies in children with ulcerative colitis. J Gastroenterol Hepatol 2021;36:1538-44. [PMID: 33047817 DOI: 10.1111/jgh.15296] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
155 Moayyedi P, MacQueen G, Bernstein CN, Vanner S, Bercik P, Madsen KL, Surette M, Rioux JD, Dieleman LA, Verdú E, de Souza RJ, Otley A, Targownik L, Lavis J, Cunningham J, Marshall DA, Zelinsky S, Fernandes A. IMAGINE Network's Mind And Gut Interactions Cohort (MAGIC) Study: a protocol for a prospective observational multicentre cohort study in inflammatory bowel disease and irritable bowel syndrome. BMJ Open 2020;10:e041733. [PMID: 33087380 DOI: 10.1136/bmjopen-2020-041733] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
156 Strisciuglio C, Cenni S, Serra MR, Dolce P, Martinelli M, Staiano A, Miele E. Effectiveness of Mediterranean Diet's Adherence in children with Inflammatory Bowel Diseases. Nutrients 2020;12:E3206. [PMID: 33092159 DOI: 10.3390/nu12103206] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
157 Burgess CJ, Gillett P, Mitchell D, Hammond P, Henderson P, Wilson DC. Incidence of Paediatric Stricturing Duodenal Crohn Disease: A 19-Year Population-based Cohort Study. J Pediatr Gastroenterol Nutr 2019;69:539-43. [PMID: 31335835 DOI: 10.1097/MPG.0000000000002444] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
158 Patel PV, Pantell MS, Heyman MB, Verstraete S. Depression Predicts Prolonged Length of Hospital Stay in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2019;69:570-4. [PMID: 31261246 DOI: 10.1097/MPG.0000000000002426] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
159 Kansal S, Catto-Smith AG, Boniface K, Thomas S, Cameron DJ, Oliver M, Alex G, Kirkwood CD, Wagner J. Variation of Gut Mucosal Microbiome With Anti-Saccharomyces cerevisiae Antibody Status in Pediatric Crohn Disease. J Pediatr Gastroenterol Nutr 2019;69:696-703. [PMID: 31764438 DOI: 10.1097/MPG.0000000000002461] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
160 Erős A, Dohos D, Veres G, Tárnok A, Vincze Á, Tészás A, Zádori N, Gede N, Hegyi P, Sarlós P. Effect of joint transition visits on quality of life in adolescents with inflammatory bowel diseases: a protocol for a prospective, randomised, multicentre, controlled trial (TRANS-IBD). BMJ Open 2020;10:e038410. [PMID: 33028560 DOI: 10.1136/bmjopen-2020-038410] [Reference Citation Analysis]
161 Lemay JA, Yamamoto M, Kroezen Z, Shanmuganathan M, Ly R, Hart L, Pai N, Britz-McKibbin P. Lyophilized fecal short-chain fatty acid and electrolyte determination by capillary electrophoresis with indirect UV detection for assessment of pediatric inflammatory bowel disease. J Pharm Biomed Anal 2021;192:113658. [PMID: 33091761 DOI: 10.1016/j.jpba.2020.113658] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
162 De Carlo C, Bramuzzo M, Canaletti C, Udina C, Cozzi G, Pavanello PM, Rampado S, Martelossi S, Giudici F, Di Leo G, Barbi E. The Role of Distress and Pain Catastrophizing on the Health-related Quality of Life of Children With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2019;69:e99-e104. [PMID: 31335840 DOI: 10.1097/MPG.0000000000002447] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
163 Haisma SM, Verkade HJ, Scheenstra R, van der Doef HPJ, Bodewes FAJA, van Rheenen PF. Time-to-reach Target Calprotectin Level in Newly Diagnosed Patients With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2019;69:466-73. [PMID: 31365486 DOI: 10.1097/MPG.0000000000002458] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
164 Ricciuto A, Mack DR, Huynh HQ, Jacobson K, Otley AR, deBruyn J, El-Matary W, Deslandres C, Sherlock ME, Critch JN, Bax K, Jantchou P, Seidman EG, Carman N, Rashid M, Muise A, Wine E, Carroll MW, Lawrence S, Van Limbergen J, Benchimol EI, Walters TD, Griffiths AM, Church PC. Diagnostic Delay Is Associated With Complicated Disease and Growth Impairment in Paediatric Crohn's Disease. J Crohns Colitis 2021;15:419-31. [PMID: 32978629 DOI: 10.1093/ecco-jcc/jjaa197] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
165 Kurowski JA, Achkar JP, Gupta R, Barbur I, Bonfield TL, Worley S, Remer EM, Fiocchi C, Viswanath SE, Kay MH. Adipokine Resistin Levels at Time of Pediatric Crohn Disease Diagnosis Predict Escalation to Biologic Therapy. Inflamm Bowel Dis 2021;27:1088-95. [PMID: 32978938 DOI: 10.1093/ibd/izaa250] [Reference Citation Analysis]
166 Rinawi F, Ricciuto A, Church PC, Frost K, Crowley E, Walters TD, Griffiths AM. Association of Early Postinduction Adalimumab Exposure With Subsequent Clinical and Biomarker Remission in Children with Crohn's Disease. Inflamm Bowel Dis 2021;27:1079-87. [PMID: 32978946 DOI: 10.1093/ibd/izaa247] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
167 Orlanski-Meyer E, Aardoom M, Ricciuto A, Navon D, Carman N, Aloi M, Bronsky J, Däbritz J, Dubinsky M, Hussey S, Lewindon P, Martin De Carpi J, Navas-López VM, Orsi M, Ruemmele FM, Russell RK, Veres G, Walters TD, Wilson DC, Kaiser T, de Ridder L, Griffiths A, Turner D. Predicting Outcomes in Pediatric Ulcerative Colitis for Management Optimization: Systematic Review and Consensus Statements From the Pediatric Inflammatory Bowel Disease-Ahead Program. Gastroenterology 2021;160:378-402.e22. [PMID: 32976826 DOI: 10.1053/j.gastro.2020.07.066] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
168 Chan KJ, Song ZL, Chew KS, Ng RT, Mohd Taib SH, Lee WS. Exclusive enteral nutrition is effective and feasible as primary induction and re-induction therapy in Asian children with Crohn's disease. J Paediatr Child Health 2021;57:239-45. [PMID: 32936506 DOI: 10.1111/jpc.15184] [Reference Citation Analysis]
169 Lekbua A, Ouahed J, O'Connell AE, Kahn SA, Goldsmith JD, Imamura T, Duncan CN, Kelsen JR, Worthey E, Snapper SB, Softic S. Risk-factors Associated With Poor Outcomes in VEO-IBD Secondary to XIAP Deficiency: A Case Report and Literature Review. J Pediatr Gastroenterol Nutr 2019;69:e13-8. [PMID: 31232887 DOI: 10.1097/MPG.0000000000002297] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
170 Chandrakumar A, Georgy M, Agarwal P, 't Jong GW, El-Matary W. Anti-Saccharomyces cerevisiae Antibodies as a Prognostic Biomarker in Children With Crohn Disease. J Pediatr Gastroenterol Nutr 2019;69:82-7. [PMID: 30789863 DOI: 10.1097/MPG.0000000000002311] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
171 Zhou L, Liu T, Huang B, Luo M, Chen Z, Zhao Z, Wang J, Leung D, Yang X, Chan KW, Liu Y, Xiong L, Chen P, Wang H, Ye L, Liang H, Masters SL, Lew AM, Gong S, Bai F, Yang J, Pui-Wah Lee P, Yang W, Zhang Y, Lau YL, Geng L, Zhang Y, Cui J. Excessive deubiquitination of NLRP3-R779C variant contributes to very-early-onset inflammatory bowel disease development. J Allergy Clin Immunol 2021;147:267-79. [PMID: 32941940 DOI: 10.1016/j.jaci.2020.09.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
172 Courbette O, Aupiais C, Viala J, Hugot JP, Louveau B, Chatenoud L, Bourrat E, Martinez-Vinson C. Infliximab Paradoxical Psoriasis in a Cohort of Children With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2019;69:189-93. [PMID: 30921262 DOI: 10.1097/MPG.0000000000002349] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
173 van Hoeve K, Dreesen E, Hoffman I, Van Assche G, Ferrante M, Gils A, Vermeire S. Adequate Infliximab Exposure During Induction Predicts Remission in Paediatric Patients With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2019;68:847-53. [PMID: 30633108 DOI: 10.1097/MPG.0000000000002265] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 7.5] [Reference Citation Analysis]
174 Gupta N, Lustig RH, Andrews H, Gokhale R, Goyal A, Patel AS, Guthery S, Sylvester F, Siebold L, Leu CS. Clinical Variables Associated With Statural Growth in Pediatric Crohn's Disease Differ by Sex (The Growth Study). Inflamm Bowel Dis 2021;27:751-9. [PMID: 32860033 DOI: 10.1093/ibd/izaa220] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
175 Arai K. Very Early-Onset Inflammatory Bowel Disease: A Challenging Field for Pediatric Gastroenterologists. Pediatr Gastroenterol Hepatol Nutr 2020;23:411-22. [PMID: 32953636 DOI: 10.5223/pghn.2020.23.5.411] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
176 Jongsma MME, Winter DA, Huynh HQ, Norsa L, Hussey S, Kolho KL, Bronsky J, Assa A, Cohen S, Lev-Tzion R, Van Biervliet S, Rizopoulos D, de Meij TGJ, Shouval DS, Wine E, Wolters VM, Martinez-Vinson C, de Ridder L; Paediatric IBD Porto Group of ESPGHAN. Infliximab in young paediatric IBD patients: it is all about the dosing. Eur J Pediatr 2020;179:1935-44. [PMID: 32813123 DOI: 10.1007/s00431-020-03750-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
177 Arai K, Kunisaki R, Kakuta F, Hagiwara SI, Murakoshi T, Yanagi T, Shimizu T, Kato S, Ishige T, Aomatsu T, Inoue M, Saito T, Iwama I, Kawashima H, Kumagai H, Tajiri H, Iwata N, Mochizuki T, Noguchi A, Kashiwabara T, Shimizu H, Suzuki Y, Hirano Y, Fujiwara T. Phenotypic characteristics of pediatric inflammatory bowel disease in Japan: results from a multicenter registry. Intest Res 2020;18:412-20. [PMID: 32806870 DOI: 10.5217/ir.2019.00130] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
178 Sood A, Kaur K, Singh A, Midha V, Mahajan R, Bansal N, Mehta V, Singh D. Trends of inflammatory bowel disease at a tertiary care center in northern India. Intest Res 2021;19:282-90. [PMID: 32806872 DOI: 10.5217/ir.2020.00010] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
179 Srivastava A, Sathiyasekharan M, Jagadisan B, Bolia R, Peethambaran M, Mammayil G, Acharya B, Malik R, Sankaranarayanan S, Biradar V, Malhotra S, Philip M, Poddar U, Yachha SK. Paediatric inflammatory bowel disease in India: a prospective multicentre study. Eur J Gastroenterol Hepatol 2020;32:1305-11. [PMID: 32796356 DOI: 10.1097/MEG.0000000000001859] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
180 Yeh PJ, Chen CC, Chao HC, Lai JY, Hsueh C, Wang CJ, Lai MW. High initial bowel resection rate and very-early-onset inflammatory bowel disease - A challenge in a low-prevalence area. J Formos Med Assoc 2021;120:720-7. [PMID: 32819795 DOI: 10.1016/j.jfma.2020.08.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
181 Batra SK, Heier CR, Diaz-Calderon L, Tully CB, Fiorillo AA, van den Anker J, Conklin LS. Serum miRNAs Are Pharmacodynamic Biomarkers Associated With Therapeutic Response in Pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis 2020;26:1597-606. [PMID: 32793975 DOI: 10.1093/ibd/izaa209] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
182 Martin NG, Roberts AJ, Evans HM, Bishop J, Day AS. Three-year outcomes of childhood inflammatory bowel disease in New Zealand: A population-based cohort study. JGH Open 2020;4:642-8. [PMID: 32782951 DOI: 10.1002/jgh3.12310] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
183 Haberman Y, Minar P, Karns R, Dexheimer PJ, Ghandikota S, Tegge S, Shapiro D, Shuler B, Venkateswaran S, Braun T, Ta A, Walters TD, Baldassano RN, Noe JD, Rosh J, Markowitz J, Dotson JL, Mack DR, Kellermayer R, Griffiths AM, Heyman MB, Baker SS, Moulton D, Patel AS, Gulati AS, Steiner SJ, LeLeiko N, Otley A, Oliva-Hemker M, Ziring D, Gokhale R, Kim S, Guthery SL, Cohen SA, Snapper S, Aronow BJ, Stephens M, Gibson G, Dillman JR, Dubinsky M, Hyams JS, Kugathasan S, Jegga AG, Denson LA. Mucosal Inflammatory and Wound Healing Gene Programs Reveal Targets for Stricturing Behavior in Pediatric Crohn's Disease. J Crohns Colitis 2020:jjaa166. [PMID: 32770196 DOI: 10.1093/ecco-jcc/jjaa166] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
184 Melek J, Štanclová M, Dědek P, Malý J, Bayer M, Pozler O, Bureš J. Infliximab plus azathioprine is more effective than azathioprine alone in achieving mucosal healing in pediatric patients with Crohn's disease. J Dig Dis 2020;21:705-10. [PMID: 32755026 DOI: 10.1111/1751-2980.12927] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
185 Scarpato E, Strisciuglio C, Martinelli M, Russo M, Cenni S, Casertano M, Serra MR, Staiano A, Miele E. Exclusive enteral nutrition effect on the clinical course of pediatric Crohn's disease: a single center experience. Eur J Pediatr 2020;179:1925-34. [PMID: 32734315 DOI: 10.1007/s00431-020-03753-x] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
186 Krawiec P, Pac-Kożuchowska E. Serum interleukin 17A and interleukin 17F in children with inflammatory bowel disease. Sci Rep 2020;10:12617. [PMID: 32724117 DOI: 10.1038/s41598-020-69567-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
187 El-matary W, Carroll MW, Debruyn JC, Huynh H, Wine E, Lawrence S, Chandrakumar A, Morel T, Jacobson K. Discontinuation of Immunosuppressive Medications in Children With Inflammatory Bowel Disease on Combination Therapy. Journal of Pediatric Gastroenterology & Nutrition 2020;71:740-3. [DOI: 10.1097/mpg.0000000000002857] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
188 Levine A, Chanchlani N, Hussey S, Ziv-Baran T, Escher JC, Amil Dias J, Veres G, Koletzko S, Turner D, Kolho KL, Paerregaard A, Staiano A, Lionetti P, Nuti F, Sladek M, Shaoul R, Lazowska-Prezeorek I, Martin de Carpi J, Sigall Boneh R, Pfeffer Gik T, Cohen-Dolev N, Russell RK. Complicated Disease and Response to Initial Therapy Predicts Early Surgery in Paediatric Crohn's Disease: Results From the Porto Group GROWTH Study. J Crohns Colitis 2020;14:71-8. [PMID: 31162532 DOI: 10.1093/ecco-jcc/jjz111] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
189 Pasvol TJ, Horsfall L, Bloom S, Segal AW, Sabin C, Field N, Rait G. Incidence and prevalence of inflammatory bowel disease in UK primary care: a population-based cohort study. BMJ Open 2020;10:e036584. [PMID: 32690524 DOI: 10.1136/bmjopen-2019-036584] [Cited by in Crossref: 10] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
190 Ivković L, Hojsak I, Trivić I, Sila S, Hrabač P, Konjik V, Senečić-Čala I, Palčevski G, Despot R, Žaja O, Kolaček S. Incidence and Geographical Variability of Pediatric Inflammatory Bowel Disease in Croatia: Data From the Croatian National Registry for Children With Inflammatory Bowel Disease. Clin Pediatr (Phila) 2020;59:1182-90. [PMID: 32674589 DOI: 10.1177/0009922820941202] [Reference Citation Analysis]
191 Grossi V, Hyams JS, Glidden NC, Knight BE, Young EE. Characterizing Clinical Features and Creating a Gene Expression Profile Associated With Pain Burden in Children With Inflammatory Bowel Disease. Inflamm Bowel Dis 2020;26:1283-90. [PMID: 31627210 DOI: 10.1093/ibd/izz240] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
192 Putra J, Goldsmith JD. Daily Dilemmas in Pediatric Gastrointestinal Pathology. Surg Pathol Clin 2020;13:399-411. [PMID: 32773191 DOI: 10.1016/j.path.2020.05.002] [Reference Citation Analysis]
193 Rahmani F, Rayzan E, Rahmani MR, Shahkarami S, Zoghi S, Rezaei A, Aryan Z, Najafi M, Rohlfs M, Jeske T, Aflatoonian M, Chavoshzadeh Z, Farahmand F, Motamed F, Rohani P, Alimadadi H, Mahdaviani A, Mansouri M, Tavakol M, Vanderberg M, Kotlarz D, Klein C, Rezaei N. Clinical and Mutation Description of the First Iranian Cohort of Infantile Inflammatory Bowel Disease: The Iranian Primary Immunodeficiency Registry (IPIDR). Immunol Invest 2021;50:445-59. [PMID: 32633164 DOI: 10.1080/08820139.2020.1776725] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
194 Burgess CJ, Henderson P, Jones G, Lees CW, Wilson DC. Paediatric Patients (Less Than Age of 17 Years) Account for Less Than 1.5% of All Prevalent Inflammatory Bowel Disease Cases. Journal of Pediatric Gastroenterology & Nutrition 2020;71:521-3. [DOI: 10.1097/mpg.0000000000002842] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
195 Tang W, Huang Y, Shi P, Wang Y, Zhang Y, Xue A, Tang Z, Hu W, Sun H, Zhang P, Zheng C, Shi J, Wang S, Qiu X, Lu X, Miao S, Meng Y. Effect of Exclusive Enteral Nutrition on the Disease Process, Nutrition Status, and Gastrointestinal Microbiota for Chinese Children With Crohn's Disease. JPEN J Parenter Enteral Nutr 2021;45:826-38. [PMID: 32510616 DOI: 10.1002/jpen.1938] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
196 Jakubczyk D, Leszczyńska K, Górska S. The Effectiveness of Probiotics in the Treatment of Inflammatory Bowel Disease (IBD)-A Critical Review. Nutrients 2020;12:E1973. [PMID: 32630805 DOI: 10.3390/nu12071973] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 24.0] [Reference Citation Analysis]
197 Harris RE, Aloi M, de Ridder L, Croft NM, Koletzko S, Levine A, Turner D, Veereman G, Neyt M, Bigot L, Ruemmele FM, Russell RK; PIBD SETQuality consortium and PIBDnet. Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn's disease: methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease course. BMJ Open 2020;10:e034892. [PMID: 32611737 DOI: 10.1136/bmjopen-2019-034892] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
198 Choe YH. Precision medicine for pediatric inflammatory bowel disease: a perspective. Precis Future Med 2020;4:43-52. [DOI: 10.23838/pfm.2020.00058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
199 Kalla R, Adams AT, Ventham NT, Kennedy NA, White R, Clarke C, Ivens A, Bergemalm D, Vatn S, Lopez-Jimena B, Ricanek P, Vatn MH, Söderholm J, Gomollón F, Nowak JK, Jahnsen J, Halfvarson J, McTaggart S, Ho GT, Buck A, Satsangi J; IBD Character Consortium. Whole blood profiling of T-cell derived miRNA allows the development of prognostic models in inflammatory bowel disease. J Crohns Colitis 2020:jjaa134. [PMID: 32598439 DOI: 10.1093/ecco-jcc/jjaa134] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
200 Takeuchi I, Arai K, Kyodo R, Sato T, Tokita K, Hirano Y, Shimizu H. Ustekinumab for children and adolescents with inflammatory bowel disease at a tertiary children's hospital in Japan. J Gastroenterol Hepatol 2021;36:125-30. [PMID: 32497325 DOI: 10.1111/jgh.15128] [Reference Citation Analysis]
201 Sprockett D, Fischer N, Boneh RS, Turner D, Kierkus J, Sladek M, Escher JC, Wine E, Yerushalmi B, Dias JA, Shaoul R, Kori M, Snapper SB, Holmes S, Bousvaros A, Levine A, Relman DA. Treatment-Specific Composition of the Gut Microbiota Is Associated With Disease Remission in a Pediatric Crohn's Disease Cohort. Inflamm Bowel Dis 2019;25:1927-38. [PMID: 31276165 DOI: 10.1093/ibd/izz130] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
202 Saadah OI, Annese V, Mosli MH. Prevalence and Predictors of Reduced Bone Density in Child and Adolescent Patients With Crohn's Disease. J Clin Densitom 2021;24:252-8. [PMID: 32553268 DOI: 10.1016/j.jocd.2020.05.004] [Reference Citation Analysis]
203 Barbiellini Amidei C, Zingone F, Zanier L, Canova C. Risk of Prevalent Asthma among Children Affected by Inflammatory Bowel Disease: A Population-Based Birth Cohort Study. Int J Environ Res Public Health 2020;17:E4255. [PMID: 32549223 DOI: 10.3390/ijerph17124255] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
204 Ricciuto A, Hansen BE, Ngo B, Aloi M, Walters TD, Church PC, Mazurek A, Khan M, Carman N, Siddiqui I, Nguyen GC, Kamath BM, Griffiths AM. Primary Sclerosing Cholangitis in Children With Inflammatory Bowel Diseases Is Associated With Milder Clinical Activity But More Frequent Subclinical Inflammation and Growth Impairment. Clinical Gastroenterology and Hepatology 2020;18:1509-1517.e7. [DOI: 10.1016/j.cgh.2019.08.048] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
205 Levin A, Risto A, Myrelid P. The changing landscape of surgery for Crohn's disease. Seminars in Colon and Rectal Surgery 2020;31:100740. [DOI: 10.1016/j.scrs.2020.100740] [Reference Citation Analysis]
206 Bolia R, Rajanayagam J, Hardikar W, Alex G. Impact of Changing Treatment Strategies on Outcomes in Pediatric Ulcerative Colitis. Inflamm Bowel Dis 2019;25:1838-44. [PMID: 31002341 DOI: 10.1093/ibd/izz072] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
207 Adler J. Can we Improve the Prognostic Value of Phenotype at Inflammatory Bowel Disease Diagnosis? J Crohns Colitis 2020;14:429-30. [PMID: 31639187 DOI: 10.1093/ecco-jcc/jjz126] [Reference Citation Analysis]
208 Walker GJ, Chanchlani N, Thomas A, Lin S, Moore L, Heerasing NM, Hendy P, Abdelrahim M, Mole S, Perry MH, Mcdonald TJ, Bewshea CM, Hart JW, Russell RK, Ahmad T, Goodhand JR, Kennedy NA. Primary care faecal calprotectin testing in children with suspected inflammatory bowel disease: a diagnostic accuracy study. Arch Dis Child 2020;105:957-63. [PMID: 32424002 DOI: 10.1136/archdischild-2019-317823] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
209 Kerur B, Benchimol EI, Fiedler K, Stahl M, Hyams J, Stephens M, Lu Y, Pfefferkorn M, Alkhouri R, Strople J, Kelsen J, Siebold L, Goyal A, Rosh JR, LeLeiko N, Van Limbergen J, Guerrerio AL, Maltz R, Karam L, Crowley E, Griffiths A, Heyman MB, Deneau M, Benkov K, Noe J, Mouton D, Pappa H, Galanko JA, Snapper S, Muise AM, Kappelman MD. Natural History of  Very Early Onset Inflammatory Bowel Disease in North America: A Retrospective Cohort Study. Inflamm Bowel Dis 2021;27:295-302. [PMID: 32386060 DOI: 10.1093/ibd/izaa080] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
210 Tan ZV, Kosana K, Savarino J, Croft N, Naik S, Kaplan J, Giles E. Histology at diagnostic gastroscopy predicts outcome after intestinal resection in pediatric Crohn's disease. J Gastroenterol Hepatol 2020;35:2074-9. [PMID: 32343456 DOI: 10.1111/jgh.15080] [Reference Citation Analysis]
211 Daniluk U, Daniluk J, Guzinska‐ustymowicz K, Pryczynicz A, Lebensztejn D. Usefulness of metalloproteinase‐9 and tissue inhibitor of metalloproteinase‐1 in clinical characterisation of children with newly diagnosed Crohn's disease. J Paediatr Child Health 2020;56:1233-41. [DOI: 10.1111/jpc.14908] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
212 Chandrakumar A, Wang A, Grover K, El-matary W. Obesity Is More Common in Children Newly Diagnosed With Ulcerative Colitis as Compared to Those With Crohn Disease. Journal of Pediatric Gastroenterology & Nutrition 2020;70:593-7. [DOI: 10.1097/mpg.0000000000002639] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
213 Levy-Shraga Y, Shenkar A, Modan-Moses D, Assa A, Haberman Y, Shouval D, Guz-Mark A, Lahad A, Weiss B. Longitudinal changes in bone mineral density in children with inflammatory bowel diseases. Acta Paediatr 2020;109:1026-32. [PMID: 31594031 DOI: 10.1111/apa.15046] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
214 Hooper KM, Casanova V, Kemp S, Staines KA, Satsangi J, Barlow PG, Henderson P, Stevens C. The Inflammatory Bowel Disease Drug Azathioprine Induces Autophagy via mTORC1 and the Unfolded Protein Response Sensor PERK. Inflamm Bowel Dis 2019;25:1481-96. [PMID: 30889246 DOI: 10.1093/ibd/izz039] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
215 Choi SY, Choi YO, Choe YH, Kang B. Potential Utility of Therapeutic Drug Monitoring of Adalimumab in Predicting Short-Term Mucosal Healing and Histologic Remission in Pediatric Crohn's Disease Patients. J Korean Med Sci 2020;35:e114. [PMID: 32329259 DOI: 10.3346/jkms.2020.35.e114] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
216 Poddar U, Yachha SK, Srivastava A, Kumari N. Pediatric inflammatory bowel disease: Is it really uncommon in Asian children? JGH Open 2020;4:860-6. [PMID: 33102756 DOI: 10.1002/jgh3.12330] [Reference Citation Analysis]
217 Moriczi M, Pujol-Muncunill G, Martín-Masot R, Jiménez Treviño S, Segarra Cantón O, Ochoa Sangrador C, Peña Quintana L, González Santana D, Rodríguez Martínez A, Rosell Camps A, Armas H, Barrio J, González de Caldas R, Rodríguez Salas M, Balmaseda Serrano E, Donat Aliaga E, Bodas Pinedo A, Vaquero Sosa E, Vecino López R, Solar Boga A, Moreno Álvarez A, Sánchez Sánchez C, Tolín Hernani M, Gutiérrez Junquera C, Martinón Torres N, Leis Trabazo MR, Eizaguirre FJ, García Peris M, Medina Benítez E, Fernández Caamaño B, Vegas Álvarez AM, Crespo Valderrábano L, Alonso Vicente C, Rubio Santiago J, Galera-Martínez R, García-Romero R, Ros Arnal I, Fernández Cebrián S, Lorenzo Garrido H, Viada Bris JF, Velasco Rodríguez-Belvis M, Bartolomé Porro JM, Blanco Rodríguez M, Barros García P, Botija G, Chicano Marín FJ, La Orden Izquierdo E, Crehuá-Gaudiza E, Navas-López VM, Martín-de-Carpi J. Predictors of Response to Exclusive Enteral Nutrition in Newly Diagnosed Crohn´s Disease in Children: PRESENCE Study from SEGHNP. Nutrients 2020;12:E1012. [PMID: 32272604 DOI: 10.3390/nu12041012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
218 Ledder O, Church P, Cytter-Kuint R, Martínez-León M, Sladek M, Coppenrath E, Weiss B, Yerushalmi B, Martin de Carpi J, Duchano L, Towbin A, Assa A, Shaoul R, Mearin ML, Alex G, Griffiths A, Turner D; ImageKids study group . A Simple Endoscopic Score Modified for the Upper Gastrointestinal Tract in Crohn's Disease [UGI-SES-CD]: A Report From the ImageKids Study. J Crohns Colitis 2018;12:1073-8. [PMID: 29800422 DOI: 10.1093/ecco-jcc/jjy072] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
219 Canova C, Ludvigsson JF, Di Domenicantonio R, Zanier L, Barbiellini Amidei C, Zingone F. Perinatal and Antibiotic Exposures and the Risk of Developing Childhood-Onset Inflammatory Bowel Disease: A Nested Case-Control Study Based on a Population-Based Birth Cohort. Int J Environ Res Public Health 2020;17:E2409. [PMID: 32252276 DOI: 10.3390/ijerph17072409] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
220 Ehrlich S, Mark AG, Rinawi F, Shamir R, Assa A. Micronutrient Deficiencies in Children With Inflammatory Bowel Diseases. Nutrition in Clinical Practice 2020;35:315-22. [DOI: 10.1002/ncp.10373] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
221 Martín-de-carpi J, Treviño SJ, Muncunill GP, Martín-masot R, Navas-lópez VM. Time to diagnosis in paediatric inflammatory bowel disease: Key points for an early diagnosis. Anales de Pediatría (English Edition) 2020;92:242.e1-9. [DOI: 10.1016/j.anpede.2019.11.004] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
222 Jarasvaraparn C, Zlomke K, Vann NC, Wang B, Crissinger KD, Gremse DA. The Relationship Between Sleep Disturbance and Disease Activity in Pediatric Patients With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2019;68:237-43. [PMID: 30256267 DOI: 10.1097/MPG.0000000000002156] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
223 Jansson S, Malham M, Paerregaard A, Jakobsen C, Wewer V. Extraintestinal Manifestations Are Associated With Disease Severity in Pediatric Onset Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2020;71:40-5. [PMID: 32187141 DOI: 10.1097/MPG.0000000000002707] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
224 Moore H, Dolce P, Devas N, Baldassano R, Martinelli M. Post-induction infliximab trough levels and disease activity in the clinical evolution of pediatric ulcerative colitis. United European Gastroenterol J 2020;8:425-35. [PMID: 32213038 DOI: 10.1177/2050640620912877] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
225 Kowalska-Duplaga K, Kapusta P, Gosiewski T, Sroka-Oleksiak A, Ludwig-Słomczyńska AH, Wołkow PP, Fyderek K. Changes in the Intestinal Microbiota Are Seen Following Treatment with Infliximab in Children with Crohn's Disease. J Clin Med 2020;9:E687. [PMID: 32143438 DOI: 10.3390/jcm9030687] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
226 Courbette O, Aupiais C, Viala J, Hugot J, Roblin X, Candon S, Louveau B, Chatenoud L, Martinez-vinson C. Trough Levels of Infliximab at Week 6 Are Predictive of Remission at Week 14 in Pediatric Crohn's Disease. Journal of Pediatric Gastroenterology & Nutrition 2020;70:310-7. [DOI: 10.1097/mpg.0000000000002536] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
227 Krzesiek E, Nienartowicz E, Iwańczak B. Value of magnetic resonance enterography in diagnosis and treatment follow up in Crohn's disease in children. Adv Med Sci 2020;65:214-22. [PMID: 32087571 DOI: 10.1016/j.advms.2020.01.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
228 Hartono S, Ippoliti MR, Mastroianni M, Torres R, Rider NL. Gastrointestinal Disorders Associated with Primary Immunodeficiency Diseases. Clin Rev Allergy Immunol 2019;57:145-65. [PMID: 29754192 DOI: 10.1007/s12016-018-8689-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
229 Serra EG, Schwerd T, Moutsianas L, Cavounidis A, Fachal L, Pandey S, Kammermeier J, Croft NM, Posovszky C, Rodrigues A, Russell RK, Barakat F, Auth MKH, Heuschkel R, Zilbauer M, Fyderek K, Braegger C, Travis SP, Satsangi J, Parkes M, Thapar N, Ferry H, Matte JC, Gilmour KC, Wedrychowicz A, Sullivan P, Moore C, Sambrook J, Ouwehand W, Roberts D, Danesh J, Baeumler TA, Fulga TA, Karaminejadranjbar M, Ahmed A, Wilson R, Barrett JC, Elkadri A, Griffiths AM, Snapper SB, Shah N, Muise AM, Wilson DC, Uhlig HH, Anderson CA; COLORS in IBD group investigators., Oxford IBD cohort study investigators., INTERVAL Study., Swiss IBD cohort investigators., UK IBD Genetics Consortium., NIDDK IBD Genetics Consortium. Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease. Nat Commun 2020;11:995. [PMID: 32081864 DOI: 10.1038/s41467-019-14275-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
230 Crowley E, Warner N, Pan J, Khalouei S, Elkadri A, Fiedler K, Foong J, Turinsky AL, Bronte-Tinkew D, Zhang S, Hu J, Tian D, Li D, Horowitz J, Siddiqui I, Upton J, Roifman CM, Church PC, Wall DA, Ramani AK, Kotlarz D, Klein C, Uhlig H, Snapper SB, Gonzaga-Jauregui C, Paterson AD, McGovern DPB, Brudno M, Walters TD, Griffiths AM, Muise AM. Prevalence and Clinical Features of Inflammatory Bowel Diseases Associated With Monogenic Variants, Identified by Whole-Exome Sequencing in 1000 Children at a Single Center. Gastroenterology 2020;158:2208-20. [PMID: 32084423 DOI: 10.1053/j.gastro.2020.02.023] [Cited by in Crossref: 21] [Cited by in F6Publishing: 36] [Article Influence: 10.5] [Reference Citation Analysis]
231 Ihekweazu FD, Fofanova T, Palacios R, Ajjarapu A, Karam L, Vogel AM, Rodriguez JR, Kellermayer R. Progression to colectomy in the era of biologics: A single center experience with pediatric ulcerative colitis. J Pediatr Surg 2020;55:1815-23. [PMID: 32087936 DOI: 10.1016/j.jpedsurg.2020.01.054] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
232 Guimarães LS, Greer MC, Dillman JR, Fletcher JG. Magnetic Resonance in Crohn’s Disease. Magnetic Resonance Imaging Clinics of North America 2020;28:31-44. [DOI: 10.1016/j.mric.2019.08.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
233 Church PC, Ho S, Sharma A, Tomalty D, Frost K, Muise A, Walters TD, Griffiths AM. Intensified Infliximab Induction is Associated with Improved Response and Decreased Colectomy in Steroid-Refractory Paediatric Ulcerative Colitis. J Crohns Colitis 2019;13:982-9. [PMID: 30715240 DOI: 10.1093/ecco-jcc/jjz019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
234 Oh SH, Sung YH, Kim I, Sim CK, Lee JH, Baek M, Pack CG, Seok C, Seo EJ, Lee MS, Kim KM. Novel Compound Heterozygote Mutation in IL10RA in a Patient With Very Early-Onset Inflammatory Bowel Disease. Inflamm Bowel Dis 2019;25:498-509. [PMID: 30462267 DOI: 10.1093/ibd/izy353] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
235 Mizuochi T, Arai K, Kudo T, Nambu R, Tajiri H, Aomatsu T, Abe N, Kakiuchi T, Hashimoto K, Sogo T, Takahashi M, Etani Y, Takaki Y, Konishi KI, Ishihara J, Obara H, Kakuma T, Kurei S, Yamashita Y, Mitsuyama K. Antibodies to Crohn's disease peptide 353 as a diagnostic marker for pediatric Crohn's disease: a prospective multicenter study in Japan. J Gastroenterol 2020;55:515-22. [PMID: 31980893 DOI: 10.1007/s00535-019-01661-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
236 Erolu E, Polat E. Cardiac functions and aortic elasticity in children with inflammatory bowel disease: effect of age at disease onset. Cardiol Young 2020;30:313-7. [PMID: 31964454 DOI: 10.1017/S1047951119002932] [Reference Citation Analysis]
237 Takaki Y, Mizuochi T, Eda K, Ishihara J, Yamashita Y. Laboratory values in Japanese children with newly diagnosed inflammatory bowel disease. Pediatr Int 2019;61:720-5. [PMID: 31102555 DOI: 10.1111/ped.13892] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
238 Gkiouras K, Grammatikopoulou MG, Theodoridis X, Pagkalidou E, Chatzikyriakou E, Apostolidou AG, Rigopoulou EI, Sakkas LI, Bogdanos DP. Diagnostic and clinical significance of antigen-specific pancreatic antibodies in inflammatory bowel diseases: A meta-analysis. World J Gastroenterol 2020; 26(2): 246-265 [PMID: 31988587 DOI: 10.3748/wjg.v26.i2.246] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
239 Davies M, Dodd S, Coultate M, Ross A, Pears G, Gnaneswaran B, Tzivinikos C, Konidari A, Cheng J, Auth MK, Cameron F, Tamhne S, Renji E, Nair M, Baillie C, Collins P, Smith PJ, Subramanian S. From Paris to Montreal: disease regression is common during long term follow-up of paediatric Crohn’s disease. Scandinavian Journal of Gastroenterology 2020;55:148-53. [DOI: 10.1080/00365521.2019.1710765] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
240 Selbuz S, Kansu A, Berberoğlu M, Şıklar Z, Kuloğlu Z. Nutritional status and body composition in children with inflammatory bowel disease: a prospective, controlled, and longitudinal study. Eur J Clin Nutr 2020;74:1173-80. [DOI: 10.1038/s41430-019-0555-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
241 Kang B, Kim JE, Jung JH, Choe JY, Kim MJ, Choe YH, Kim S, Koh H, Lee YM, Lee JH, Lee Y, Lee JH, Lee HJ, Jang HJ, Choi Y, Choi SY, Kim JY, Choe BH. Korean Children and Adolescents with Crohn's Disease Are More Likely to Present with Perianal Fistulizing Disease at Diagnosis Compared to Their European Counterparts. Pediatr Gastroenterol Hepatol Nutr 2020;23:49-62. [PMID: 31988875 DOI: 10.5223/pghn.2020.23.1.49] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
242 Conrad MA, Carreon CK, Dawany N, Russo P, Kelsen JR. Distinct Histopathological Features at Diagnosis of Very Early Onset Inflammatory Bowel Disease. J Crohns Colitis 2019;13:615-25. [PMID: 30551128 DOI: 10.1093/ecco-jcc/jjy212] [Cited by in Crossref: 12] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
243 Tindemans I, Joosse ME, Samsom JN. Dissecting the Heterogeneity in T-Cell Mediated Inflammation in IBD. Cells 2020;9:E110. [PMID: 31906479 DOI: 10.3390/cells9010110] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 12.5] [Reference Citation Analysis]
244 Dejban P, Rahimi N, Takzare N, Dehpour AR. Biochemical and histopathological evidence for the beneficial effects of modafinil on the rat model of inflammatory bowel disease: involvement of nitric oxide pathway. Pharmacol Rep 2020;72:135-46. [PMID: 32016839 DOI: 10.1007/s43440-019-00054-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
245 Zhao D, Wu N, Wang L, Pang X, Liu X, Zhang X. Role of microRNA-449a in the progress of inflammatory bowel disease in children. Biotechnology & Biotechnological Equipment 2020;34:144-53. [DOI: 10.1080/13102818.2020.1724828] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
246 Martín-de-Carpi J, Jiménez Treviño S, Pujol Muncunill G, Martín-Masot R, Navas-López VM. [Time to diagnosis in paediatric inflammatory bowel disease: Key points for an early diagnosis]. An Pediatr (Engl Ed) 2020;92:242.e1-9. [PMID: 31883747 DOI: 10.1016/j.anpedi.2019.11.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
247 Huang JG, Aw MM. Pediatric Inflammatory Bowel Disease in Asia: Epidemiology and natural history. Pediatr Neonatol 2020;61:263-71. [PMID: 32005607 DOI: 10.1016/j.pedneo.2019.12.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
248 El-Matary W, Walters TD, Huynh HQ, deBruyn J, Mack DR, Jacobson K, Sherlock ME, Church P, Wine E, Carroll MW, Benchimol EI, Lawrence S, Griffiths AM. Higher Postinduction Infliximab Serum Trough Levels Are Associated With Healing of Fistulizing Perianal Crohn's Disease in Children. Inflamm Bowel Dis. 2019;25:150-155. [PMID: 29912413 DOI: 10.1093/ibd/izy217] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 13.0] [Reference Citation Analysis]
249 Kumar M, Garand M, Al Khodor S. Integrating omics for a better understanding of Inflammatory Bowel Disease: a step towards personalized medicine. J Transl Med 2019;17:419. [PMID: 31836022 DOI: 10.1186/s12967-019-02174-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
250 Turner D, Bishai J, Reshef L, Abitbol G, Focht G, Marcus D, Ledder O, Lev-Tzion R, Orlanski-Meyer E, Yerushalmi B, Aloi M, Griffiths AM, Albenberg L, Kolho KL, Assa A, Cohen S, Gophna U, Vlamakis H, Lurz E, Levine A. Antibiotic Cocktail for Pediatric Acute Severe Colitis and the Microbiome: The PRASCO Randomized Controlled Trial. Inflamm Bowel Dis 2020;26:1733-42. [PMID: 31833543 DOI: 10.1093/ibd/izz298] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
251 Kowalska-Duplaga K, Gosiewski T, Kapusta P, Sroka-Oleksiak A, Wędrychowicz A, Pieczarkowski S, Ludwig-Słomczyńska AH, Wołkow PP, Fyderek K. Differences in the intestinal microbiome of healthy children and patients with newly diagnosed Crohn's disease. Sci Rep 2019;9:18880. [PMID: 31827191 DOI: 10.1038/s41598-019-55290-9] [Cited by in Crossref: 30] [Cited by in F6Publishing: 47] [Article Influence: 10.0] [Reference Citation Analysis]
252 Jasielska M, Grzybowska-Chlebowczyk U. Lactose Malabsorption and Lactose Intolerance in Children with Inflammatory Bowel Diseases. Gastroenterol Res Pract 2019;2019:2507242. [PMID: 31871445 DOI: 10.1155/2019/2507242] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
253 Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, Hayee B, Lomer MCE, Parkes GC, Selinger C, Barrett KJ, Davies RJ, Bennett C, Gittens S, Dunlop MG, Faiz O, Fraser A, Garrick V, Johnston PD, Parkes M, Sanderson J, Terry H, Gaya DR, Iqbal TH, Taylor SA, Smith M, Brookes M, Hansen R, Hawthorne AB; IBD guidelines eDelphi consensus group. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut 2019;68:s1-s106. [PMID: 31562236 DOI: 10.1136/gutjnl-2019-318484] [Cited by in Crossref: 617] [Cited by in F6Publishing: 555] [Article Influence: 205.7] [Reference Citation Analysis]
254 Fuller MK. Pediatric Inflammatory Bowel Disease. Surgical Clinics of North America 2019;99:1177-83. [DOI: 10.1016/j.suc.2019.08.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
255 Chandrakumar A, Zohni H, El-matary W. Clostridioides difficile Infection in Children With Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2020;26:1700-6. [DOI: 10.1093/ibd/izz285] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
256 Hong J, Yang HR, Moon JS, Chang JY, Ko JS. Association of IL23R Variants With Crohn's Disease in Korean Children. Front Pediatr 2019;7:472. [PMID: 31799225 DOI: 10.3389/fped.2019.00472] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
257 Shentova R, Baycheva M, Hadjiiski P, Kofinova D, Yaneva P. Role of faecal calprotectin as a predictor of endoscopic activity in paediatric patients with ulcerative colitis. Gastroenterol Hepatol 2020;43:57-61. [PMID: 31733888 DOI: 10.1016/j.gastrohep.2019.08.011] [Reference Citation Analysis]
258 van den Brink G, Stapersma L, Bom AS, Rizopolous D, van der Woude CJ, Stuyt RJL, Hendriks DM, van der Burg JAT, Beukers R, Korpershoek TA, Theuns-Valks SDM, Utens EMWJ, Escher JC. Effect of Cognitive Behavioral Therapy on Clinical Disease Course in Adolescents and Young Adults With Inflammatory Bowel Disease and Subclinical Anxiety and/or Depression: Results of a Randomized Trial. Inflamm Bowel Dis 2019;25:1945-56. [PMID: 31050763 DOI: 10.1093/ibd/izz073] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
259 Yerushalmy-Feler A, Singer D, Berkovitch G, Lubetzky R, Dotan I, Ziv-Baran T, Cohen S. Predictors for poor outcome of hospitalized children with inflammatory bowel disease. Eur J Pediatr 2020;179:157-64. [PMID: 31709474 DOI: 10.1007/s00431-019-03491-9] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
260 Strisciuglio C, Cenni S, Giugliano FP, Miele E, Cirillo G, Martinelli M, Vitale A, Tolone C, Staiano A, Miraglia Del Giudice E, Perrone L. The Role of Inflammation on Vitamin D Levels in a Cohort of Pediatric Patients With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2018;67:501-6. [PMID: 29877900 DOI: 10.1097/MPG.0000000000002049] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
261 Martinelli M, Giugliano FP, Strisciuglio C, Urbonas V, Serban DE, Banaszkiewicz A, Assa A, Hojsak I, Lerchova T, Navas-López VM, Romano C, Sladek M, Veres G, Aloi M, Kucinskiene R, Miele E. Vaccinations and Immunization Status in Pediatric Inflammatory Bowel Disease: A Multicenter Study From the Pediatric IBD Porto Group of the ESPGHAN. Inflamm Bowel Dis 2020;26:1407-14. [PMID: 31689349 DOI: 10.1093/ibd/izz264] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
262 Dipasquale V, Mattioli G, Arrigo S, Bramuzzo M, Strisciuglio C, Faraci S, Romeo EF, Contini AC, Ventimiglia M, Zuin G, Felici E, Alvisi P, Romano C. Pouchitis in pediatric ulcerative colitis: A multicenter study on behalf of Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition. Digestive and Liver Disease 2019;51:1551-6. [DOI: 10.1016/j.dld.2019.06.023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
263 Malham M, Jakobsen C, Vester‐andersen MK, Lo B, Paerregaard A, Vind I, Wewer V. Paediatric onset inflammatory bowel disease is a distinct and aggressive phenotype—a comparative population‐based study. GastroHep 2019;1:266-73. [DOI: 10.1002/ygh2.368] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
264 Turner D, Ruemmele FM, Orlanski-Meyer E, Griffiths AM, de Carpi JM, Bronsky J, Veres G, Aloi M, Strisciuglio C, Braegger CP, Assa A, Romano C, Hussey S, Stanton M, Pakarinen M, de Ridder L, Katsanos KH, Croft N, Navas-López VM, Wilson DC, Lawrence S, Russell RK. Management of Paediatric Ulcerative Colitis, Part 2: Acute Severe Colitis-An Evidence-based Consensus Guideline From the European Crohn's and Colitis Organization and the European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2018;67:292-310. [PMID: 30044358 DOI: 10.1097/MPG.0000000000002036] [Cited by in Crossref: 64] [Cited by in F6Publishing: 21] [Article Influence: 21.3] [Reference Citation Analysis]
265 Turner D, Ruemmele FM, Orlanski-Meyer E, Griffiths AM, de Carpi JM, Bronsky J, Veres G, Aloi M, Strisciuglio C, Braegger CP, Assa A, Romano C, Hussey S, Stanton M, Pakarinen M, de Ridder L, Katsanos K, Croft N, Navas-López V, Wilson DC, Lawrence S, Russell RK. Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care-An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2018;67:257-91. [PMID: 30044357 DOI: 10.1097/MPG.0000000000002035] [Cited by in Crossref: 106] [Cited by in F6Publishing: 30] [Article Influence: 35.3] [Reference Citation Analysis]
266 Gofin Y, Matar M, Shamir R, Assa A. Therapeutic Drug Monitoring Increases Drug Retention of Anti–Tumor Necrosis Factor Alpha Agents in Pediatric Patients With Crohn’s Disease. Inflammatory Bowel Diseases 2019. [DOI: 10.1093/ibd/izz257] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
267 van Hoeve K, Hoffman I, D'Hoore A, Ferrante M, Vermeire S. Long-term outcome of immunomodulator use in pediatric patients with inflammatory bowel disease. Dig Liver Dis 2020;52:164-72. [PMID: 31640916 DOI: 10.1016/j.dld.2019.09.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
268 El Manouni El Hassani S, Bosch S, Lemmen JPM, Brizzio Brentar M, Ayada I, Wicaksono AN, Covington JA, Benninga MA, de Boer NKH, de Meij TGJ. Simultaneous Assessment of Urinary and Fecal Volatile Organic Compound Analysis in De Novo Pediatric IBD. Sensors (Basel) 2019;19:E4496. [PMID: 31623289 DOI: 10.3390/s19204496] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
269 Nameirakpam J, Rikhi R, Rawat SS, Sharma J, Suri D. Genetics on early onset inflammatory bowel disease: An update. Genes Dis 2020;7:93-106. [PMID: 32181280 DOI: 10.1016/j.gendis.2019.10.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
270 Prichard DO, Hamilton Z, Savage T, Smyth M, Penner C, Lakhani A, Carroll MW, Al Sarkhy A, Lemberg DA, Enns R, Jamieson D, Jacobson K. Capsule Endoscopy Complements Magnetic Resonance Enterography and Endoscopy in Evaluating Small Bowel Crohn's Disease.J Can Assoc Gastroenterol. 2020;3:279-287. [PMID: 33241181 DOI: 10.1093/jcag/gwz028] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
271 Moses J, Lambert-Jenkins K, Momotaz H, Sattar A, Debanne SM, Splawski J, Sferra TJ. Time to antibody detection and associated factors for presence of anti-drug antibodies in pediatric inflammatory bowel disease patients treated with anti-TNF therapy. Eur J Gastroenterol Hepatol 2019;31:1228-33. [PMID: 31498282 DOI: 10.1097/MEG.0000000000001538] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
272 Tang WJ, Shi P, Zheng CF, Shi JR, Qiu XX, Wang SN, Huang Y. Special clinical characteristics and outcomes in Chinese pediatric patients with early‐onset Crohn's disease. J Dig Dis 2019;20:539-46. [DOI: 10.1111/1751-2980.12803] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
273 Ludvigsson JF, Andersson M, Bengtsson J, Eberhardson M, Fagerberg UL, Grip O, Halfvarson J, Hjortswang H, Jäghult S, Karling P, Nordenvall C, Olén O, Olsson M, Rejler M, Strid H, Myrelid P. Swedish Inflammatory Bowel Disease Register (SWIBREG) - a nationwide quality register. Scand J Gastroenterol 2019;54:1089-101. [PMID: 31498717 DOI: 10.1080/00365521.2019.1660799] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
274 Chandrakumar A, Loeppky R, Deneau M, El-Matary W. Inflammatory Bowel Disease in Children with Elevated Serum Gamma Glutamyltransferase Levels. J Pediatr 2019;215:144-151.e3. [PMID: 31500861 DOI: 10.1016/j.jpeds.2019.07.065] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
275 Alvisi P, Dipasquale V, Barabino A, Martellossi S, Miele E, Lionetti P, Lombardi G, Cucchiara S, Torre G, Romano C. Infections and malignancies risks related to TNF-α-blocking agents in pediatric inflammatory bowel diseases. Expert Rev Gastroenterol Hepatol 2019;13:957-61. [PMID: 31490707 DOI: 10.1080/17474124.2019.1663173] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
276 Stochel-gaudyn A, Fyderek K, Kościelniak P. Serum trace elements profile in the pediatric inflammatory bowel disease progress evaluation. Journal of Trace Elements in Medicine and Biology 2019;55:121-6. [DOI: 10.1016/j.jtemb.2019.06.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
277 Li D, Haritunians T, Landers C, Potdar AA, Yang S, Huang H, Schumm LP, Daly M, Targan SR, McGovern DPB. Late-Onset Crohn's Disease Is A Subgroup Distinct in Genetic and Behavioral Risk Factors With UC-Like Characteristics. Inflamm Bowel Dis 2018;24:2413-22. [PMID: 29860388 DOI: 10.1093/ibd/izy148] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
278 Bosch S, van Gaal N, Zuurbier RP, Covington JA, Wicaksono AN, Biezeveld MH, Benninga MA, Mulder CJ, de Boer NKH, de Meij TGJ. Differentiation Between Pediatric Irritable Bowel Syndrome and Inflammatory Bowel Disease Based on Fecal Scent: Proof of Principle Study. Inflamm Bowel Dis 2018;24:2468-75. [PMID: 29788410 DOI: 10.1093/ibd/izy151] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
279 Le Berre C, Trang-Poisson C, Bourreille A. Small bowel capsule endoscopy and treat-to-target in Crohn's disease: A systematic review. World J Gastroenterol 2019; 25(31): 4534-4554 [PMID: 31496630 DOI: 10.3748/wjg.v25.i31.4534] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
280 Nambu R, Hagiwara SI, Kakuta F, Hara T, Shimizu H, Abukawa D, Iwama I, Kagimoto S, Arai K. Current role of colonoscopy in infants and young children: a multicenter study. BMC Gastroenterol 2019;19:149. [PMID: 31429721 DOI: 10.1186/s12876-019-1060-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
281 Sila S, Trivić I, Pavić AM, Niseteo T, Kolaček S, Hojsak I. Nutritional status and food intake in pediatric patients with inflammatory bowel disease at diagnosis significantly differs from healthy controls. Eur J Pediatr 2019;178:1519-27. [PMID: 31422462 DOI: 10.1007/s00431-019-03443-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
282 Karaskova E, Volejnikova J, Holub D, Velganova-Veghova M, Spenerova M, Mihal V, Pospisilova D. Changes in serum hepcidin levels in children with inflammatory bowel disease during anti-inflammatory treatment. J Paediatr Child Health 2020;56:276-82. [PMID: 31411363 DOI: 10.1111/jpc.14593] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
283 Adler J, Jary HK, Eder SJ, Dong S, Brandt E, Haraga JK, Dombkowski KJ. Identifying perianal fistula complications in pediatric patients with Crohn's disease using administrative claims. PLoS One 2019;14:e0219893. [PMID: 31412045 DOI: 10.1371/journal.pone.0219893] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
284 Sharma Y, Bousvaros A, Liu E, Bender Stern J. Natural history of children with mild Crohn’s disease. World J Gastroenterol 2019; 25(30): 4235-4245 [PMID: 31435176 DOI: 10.3748/wjg.v25.i30.4235] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
285 Cohen S, Padlipsky J, Yerushalmy-Feler A. Risk factors associated with extraintestinal manifestations in children with inflammatory bowel disease. Eur J Clin Nutr 2020;74:691-7. [PMID: 31395971 DOI: 10.1038/s41430-019-0490-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
286 Frivolt K, Schwerd T, Schatz SB, Freudenberg F, Prell C, Werkstetter KJ, Bufler P, Koletzko S. Hyperadiponectinemia During Infliximab Induction Therapy in Pediatric Crohn Disease. J Pediatr Gastroenterol Nutr 2018;66:915-9. [PMID: 29287006 DOI: 10.1097/MPG.0000000000001876] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
287 Martinelli M, Giugliano FP, Russo M, Giannetti E, Andreozzi M, Bruzzese D, Perrone L, Staiano A, Miraglia Del Giudice E, Miele E, Marzuillo P, Strisciuglio C. The Changing Face of Pediatric Ulcerative Colitis: A Population-based Cohort Study. J Pediatr Gastroenterol Nutr 2018;66:903-8. [PMID: 29135823 DOI: 10.1097/MPG.0000000000001833] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
288 Hejazi R, Hasosah M. Tuberculosis, onychomycosis and immune deficiency in complicated Crohn's disease. BMJ Case Rep 2019;12:e228986. [PMID: 31383674 DOI: 10.1136/bcr-2018-228986] [Reference Citation Analysis]
289 Mack DR, Benchimol EI, Critch J, deBruyn J, Tse F, Moayyedi P, Church P, Deslandres C, El-matary W, Huynh H, Jantchou P, Lawrence S, Otley A, Sherlock M, Walters T, Kappelman MD, Sadowski D, Marshall JK, Griffiths A. Canadian Association of Gastroenterology Clinical Practice Guideline for the Medical Management of Pediatric Luminal Crohn's Disease. Gastroenterology 2019;157:320-48. [DOI: 10.1053/j.gastro.2019.03.022] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 5.7] [Reference Citation Analysis]
290 Strisciuglio C, Bellini G, Miele E, Martinelli M, Cenni S, Tortora C, Tolone C, Miraglia Del Giudice E, Rossi F. Cannabinoid Receptor 2 Functional Variant Contributes to the Risk for Pediatric Inflammatory Bowel Disease. J Clin Gastroenterol. 2018;52:e37-e43. [PMID: 27875353 DOI: 10.1097/mcg.0000000000000755] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
291 Logan M, Clark CM, Ijaz UZ, Gervais L, Duncan H, Garrick V, Curtis L, Buchanan E, Cardigan T, Armstrong L, Delahunty C, Flynn DM, Barclay AR, Tayler R, McDonald E, Milling S, Hansen RK, Gerasimidis K, Russell RK. The reduction of faecal calprotectin during exclusive enteral nutrition is lost rapidly after food re-introduction. Aliment Pharmacol Ther 2019;50:664-74. [PMID: 31342536 DOI: 10.1111/apt.15425] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 9.7] [Reference Citation Analysis]
292 Batura V, Muise AM. Very early onset IBD: novel genetic aetiologies. Curr Opin Allergy Clin Immunol 2018;18:470-80. [PMID: 30299396 DOI: 10.1097/ACI.0000000000000486] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
293 Suskind DL, Cohen SA, Brittnacher MJ, Wahbeh G, Lee D, Shaffer ML, Braly K, Hayden HS, Klein J, Gold B, Giefer M, Stallworth A, Miller SI. Clinical and Fecal Microbial Changes With Diet Therapy in Active Inflammatory Bowel Disease. J Clin Gastroenterol. 2018;52:155-163. [PMID: 28030510 DOI: 10.1097/mcg.0000000000000772] [Cited by in Crossref: 52] [Cited by in F6Publishing: 28] [Article Influence: 17.3] [Reference Citation Analysis]
294 Malham M, Lilje B, Houen G, Winther K, Andersen PS, Jakobsen C. The microbiome reflects diagnosis and predicts disease severity in paediatric onset inflammatory bowel disease. Scand J Gastroenterol 2019;54:969-75. [PMID: 31329473 DOI: 10.1080/00365521.2019.1644368] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
295 Diederen K, de Ridder L, van Rheenen P, Wolters VM, Mearin ML, de Meij TG, van Wering H, Oomen MW, de Jong JR, Sloots CE, Benninga MA, Kindermann A. Quality of life and colorectal function in Crohn's disease patients that underwent ileocecal resection during childhood. Eur J Pediatr. 2019;178:1413-1421. [PMID: 31327075 DOI: 10.1007/s00431-019-03427-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
296 Schütz L, Radke M, Menzel S, Däbritz J. Long-term implications of structured transition of adolescents with inflammatory bowel disease into adult health care: a retrospective study. BMC Gastroenterol 2019;19:128. [PMID: 31324228 DOI: 10.1186/s12876-019-1046-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
297 Furey TS, Sethupathy P, Sheikh SZ. Redefining the IBDs using genome-scale molecular phenotyping. Nat Rev Gastroenterol Hepatol. 2019;16:296-311. [PMID: 30787446 DOI: 10.1038/s41575-019-0118-x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 12.3] [Reference Citation Analysis]
298 Diederen K, Krom H, Koole JCD, Benninga MA, Kindermann A. Diet and Anthropometrics of Children With Inflammatory Bowel Disease: A Comparison With the General Population. Inflamm Bowel Dis 2018;24:1632-40. [PMID: 29697827 DOI: 10.1093/ibd/izy027] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
299 Lee D, Lewis JD, Shults J, Baldassano RN, Long J, Herskovitz R, Zemel B, Leonard MB. The Association of Diet and Exercise With Body Composition in Pediatric Crohn's Disease. Inflamm Bowel Dis 2018;24:1368-75. [PMID: 29718224 DOI: 10.1093/ibd/izy024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
300 Cantoro L, Lenti MV, Monterubbianesi R, Cicala M, Giannarelli D, Papi C, Kohn A, Di Sabatino A. Early-onset versus late-onset Crohn's disease: An Italian cohort study. United European Gastroenterol J 2020;8:52-8. [PMID: 32213053 DOI: 10.1177/2050640619860661] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
301 Wasielewska Z, Dolińska A, Wilczyńska D, Szaflarska-Popławska A, Krogulska A. Prevalence of allergic diseases in children with inflammatory bowel disease. Postepy Dermatol Alergol 2019;36:282-90. [PMID: 31333345 DOI: 10.5114/ada.2018.81189] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
302 Andreozzi M, Giugliano FP, Strisciuglio T, Pirozzi E, Papparella A, Caprio AM, Miele E, Strisciuglio C, Perrone Filardi P. The Role of Inflammation in the Endothelial Dysfunction in a Cohort of Pediatric Patients With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2019;69:330-5. [PMID: 31169657 DOI: 10.1097/MPG.0000000000002374] [Reference Citation Analysis]
303 Levine A, Wine E, Assa A, Sigall Boneh R, Shaoul R, Kori M, Cohen S, Peleg S, Shamaly H, On A, Millman P, Abramas L, Ziv-Baran T, Grant S, Abitbol G, Dunn KA, Bielawski JP, Van Limbergen J. Crohn's Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial. Gastroenterology. 2019;157:440-450. [PMID: 31170412 DOI: 10.1053/j.gastro.2019.04.021] [Cited by in Crossref: 135] [Cited by in F6Publishing: 190] [Article Influence: 45.0] [Reference Citation Analysis]
304 D’arcangelo G, Oliva S, Dilillo A, Viola F, Civitelli F, Isoldi S, Cucchiara S, Aloi M. Predictors of Long-term Clinical and Endoscopic Remission in Children With Crohn Disease Treated With Infliximab. Journal of Pediatric Gastroenterology & Nutrition 2019;68:841-6. [DOI: 10.1097/mpg.0000000000002262] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
305 van Hoeve K, Dreesen E, Hoffman I, Van Assche G, Ferrante M, Gils A, Vermeire S. Efficacy, Pharmacokinetics, and Immunogenicity is Not Affected by Switching From Infliximab Originator to a Biosimilar in Pediatric Patients With Inflammatory Bowel Disease. Therapeutic Drug Monitoring 2019;41:317-24. [DOI: 10.1097/ftd.0000000000000601] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 3.7] [Reference Citation Analysis]
306 Kang B, Choi SY, Choi YO, Lee SY, Baek SY, Sohn I, Choe BH, Lee HJ, Choe YH. Infliximab Trough Levels Are Associated With Mucosal Healing During Maintenance Treatment With Infliximab in Paediatric Crohn's Disease. J Crohns Colitis. 2019;13:189-197. [PMID: 30452616 DOI: 10.1093/ecco-jcc/jjy155] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 4.7] [Reference Citation Analysis]
307 Kellermayer R. Fecal microbiota transplantation: great potential with many challenges. Transl Gastroenterol Hepatol 2019;4:40. [PMID: 31231707 DOI: 10.21037/tgh.2019.05.10] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
308 Uyeda JW. Utility of MR Imaging in Abdominopelvic Emergencies. Radiol Clin North Am 2019;57:705-15. [PMID: 31076027 DOI: 10.1016/j.rcl.2019.02.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
309 Sun XW, Wei J, Yang Z, Jin XX, Wan HJ, Yuan BS, Yang MF, Liu J, Wang FY. Clinical Features and Prognosis of Crohn's Disease with Upper Gastrointestinal Tract Phenotype in Chinese Patients. Dig Dis Sci 2019;64:3291-9. [PMID: 31079261 DOI: 10.1007/s10620-019-05651-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
310 Kang B, Lee Y, Lee K, Choi YO, Choe YH. Long-term Outcomes After Switching to CT-P13 in Pediatric-Onset Inflammatory Bowel Disease: A Single-Center Prospective Observational Study. Inflamm Bowel Dis. 2018;24:607-616. [PMID: 29390113 DOI: 10.1093/ibd/izx047] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 13.0] [Reference Citation Analysis]
311 Winderman R, Rabinowitz SS, Vaidy K, Schwarz SM. Measurement of Microvascular Function in Pediatric Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology & Nutrition 2019;68:662-8. [DOI: 10.1097/mpg.0000000000002252] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
312 Ahmed S, Vachaparambil C, Kugathasan S. Pediatric inflammatory bowel disease: continuous lessons for adult inflammatory bowel disease. Curr Opin Gastroenterol 2019;35:265-74. [PMID: 31021923 DOI: 10.1097/MOG.0000000000000548] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
313 Ormsby MJ, Logan M, Johnson SA, McIntosh A, Fallata G, Papadopoulou R, Papachristou E, Hold GL, Hansen R, Ijaz UZ, Russell RK, Gerasimidis K, Wall DM. Inflammation associated ethanolamine facilitates infection by Crohn's disease-linked adherent-invasive Escherichia coli. EBioMedicine 2019;43:325-32. [PMID: 31036531 DOI: 10.1016/j.ebiom.2019.03.071] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
314 Bramuzzo M, Arrigo S, Romano C, Filardi MC, Lionetti P, Agrusti A, Dipasquale V, Paci M, Zuin G, Aloi M, Strisciuglio C, Miele E, Pastore M, Martelossi S, Alvisi P; SIGENP IBD Working Group. Efficacy and safety of infliximab in very early onset inflammatory bowel disease: a national comparative retrospective study. United European Gastroenterol J 2019;7:759-66. [PMID: 31316780 DOI: 10.1177/2050640619847592] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
315 Rolandsdotter H, Jönsson-Videsäter K, L Fagerberg U, Eberhardson M, Finkel Y. Mucosal Cytokine Profiles After Induction Therapy With Granulocyte/Monocyte Apheresis in New-onset Inflammatory Colitis. J Pediatr Gastroenterol Nutr 2018;66:e103-7. [PMID: 28891831 DOI: 10.1097/MPG.0000000000001735] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
316 Lee EH, Yang HR, Kim JY. Comparison of Transperianal Ultrasound With Colonoscopy and Magnetic Resonance Imaging in Perianal Crohn Disease. J Pediatr Gastroenterol Nutr 2018;66:614-9. [PMID: 28953535 DOI: 10.1097/MPG.0000000000001752] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
317 Diederen K, Gerritsma JJ, Koot BGP, Tabbers MM, Benninga MA, Kindermann A. Do Children and Adolescents With Inflammatory Bowel Disease Complete Clinical Disease Indices Similar to Physicians? J Pediatr Gastroenterol Nutr 2018;66:410-6. [PMID: 28832362 DOI: 10.1097/MPG.0000000000001712] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
318 Ashton JJ, Bonduelle Q, Mossotto E, Coelho T, Batra A, Afzal NA, Vadgama B, Ennis S, Beattie RM. Endoscopic and Histological Assessment of Paediatric Inflammatory Bowel Disease Over a 3-Year Follow-up Period. J Pediatr Gastroenterol Nutr. 2018;66:402-409. [PMID: 28922257 DOI: 10.1097/mpg.0000000000001729] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.7] [Reference Citation Analysis]
319 deBruyn JC, Jacobson K, El-Matary W, Carroll M, Wine E, Wrobel I, Van Woudenberg M, Huynh HQ. Long-term Outcomes of Infliximab Use for Pediatric Crohn Disease: A Canadian Multicenter Clinical Practice Experience. J Pediatr Gastroenterol Nutr 2018;66:268-73. [PMID: 28657923 DOI: 10.1097/MPG.0000000000001672] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 4.7] [Reference Citation Analysis]
320 Lopez RN, Appleton L, Gearry RB, Day AS. Rising Incidence of Paediatric Inflammatory Bowel Disease in Canterbury, New Zealand, 1996-2015. J Pediatr Gastroenterol Nutr. 2018;66:e45-e50. [PMID: 28727653 DOI: 10.1097/mpg.0000000000001688] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
321 Sun S, Ye Z, Zheng S, Chen G, Qian X, Dong K, Huang Y. Surgical treatment of monogenic inflammatory bowel disease: A single clinical center experience. J Pediatr Surg 2019;54:2155-61. [PMID: 31027905 DOI: 10.1016/j.jpedsurg.2019.02.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
322 Cozijnsen MA, Ben Shoham A, Kang B, Choe BH, Choe YH, Jongsma MME, Russell RK, Ruemmele FM, Escher JC, de Ridder L, Koletzko S, Martín-de-Carpi J, Hyams J, Walters T, Griffiths A, Turner D. Development and Validation of the Mucosal Inflammation Noninvasive Index For Pediatric Crohn's Disease. Clin Gastroenterol Hepatol 2020;18:133-140.e1. [PMID: 30981008 DOI: 10.1016/j.cgh.2019.04.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
323 Schoepfer A, Santos J, Fournier N, Schibli S, Spalinger J, Vavricka S, Safroneeva E, Aslan N, Rogler G, Braegger C, Nydegger A. Systematic Analysis of the Impact of Diagnostic Delay on Bowel Damage in Paediatric Versus Adult Onset Crohn’s Disease. Journal of Crohn's and Colitis 2019;13:1334-42. [DOI: 10.1093/ecco-jcc/jjz065] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
324 Brückner A, Werkstetter KJ, de Laffolie J, Wendt C, Prell C, Weidenhausen T, Zimmer KP, Koletzko S; CEDATA-GPGE study group. Incidence and Risk Factors for Perianal Disease in Pediatric Crohn Disease Patients Followed in CEDATA-GPGE Registry. J Pediatr Gastroenterol Nutr 2018;66:73-8. [PMID: 28604511 DOI: 10.1097/MPG.0000000000001649] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 3.7] [Reference Citation Analysis]
325 Schwimmer D, Glover S. Primary Immunodeficiency and the Gut. Gastroenterol Clin North Am 2019;48:199-220. [PMID: 31046971 DOI: 10.1016/j.gtc.2019.02.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
326 Eloi C, Foulon G, Bridoux-henno L, Breton E, Pelatan C, Chaillou E, Grimal I, Darviot E, Carré E, Gastineau S, Tourtelier Y, Nicaise D, Rousseau C, Dabadie A. Inflammatory Bowel Diseases and School Absenteeism. Journal of Pediatric Gastroenterology & Nutrition 2019;68:541-6. [DOI: 10.1097/mpg.0000000000002207] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
327 Kansal S, Catto-smith A, Boniface K, Thomas S, Cameron D, Oliver M, Alex G, Kirkwood C, Wagner J. The Microbiome in Paediatric Crohn’s Disease—A Longitudinal, Prospective, 
Single-Centre Study. Journal of Crohn's and Colitis 2019;13:1044-54. [DOI: 10.1093/ecco-jcc/jjz016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
328 Malmborg P, Mouratidou N, Sachs MC, Hammar U, Khalili H, Neovius M, Hjern A, Smedby KE, Ekbom A, Askling J, Ludvigsson JF, Olén O. Effects of Childhood-onset Inflammatory Bowel Disease on School Performance: A Nationwide Population-based Cohort Study Using Swedish Health and Educational Registers. Inflammatory Bowel Diseases 2019;25:1663-73. [DOI: 10.1093/ibd/izz040] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
329 Lerchova T, Hradsky O, Copova I, Potuznikova K, Gonsorcikova L, Bronsky J. The Accuracy of a Home-performed Faecal Calprotectin Test in Paediatric Patients With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2019;69:75-81. [PMID: 30908389 DOI: 10.1097/MPG.0000000000002331] [Reference Citation Analysis]
330 Teng X, Xu L, Sun M, Guo J. Phenotypic characteristics and clinical manifestations of inflammatory bowel disease in infants and children under 2 years of age in Liaoning Province, China: five of six infants with IL-10R mutations. Paediatr Int Child Health 2019;39:59-64. [PMID: 30900524 DOI: 10.1080/20469047.2018.1560700] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
331 Dalzell AM, Ba’ath ME. Paediatric inflammatory bowel disease: review with a focus on practice in low- to middle-income countries. Paediatrics and International Child Health 2019;39:48-58. [DOI: 10.1080/20469047.2019.1575056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
332 Foster AJ, Smyth M, Lakhani A, Jung B, Brant RF, Jacobson K. Consecutive fecal calprotectin measurements for predicting relapse in pediatric Crohn’s disease patients. World J Gastroenterol 2019; 25(10): 1266-1277 [PMID: 30886509 DOI: 10.3748/wjg.v25.i10.1266] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
333 Levy R, Amarilyo G, Tal R, Amir J, Assa A, Rinawi F, Harel L. Musculoskeletal Manifestations as Presenting Symptoms of Inflammatory Bowel Disease in Children and Adolescents. J Pediatr 2019;209:233-5. [PMID: 30857776 DOI: 10.1016/j.jpeds.2018.12.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
334 Almana Y, Mohammed R. Current concepts in pediatric inflammatory bowel disease; IL10/IL10R colitis as a model disease. Int J Pediatr Adolesc Med 2019;6:1-5. [PMID: 31304220 DOI: 10.1016/j.ijpam.2019.02.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
335 Pimentel AM, Rocha R, Santana GO. Crohn’s disease of esophagus, stomach and duodenum. World J Gastrointest Pharmacol Ther 2019; 10(2): 35-49 [PMID: 30891327 DOI: 10.4292/wjgpt.v10.i2.35] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 22] [Article Influence: 9.3] [Reference Citation Analysis]
336 Bosch S, Struys EA, van Gaal N, Bakkali A, Jansen EW, Diederen K, Benninga MA, Mulder CJ, de Boer NKH, de Meij TGJ. Fecal Amino Acid Analysis Can Discriminate De Novo Treatment-Naïve Pediatric Inflammatory Bowel Disease From Controls. J Pediatr Gastroenterol Nutr 2018;66:773-8. [PMID: 29112087 DOI: 10.1097/MPG.0000000000001812] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 4.7] [Reference Citation Analysis]
337 Lopez RN, Evans HM, Appleton L, Bishop J, Chin S, Mouat S, Gearry RB, Day AS. Prospective Incidence of Paediatric Inflammatory Bowel Disease in New Zealand in 2015: Results From the Paediatric Inflammatory Bowel Disease in New Zealand (PINZ) Study. J Pediatr Gastroenterol Nutr. 2018;66:e122-e126. [PMID: 29077643 DOI: 10.1097/mpg.0000000000001806] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.7] [Reference Citation Analysis]
338 Wright SS, Trauernicht A, Bonkowski E, McCall CA, Maier EA, Bezold R, Lake K, Chalk C, Trapnell BC, Kim MO, Kugathasan S, Denson LA. Familial Association of Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2018;66:767-772. [PMID: 29216019 DOI: 10.1097/mpg.0000000000001851] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
339 Daniluk U, Daniluk J, Krasnodebska M, Lotowska JM, Sobaniec-Lotowska ME, Lebensztejn DM. The combination of fecal calprotectin with ESR, CRP and albumin discriminates more accurately children with Crohn's disease. Adv Med Sci 2019;64:9-14. [PMID: 30237086 DOI: 10.1016/j.advms.2018.08.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 7.7] [Reference Citation Analysis]
340 Krawiec P, Pac-kożuchowska E. Soluble transferrin receptor and soluble transferrin receptor/log ferritin index in diagnosis of iron deficiency anemia in pediatric inflammatory bowel disease. Digestive and Liver Disease 2019;51:352-7. [DOI: 10.1016/j.dld.2018.11.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
341 Rinawi F, Zevit N, Eliakim R, Niv Y, Shamir R, Assa A. Long-Term Outcomes After Primary Bowel Resection in Pediatric-Onset Crohn's Disease. Inflamm Bowel Dis 2017;24:149-58. [PMID: 29272491 DOI: 10.1093/ibd/izx030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
342 Bertha M, Vasantharoopan A, Kumar A, Bruce BB, Prince J, Hofmekler T, Okou D, Chopra P, Wang G, Sauer C, Landers CJ, Hussain SZ, Cross RK, Baldassano RN, Kappelman MD, Katz J, Alexander JS, Kirschner BS, Moulton DE, Osuntokun BO, Patel A, Saeed S, Klapproth JA, Dhere TA, Dubinsky MC, McGovern D, Kugathasan S. IBD Serology and Disease Outcomes in African Americans With Crohn's Disease. Inflamm Bowel Dis 2017;24:209-16. [PMID: 29272484 DOI: 10.1093/ibd/izx021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
343 Rolandsdotter H, Jönsson-Videsäter K, L Fagerberg U, Finkel Y, Eberhardson M. Exclusive Enteral Nutrition: Clinical Effects and Changes in Mucosal Cytokine Profile in Pediatric New Inflammatory Bowel Disease. Nutrients 2019;11:E414. [PMID: 30781421 DOI: 10.3390/nu11020414] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
344 Maccioni F, Bencardino D, Buonocore V, Mazzamurro F, Viola F, Oliva S, Vernia P, Merli M, Vestri AR, Catalano C, Cucchiara S. MRI reveals different Crohn's disease phenotypes in children and adults. Eur Radiol. 2019;29:5082-5092. [PMID: 30729332 DOI: 10.1007/s00330-019-6006-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
345 Olén O, Askling J, Sachs MC, Frumento P, Neovius M, Smedby KE, Ekbom A, Malmborg P, Ludvigsson JF. Increased Mortality of Patients With Childhood-Onset Inflammatory Bowel Diseases, Compared With the General Population. Gastroenterology 2019;156:614-22. [DOI: 10.1053/j.gastro.2018.10.028] [Cited by in Crossref: 27] [Cited by in F6Publishing: 36] [Article Influence: 9.0] [Reference Citation Analysis]
346 Levine A, Kori M, Kierkus J, Sigall Boneh R, Sladek M, Escher JC, Wine E, Yerushalmi B, Amil Dias J, Shaoul R, Veereman Wauters G, Boaz M, Abitbol G, Bousvaros A, Turner D. Azithromycin and metronidazole versus metronidazole-based therapy for the induction of remission in mild to moderate paediatric Crohn's disease : a randomised controlled trial. Gut 2019;68:239-47. [PMID: 29420227 DOI: 10.1136/gutjnl-2017-315199] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
347 Olbjørn C, Cvancarova Småstuen M, Thiis-Evensen E, Nakstad B, Vatn MH, Jahnsen J, Ricanek P, Vatn S, Moen AEF, Tannæs TM, Lindstrøm JC, Söderholm JD, Halfvarson J, Gomollón F, Casén C, Karlsson MK, Kalla R, Adams AT, Satsangi J, Perminow G. Fecal microbiota profiles in treatment-naïve pediatric inflammatory bowel disease - associations with disease phenotype, treatment, and outcome. Clin Exp Gastroenterol 2019;12:37-49. [PMID: 30774408 DOI: 10.2147/CEG.S186235] [Cited by in Crossref: 36] [Cited by in F6Publishing: 21] [Article Influence: 12.0] [Reference Citation Analysis]
348 Guilcher K, Fournier N, Schoepfer A, Schibli S, Spalinger J, Braegger C, Nydegger A; Swiss IBD Cohort Study. Change of treatment modalities over the last 10 years in pediatric patients with inflammatory bowel disease in Switzerland. Eur J Gastroenterol Hepatol 2018;30:1159-67. [PMID: 29985208 DOI: 10.1097/MEG.0000000000001197] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
349 Agrawal M, Cohen-mekelburg S, Kayal M, Axelrad J, Galati J, Tricomi B, Kamal K, Faye AS, Abrudescu P, Scherl E, Lawlor G, Sultan K, Lukin D, Colombel J, Ungaro RC. Disability in inflammatory bowel disease patients is associated with race, ethnicity and socio-economic factors. Aliment Pharmacol Ther 2019;49:564-71. [DOI: 10.1111/apt.15107] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
350 Kanegane H. Inflammatory bowel diseases and primary immunodeficiency diseases. Immunol Med 2018;41:154-61. [PMID: 30632919 DOI: 10.1080/25785826.2018.1556025] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
351 Moon JS. Clinical Aspects and Treatments for Pediatric Inflammatory Bowel Diseases. Pediatr Gastroenterol Hepatol Nutr. 2019;22:50-56. [PMID: 30671373 DOI: 10.5223/pghn.2019.22.1.50] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
352 Shim JO. Recent Advance in Very Early Onset Inflammatory Bowel Disease. Pediatr Gastroenterol Hepatol Nutr 2019;22:41-9. [PMID: 30671372 DOI: 10.5223/pghn.2019.22.1.41] [Cited by in Crossref: 15] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
353 Moon JS. Clinical aspects and treatments for pediatric inflammatory bowel disease. Intest Res 2019;17:17-23. [PMID: 30625263 DOI: 10.5217/ir.2018.00139] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
354 Alvisi P, Arrigo S, Cucchiara S, Lionetti P, Miele E, Romano C, Ravelli A, Knafelz D, Martelossi S, Guariso G, Accomando S, Zuin G, De Giacomo C, Balzani L, Gennari M, Aloi M; SIGENP IBD Working Group. Efficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn's disease patients who failed infliximab therapy: the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition experience. Biologics 2019;13:13-21. [PMID: 30655661 DOI: 10.2147/BTT.S183088] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
355 Armstrong H, Alipour M, Valcheva R, Bording-Jorgensen M, Jovel J, Zaidi D, Shah P, Lou Y, Ebeling C, Mason AL, Lafleur D, Jerasi J, Wong GK, Madsen K, Carroll MW, Huynh HQ, Dieleman LA, Wine E. Host immunoglobulin G selectively identifies pathobionts in pediatric inflammatory bowel diseases. Microbiome 2019;7:1. [PMID: 30606251 DOI: 10.1186/s40168-018-0604-3] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 18.7] [Reference Citation Analysis]
356 Naviglio S, Lacorte D, Lucafò M, Cifù A, Favretto D, Cuzzoni E, Silvestri T, Pozzi Mucelli M, Radillo O, Decorti G, Fabris M, Bramuzzo M, Taddio A, Stocco G, Alvisi P, Ventura A, Martelossi S. Causes of Treatment Failure in Children With Inflammatory Bowel Disease Treated With Infliximab: A Pharmacokinetic Study. Journal of Pediatric Gastroenterology & Nutrition 2019;68:37-44. [DOI: 10.1097/mpg.0000000000002112] [Cited by in Crossref: 26] [Cited by in F6Publishing: 8] [Article Influence: 8.7] [Reference Citation Analysis]
357 Kim S, Park S, Kang Y, Kim JE, Kang B, Choe B, Lee YJ, Park JH, Yang HR, Lee SH, Kim KM, Ryoo E, Tchah H, Shim JO, Koh H. Can We Estimate Quality of Life in Pediatric Inflammatory Bowel Disease Patients? An Asian Multicenter Study. Journal of Pediatric Gastroenterology & Nutrition 2019;68:45-9. [DOI: 10.1097/mpg.0000000000002119] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
358 Kim S, Park S, Kang Y, Kwon N, Koh H. Medical staff tend to underestimate the quality of life in children and adolescents with inflammatory bowel disease. Acta Paediatr 2019;108:138-42. [PMID: 29998507 DOI: 10.1111/apa.14498] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
359 Ishige T. Growth failure in pediatric onset inflammatory bowel disease: mechanisms, epidemiology, and management. Transl Pediatr 2019;8:16-22. [PMID: 30881894 DOI: 10.21037/tp.2018.12.04] [Cited by in Crossref: 10] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
360 Rottoli M, Vallicelli C, Ghignone F, Tanzanu M, Vitali G, Gionchetti P, Rizzello F, Poggioli G. Predictors of early recurrence after strictureplasty for Crohn's disease of the small bowel during the years of biologics. Dig Liver Dis 2019;51:663-8. [PMID: 30583997 DOI: 10.1016/j.dld.2018.11.027] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
361 Magro F, Gionchetti P, Eliakim R, Ardizzone S, Armuzzi A, Barreiro-de Acosta M, Burisch J, Gecse KB, Hart AL, Hindryckx P. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. J Crohns Colitis. 2017;11:649-670. [PMID: 28158501 DOI: 10.1093/ecco-jcc/jjx008] [Cited by in Crossref: 682] [Cited by in F6Publishing: 783] [Article Influence: 170.5] [Reference Citation Analysis]
362 Turner D, Muise AM. Very Early Onset IBD: How Very Different 'on Average'? J Crohns Colitis 2017;11:517-8. [PMID: 28082310 DOI: 10.1093/ecco-jcc/jjw217] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
363 Ong C, Lim PT, Logarajah V, Liwanag MJ, Ang BX, Cher Y, Chiou FK, Kader A. Exclusive enteral nutrition with concomitant early thiopurine use was effective in maintaining steroid-free remission in a Southeast Asian cohort of children with Crohn's disease. BMC Gastroenterol 2018;18:185. [PMID: 30541458 DOI: 10.1186/s12876-018-0907-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
364 Haberman Y, Schirmer M, Dexheimer PJ, Karns R, Braun T, Kim MO, Walters TD, Baldassano RN, Noe JD, Rosh J, Markowitz J, Crandall WV, Mack DR, Griffiths AM, Heyman MB, Baker SS, Kellermayer R, Moulton D, Patel AS, Gulati AS, Steiner SJ, LeLeiko N, Otley A, Oliva-Hemker M, Ziring D, Kirschner BS, Keljo DJ, Guthery SL, Cohen SA, Snapper S, Evans J, Dubinsky M, Aronow B, Hyams JS, Kugathasan S, Huttenhower C, Xavier RJ, Denson LA. Age-of-diagnosis dependent ileal immune intensification and reduced alpha-defensin in older versus younger pediatric Crohn Disease patients despite already established dysbiosis. Mucosal Immunol 2019;12:491-502. [PMID: 30542108 DOI: 10.1038/s41385-018-0114-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
365 Crowley E, Muise A. Inflammatory Bowel Disease. Gastroenterology Clinics of North America 2018;47:755-72. [DOI: 10.1016/j.gtc.2018.07.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
366 Altowati MM, Shepherd S, Mcmillan M, Mcgrogan P, Russell R, Ahmed SF, Wong SC. Persistence of Muscle-bone Deficits Following Anti-tumour Necrosis Factor Therapy in Adolescents With Crohn Disease. Journal of Pediatric Gastroenterology & Nutrition 2018;67:738-44. [DOI: 10.1097/mpg.0000000000002099] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
367 Pagani S, Bozzola E, Strisciuglio C, Meazza C, Miele E, Malamisura M, De Angelis P, Bozzola M. Growth Hormone Receptor Gene Expression Increase Reflects Nutritional Status Improvement in Patients Affected by Crohn's Disease. Front Pediatr 2018;6:338. [PMID: 30483486 DOI: 10.3389/fped.2018.00338] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
368 Ziv-Baran T, Hussey S, Sladek M, Amil Dias J, Martin de Carpi J, Miele E, Veres G, Lionetti P, Koletzko S, Nuti F, Paerregaard A, Kolho KL, Russell RK, Shaoul R, Weiner D, Sigall Boneh R, Escher J, Finnby L, Turner D, Levine A. Response to treatment is more important than disease severity at diagnosis for prediction of early relapse in new-onset paediatric Crohn's disease. Aliment Pharmacol Ther 2018;48:1242-50. [PMID: 30450578 DOI: 10.1111/apt.15016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
369 Shim JO. Recent advance in very early-onset inflammatory bowel disease. Intest Res 2019;17:9-16. [PMID: 30419637 DOI: 10.5217/ir.2018.00130] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
370 Däbritz J, Gerner P, Enninger A, Claßen M, Radke M. Inflammatory Bowel Disease in Childhood and Adolescence. Dtsch Arztebl Int 2017;114:331-8. [PMID: 28597827 DOI: 10.3238/arztebl.2017.0331] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
371 Capriati T, Bizzarri C, Dilillo A, Nobili V, Oliva S, Diamanti A. Growth failure in Crohn's disease children: may the first treatment have a role? Expert Rev Clin Immunol 2019;15:97-104. [PMID: 30403894 DOI: 10.1080/1744666X.2019.1543590] [Reference Citation Analysis]
372 Choi J, Kang B, Kim MJ, Sohn I, Lee HJ, Choe YH. Early Infliximab Yields Superior Long-Term Effects on Linear Growth in Pediatric Crohn's Disease Patients. Gut Liver 2018;12:255-62. [PMID: 29298460 DOI: 10.5009/gnl17290] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
373 Ashton JJ, Batra A, Beattie RM. Paediatric inflammatory bowel disease- brief update on current practice. Paediatrics and Child Health 2018;28:507-14. [DOI: 10.1016/j.paed.2018.08.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
374 Serban ED. Treat-to-target in Crohn’s disease: Will transmural healing become a therapeutic endpoint? World J Clin Cases 2018; 6(12): 501-513 [PMID: 30397606 DOI: 10.12998/wjcc.v6.i12.501] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
375 Ramsey LB, Mizuno T, Vinks AA, Margolis PA. Learning Health Systems as Facilitators of Precision Medicine. Clin Pharmacol Ther 2017;101:359-67. [PMID: 27984650 DOI: 10.1002/cpt.594] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
376 Cho R, Wickert NM, Klassen AF, Tsangaris E, Marshall JK, Brill H. Identifying Needs in Young Adults With Inflammatory Bowel Disease: A Qualitative Study. Gastroenterol Nurs 2018;41:19-28. [PMID: 29373352 DOI: 10.1097/SGA.0000000000000288] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
377 Holmes EA, Rodney Harris RM, Lucas RM. Low Sun Exposure and Vitamin D Deficiency as Risk Factors for Inflammatory Bowel Disease, With a Focus on Childhood Onset. Photochem Photobiol 2019;95:105-18. [PMID: 30155900 DOI: 10.1111/php.13007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
378 Ouldali N, Hugot JP, Viala J, Damir M, Martinez-Vinson C, Meinzer U. Early Arthritis Is Associated With Failure of Immunosuppressive Drugs and Severe Pediatric Crohn's Disease Evolution. Inflamm Bowel Dis 2018;24:2423-30. [PMID: 29788152 DOI: 10.1093/ibd/izy137] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
379 Herzog D, Fournier N, Buehr P, Rueger V, Koller R, Heyland K, Nydegger A, Spalinger J, Schibli S, Petit LM, Braegger CP; Swiss IBD Cohort Study Group. Age at disease onset of inflammatory bowel disease is associated with later extraintestinal manifestations and complications. Eur J Gastroenterol Hepatol. 2018;30:598-607. [PMID: 29360691 DOI: 10.1097/meg.0000000000001072] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
380 Lee WS, Karthik SV, Ng RT, Ong SY, Ong C, Chiou FK, Wong SY, Quak SH, Aw MM. Characteristics and outcome of primary sclerosing cholangitis associated with inflammatory bowel disease in Asian children. Pediatr Neonatol 2019;60:396-404. [PMID: 31409456 DOI: 10.1016/j.pedneo.2018.09.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
381 Carman N, Tomalty D, Church PC, Mack DR, Benchimol EI, Otley AR, Jacobson K, Huynh HQ, DeBruyn JC, El-Matary W, Sherlock M, Van Limbergen J, Griffiths AM, Walters TD; Canadian Children Inflammatory Bowel Disease Network: A Joint Partnership of Canadian Institutes of Health Research and the Children with Intestinal and Liver Disorders Foundation. Clinical disease activity and endoscopic severity correlate poorly in children newly diagnosed with Crohn's disease. Gastrointest Endosc 2019;89:364-72. [PMID: 30273592 DOI: 10.1016/j.gie.2018.09.025] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
382 van Hoeve K, Dreesen E, Hoffman I, Van Assche G, Ferrante M, Gils A, Vermeire S. Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2018;12:1316-25. [DOI: 10.1093/ecco-jcc/jjy111] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 6.5] [Reference Citation Analysis]
383 Naddei R, Martinelli M, Strisciuglio C, DʼArmiento M, Vollaro A, Staiano A, Miele E. Yersinia Enterocolitica Ileitis Mimicking Pediatric Crohn's Disease. Inflamm Bowel Dis 2017;23:E15-6. [PMID: 28230560 DOI: 10.1097/MIB.0000000000001052] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
384 Barber J, Shah N, Watson T. Early onset inflammatory bowel disease – What the radiologist needs to know. European Journal of Radiology 2018;106:173-82. [DOI: 10.1016/j.ejrad.2018.07.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
385 Baker ME, Fletcher JG, Al-hawary M, Bruining D. Interdisciplinary Updates in Crohn’s Disease Reporting Nomenclature, and Cross-Sectional Disease Monitoring. Radiologic Clinics of North America 2018;56:691-707. [DOI: 10.1016/j.rcl.2018.04.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
386 Kulaylat AS, Boltz MM, Moyer M, Mathew A, McKenna K, Messaris E. Management of Large Cecal Polyps: When Can the Ileocecal Valve Be Spared? Dis Colon Rectum 2018;61:1089-95. [PMID: 30086058 DOI: 10.1097/DCR.0000000000001159] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
387 Moran CJ, Kaplan JL, Winter HS. Genetic Variation Affects C-Reactive Protein Elevations in Crohn's Disease. Inflamm Bowel Dis 2018;24:2048-52. [PMID: 29718222 DOI: 10.1093/ibd/izy100] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
388 de Meij TGJ, de Groot EFJ, Peeters CFW, de Boer NKH, Kneepkens CMF, Eck A, Benninga MA, Savelkoul PHM, van Bodegraven AA, Budding AE. Variability of core microbiota in newly diagnosed treatment-naïve paediatric inflammatory bowel disease patients. PLoS One 2018;13:e0197649. [PMID: 30102706 DOI: 10.1371/journal.pone.0197649] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
389 Assa A, Rinawi F, Shamir R. The Long-Term Predictive Properties of the Paris Classification in Paediatric Inflammatory Bowel Disease Patients. J Crohns Colitis. 2018;12:39-47. [PMID: 28961726 DOI: 10.1093/ecco-jcc/jjx125] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
390 Lawley M, Wu JW, Navas-lópez VM, Huynh HQ, Carroll MW, Chen M, Medvedev P, Day AS, Hussey S, Sigall-boneh R, Levine A, Wine E. Global Variation in Use of Enteral Nutrition for Pediatric Crohn Disease. Journal of Pediatric Gastroenterology & Nutrition 2018;67:e22-9. [DOI: 10.1097/mpg.0000000000001946] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
391 El-matary W, Stefanovici C, Van Caeseele P, Deora V, Mccurdy J. Detection of Cytomegalovirus in Colonic Mucosa of Children With Inflammatory Bowel Disease: Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology & Nutrition 2018;67:221-4. [DOI: 10.1097/mpg.0000000000001976] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
392 Ong C, Aw MM, Liwanag MJ, Quak SH, Phua KB. Rapid rise in the incidence and clinical characteristics of pediatric inflammatory bowel disease in a South-East Asian cohort in Singapore, 1994-2015. J Dig Dis 2018;19:395-403. [PMID: 29927059 DOI: 10.1111/1751-2980.12641] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
393 Afzali A, Katz S. Inflammatory Bowel Disease in the Baby to Baby Boomer: Pediatric and Elderly Onset of IBD. Curr Treat Options Gastroenterol 2018;16:289-305. [PMID: 30006766 DOI: 10.1007/s11938-018-0188-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
394 Wang XQ, Xiao Y, Xu X, Yu Y, Shan CY, Guo Y, Gong L, Zhou T, Gao SS, Yuan YZ, Wang XJ, Xu CD. Study of disease phenotype and its association with prognosis of paediatric inflammatory bowel disease in China. BMC Pediatr. 2018;18:229. [PMID: 30001197 DOI: 10.1186/s12887-018-1212-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
395 Mack DR, Benchimol EI, Critch J, deBruyn J, Tse F, Moayyedi P, Church P, Deslandres C, El-Matary W, Huynh H, Jantchou P, Lawrence S, Otley A, Sherlock M, Walters T, Kappelman MD, Sadowski D, Marshall JK, Griffiths A. Canadian Association of Gastroenterology Clinical Practice Guideline for the Medical Management of Pediatric Luminal Crohn's Disease. J Can Assoc Gastroenterol 2019;2:e35-63. [PMID: 31294379 DOI: 10.1093/jcag/gwz018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
396 Joosse ME, Aardoom MA, Kemos P, Turner D, Wilson DC, Koletzko S, Martin-de-Carpi J, Fagerberg UL, Spray C, Tzivinikos C, Sladek M, Shaoul R, Roma-Giannikou E, Bronsky J, Serban DE, Ruemmele FM, Garnier-Lengline H, Veres G, Hojsak I, Kolho KL, Davies IH, Aloi M, Lionetti P, Hussey S, Veereman G, Braegger CP, Trindade E, Wewer AV, Hauer AC, de Vries ACH, Sigall Boneh R, Sarbagili Shabat C, Levine A, de Ridder L, Paediatric IBD Porto group of ESPGHAN. Malignancy and mortality in paediatric-onset inflammatory bowel disease: a 3-year prospective, multinational study from the paediatric IBD Porto group of ESPGHAN. Aliment Pharmacol Ther. 2018;48:523-537. [PMID: 29984520 DOI: 10.1111/apt.14893] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 7.8] [Reference Citation Analysis]
397 Basturk A, Artan R, Yılmaz A, Gelen MT. Gastritis Associated with Initially Pediatric Crohn's Disease and Ulcerative Colitis. Pediatr Gastroenterol Hepatol Nutr 2018;21:163-9. [PMID: 29992115 DOI: 10.5223/pghn.2018.21.3.163] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
398 Bosch S, El Manouni El Hassani S, Covington JA, Wicaksono AN, Bomers MK, Benninga MA, Mulder CJJ, de Boer NKH, de Meij TGJ. Optimized Sampling Conditions for Fecal Volatile Organic Compound Analysis by Means of Field Asymmetric Ion Mobility Spectrometry. Anal Chem 2018;90:7972-81. [PMID: 29860824 DOI: 10.1021/acs.analchem.8b00688] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
399 van den Brink G, Stapersma L, Vlug LE, Rizopolous D, Bodelier AG, van Wering H, Hurkmans PCWM, Stuyt RJL, Hendriks DM, van der Burg JAT, Utens EMWJ, Escher JC. Clinical disease activity is associated with anxiety and depressive symptoms in adolescents and young adults with inflammatory bowel disease. Aliment Pharmacol Ther 2018;48:358-69. [PMID: 29897134 DOI: 10.1111/apt.14832] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
400 Mao R, Tang RH, Qiu Y, Chen BL, Guo J, Zhang SH, Li XH, Feng R, He Y, Li ZP, Zeng ZR, Eliakim R, Ben-Horin S, Chen MH. Different clinical outcomes in Crohn's disease patients with esophagogastroduodenal, jejunal, and proximal ileal disease involvement: is L4 truly a single phenotype? Therap Adv Gastroenterol. 2018;11:1756284818777938. [PMID: 29899757 DOI: 10.1177/1756284818777938] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
401 Aloi M, Bramuzzo M, Arrigo S, Romano C, D’arcangelo G, Lacorte D, Gatti S, Illiceto MT, Zucconi F, Dilillo D, Zuin G, Knafelz D, Ravelli A, Cucchiara S, Alvisi P. Efficacy and Safety of Adalimumab in Pediatric Ulcerative Colitis: A Real-life Experience from the SIGENP-IBD Registry. Journal of Pediatric Gastroenterology & Nutrition 2018;66:920-5. [DOI: 10.1097/mpg.0000000000001883] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 2.8] [Reference Citation Analysis]
402 Timmer A, Stark R, Peplies J, Classen M, Laass MW, Koletzko S. Current health status and medical therapy of patients with pediatric-onset inflammatory bowel disease: a survey-based analysis on 1280 patients aged 10-25 years focusing on differences by age of onset. Eur J Gastroenterol Hepatol 2017;29:1276-83. [PMID: 28877085 DOI: 10.1097/MEG.0000000000000956] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
403 Shaikhkhalil AK, Boyle B, Smith J, Dotson JL, Donegan A, Kim SC, Maltz RM, Crandall W. Using Quality Improvement to Increase Utilization of Enteral Therapy in Pediatric Crohn Disease: Results and Outcomes. Journal of Pediatric Gastroenterology & Nutrition 2018;66:909-14. [DOI: 10.1097/mpg.0000000000001879] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
404 Zheng C, Huang Y, Ye Z, Wang Y, Tang Z, Lu J, Wu J, Zhou Y, Wang L, Huang Z, Yang H, Xue A. Infantile Onset Intractable Inflammatory Bowel Disease Due to Novel Heterozygous Mutations in TNFAIP3 (A20). Inflammatory Bowel Diseases 2018;24:2613-20. [DOI: 10.1093/ibd/izy165] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
405 Herman Y, Rinawi F, Rothschild B, Nir O, Shamir R, Assa A. The Characteristics and Long-term Outcomes of Pediatric Crohn's Disease Patients with Perianal Disease. Inflamm Bowel Dis 2017;23:1659-65. [PMID: 28590344 DOI: 10.1097/MIB.0000000000001171] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 4.8] [Reference Citation Analysis]
406 Wauters L, Smets F, De Greef E, Bontems P, Hoffman I, Hauser B, Alliet P, Arts W, Peeters H, Van Biervliet S, Paquot I, Van de Vijver E, De Vos M, Bossuyt P, Rahier JF, Dewit O, Moreels T, Franchimont D, Muls V, Fontaine F, Louis E, Coche JC, Baert F, Paul J, Vermeire S, Veereman G. Long-term Outcomes with Anti-TNF Therapy and Accelerated Step-up in the Prospective Pediatric Belgian Crohn's Disease Registry (BELCRO). Inflamm Bowel Dis 2017;23:1584-91. [PMID: 28696956 DOI: 10.1097/MIB.0000000000001193] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
407 Röber N, Noß L, Goihl A, Reinhold D, Jahn J, de Laffolie J, Johannes W, Flemming GM, Roggenbuck D, Conrad K, Laass MW. Autoantibodies Against Glycoprotein 2 Isoforms in Pediatric Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis 2017;23:1624-36. [PMID: 28691939 DOI: 10.1097/MIB.0000000000001159] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
408 Deeke SA, Starr AE, Ning Z, Ahmadi S, Zhang X, Mayne J, Chiang C, Singleton R, Benchimol EI, Mack DR, Stintzi A, Figeys D. Open: Mucosal-luminal interface proteomics reveals biomarkers of pediatric inflammatory bowel disease-associated colitis: . American Journal of Gastroenterology 2018;113:713-24. [DOI: 10.1038/s41395-018-0024-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
409 Rialon KL, Crowley E, Seemann NM, Fahy AS, Muise A, Langer JC. Long-term outcomes for children with very early-onset colitis: Implications for surgical management. Journal of Pediatric Surgery 2018;53:964-7. [DOI: 10.1016/j.jpedsurg.2018.02.023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
410 Shiau H, Ihekweazu FD, Amin M, Fofanova T, Miloh T, Kellermayer R. Unique Inflammatory Bowel Disease Phenotype of Pediatric Primary Sclerosing Cholangitis: A Single-Center Study. J Pediatr Gastroenterol Nutr. 2017;65:404-409. [PMID: 28141677 DOI: 10.1097/mpg.0000000000001531] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
411 Yerushalmy-Feler A, Ben-Tov A, Weintraub Y, Amir A, Galai T, Moran-Lev H, Cohen S. High and low body mass index may predict severe disease course in children with inflammatory bowel disease. Scand J Gastroenterol. 2018;53:708-713. [PMID: 29688090 DOI: 10.1080/00365521.2018.1464595] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
412 Herzog D, Fournier N, Buehr P, Rueger V, Koller R, Heyland K, Nydegger A, Braegger CP; Swiss IBD Cohort Study Group. Prevalence of intestinal complications in inflammatory bowel disease: a comparison between paediatric-onset and adult-onset patients. Eur J Gastroenterol Hepatol 2017;29:926-31. [PMID: 28471820 DOI: 10.1097/MEG.0000000000000896] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 5.3] [Reference Citation Analysis]
413 Sieczkowska-Golub J, Meglicka M, Plocek A, Banaszkiewicz A, Jarzębicka D, Toporowska-Kowalska E, Gawronska A, Oracz G, Kierkus J. Induction Therapy With Biosimilar Infliximab in Children With Crohn Disease. J Pediatr Gastroenterol Nutr 2017;65:285-8. [PMID: 28542043 DOI: 10.1097/MPG.0000000000001643] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
414 Dionne S, Duchatelier CF, Seidman EG. The influence of vitamin D on M1 and M2 macrophages in patients with Crohn's disease. Innate Immun 2017;23:557-65. [PMID: 28770666 DOI: 10.1177/1753425917721965] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 7.5] [Reference Citation Analysis]
415 Assa A, Amitai M, Greer ML, Castro DA, Kuint RC, Martínez-León M, Herman-Sucharska I, Coppenrath E, Anupindi S, Towbin A, Moote D, Konen O, Pratt LT, Griffiths A, Turner D; ImageKids Study Group. Perianal Pediatric Crohn Disease Is Associated With a Distinct Phenotype and Greater Inflammatory Burden. J Pediatr Gastroenterol Nutr 2017;65:293-8. [PMID: 28362690 DOI: 10.1097/MPG.0000000000001484] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 4.8] [Reference Citation Analysis]
416 Auth MK, Bunn SK, Protheroe AL, Williams LJ, Fell JM, Muhammed R, Croft NM, Beattie RM, Willmott A, Spray C, Vadamalayan B, Rodrigues A, Puntis J, Pigott AJ, Wilson DC, Mitton S, Furman M, Charlton C, Chong SKF, Russell RK; BSPGHAN IBD working group, BSPGHAN IBD site leads. Improved Medical Treatment and Surgical Surveillance of Children and Adolescents with Ulcerative Colitis in the United Kingdom. Inflammatory Bowel Diseases 2018;24:1520-30. [DOI: 10.1093/ibd/izy042] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
417 Hong SJ, Cho SM, Choe BH, Jang HJ, Choi KH, Kang B, Kim JE, Hwang JH. Characteristics and Incidence Trends for Pediatric Inflammatory Bowel Disease in Daegu-Kyungpook Province in Korea: a Multi-Center Study. J Korean Med Sci 2018;33:e132. [PMID: 29713253 DOI: 10.3346/jkms.2018.33.e132] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
418 Cicero G, D'Angelo T, Bottari A, Costantino G, Visalli C, Racchiusa S, Marino MA, Cavallaro M, Frosina L, Blandino A, Mazziotti S. Superior Mesenteric Artery Syndrome in Patients with Crohn's Disease: A Description of 2 Cases Studied with a Novel Magnetic Resonance Enterography (MRE) Procedure. Am J Case Rep 2018;19:431-7. [PMID: 29643328 DOI: 10.12659/ajcr.908273] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
419 Claar RL, van Tilburg MAL, Abdullah B, Langer S, Sherif D, Whitehead WE, Drossman DA, Levy RL. Psychological Distress and Quality of Life in Pediatric Crohn Disease: Impact of Pain and Disease State. J Pediatr Gastroenterol Nutr 2017;65:420-4. [PMID: 28945206 DOI: 10.1097/MPG.0000000000001549] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 3.8] [Reference Citation Analysis]
420 Rinawi F, Assa A, Hartman C, Mozer Glassberg Y, Nachmias Friedler V, Rosenbach Y, Silbermintz A, Zevit N, Shamir R. Long-term Extent Change of Pediatric-Onset Ulcerative Colitis. Journal of Clinical Gastroenterology 2018;52:326-32. [DOI: 10.1097/mcg.0000000000000741] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
421 Diederen K, Haverman L, Grootenhuis MA, Benninga MA, Kindermann A. Parental Distress and Quality of Life in Pediatric Inflammatory Bowel Disease: Implications for the Outpatient Clinic. Journal of Pediatric Gastroenterology & Nutrition 2018;66:630-6. [DOI: 10.1097/mpg.0000000000001756] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 3.3] [Reference Citation Analysis]
422 Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE. ACG Clinical Guideline: Management of Crohn's Disease in Adults. Am J Gastroenterol. 2018;113:481-517. [PMID: 29610508 DOI: 10.1038/ajg.2018.27] [Cited by in Crossref: 390] [Cited by in F6Publishing: 451] [Article Influence: 97.5] [Reference Citation Analysis]
423 Akintimehin AO, O'Neill RS, Ring C, Raftery T, Hussey S. Outcomes of a National Cohort of Children with Acute Severe Ulcerative Colitis. Front Pediatr 2018;6:48. [PMID: 29568735 DOI: 10.3389/fped.2018.00048] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
424 Ricciuto A, Fish J, Carman N, Walters TD, Church PC, Hansen BE, Crowley E, Siddiqui I, Nguyen GC, Kamath BM, Griffiths AM. Symptoms Do Not Correlate With Findings From Colonoscopy in Children With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis. Clin Gastroenterol Hepatol. 2018;16:1098-1105.e1. [PMID: 29378308 DOI: 10.1016/j.cgh.2018.01.020] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
425 Sonavane AD, Sonawane P, Amarapurkar DN. Inflammatory Bowel Disease Across the Age Continuum: Similarity and Disparity. Indian J Pediatr. 2018;85:989-994. [PMID: 29572605 DOI: 10.1007/s12098-018-2665-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
426 Fabian O, Hradsky O, Drskova T, Mikus F, Zamecnik J, Bronsky J. Immunohistochemical Assessment of CD30+ Lymphocytes in the Intestinal Mucosa Facilitates Diagnosis of Pediatric Ulcerative Colitis. Dig Dis Sci 2018;63:1811-8. [PMID: 29541900 DOI: 10.1007/s10620-018-5018-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
427 Turner D, Yerushalmi B, Kori M, Broide E, Mozer-Glassberg Y, Shaoul R, Kolho KL, Shteyer E, Shamaly H, Ledder O, Cohen S, Peleg S, On A, Levine A. Once- Versus Twice-daily Mesalazine to Induce Remission in Paediatric Ulcerative Colitis: A Randomised Controlled Trial. J Crohns Colitis 2017;11:527-33. [PMID: 28453754 DOI: 10.1093/ecco-jcc/jjw180] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
428 Bequet E, Sarter H, Fumery M, Vasseur F, Armengol-Debeir L, Pariente B, Ley D, Spyckerelle C, Coevoet H, Laberenne JE. Incidence and Phenotype at Diagnosis of Very-early-onset Compared with Later-onset Paediatric Inflammatory Bowel Disease: A Population-based Study [1988-2011]. J Crohns Colitis. 2017;11:519-526. [PMID: 28453757 DOI: 10.1093/ecco-jcc/jjw194] [Cited by in Crossref: 9] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
429 Fang YH, Luo YY, Yu JD, Lou JG, Chen J. Phenotypic and genotypic characterization of inflammatory bowel disease in children under six years of age in China. World J Gastroenterol 2018; 24(9): 1035-1045 [PMID: 29531467 DOI: 10.3748/wjg.v24.i9.1035] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 21] [Article Influence: 6.5] [Reference Citation Analysis]
430 Amininejad L, Charloteaux B, Theatre E, Liefferinckx C, Dmitrieva J, Hayard P, Muls V, Maisin JM, Schapira M, Ghislain JM, Closset P, Talib M, Abramowicz M, Momozawa Y, Deffontaine V, Crins F, Mni M, Karim L, Cambisano N, Ornemese S, Zucchi A, Minsart C, Deviere J, Hugot JP, De Vos M, Louis E, Vermeire S, Van Gossum A, Coppieters W, Twizere JC, Georges M, Franchimont D; International IBD Genetics Consortium. Analysis of Genes Associated With Monogenic Primary Immunodeficiency Identifies Rare Variants in XIAP in Patients With Crohn's Disease. Gastroenterology 2018;154:2165-77. [PMID: 29501442 DOI: 10.1053/j.gastro.2018.02.028] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
431 Giugliano FP, Strisciuglio C, Martinelli M, Andreozzi M, Cenni S, Campione S, D’armiento M, Staiano A, Miele E. Does Azathioprine induce endoscopic and histologic healing in pediatric inflammatory bowel disease? A prospective, observational study. Digestive and Liver Disease 2018;50:240-6. [DOI: 10.1016/j.dld.2017.10.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
432 Ling J, Buurman D, Ravikumara M, Mews C, Thacker K, Grover Z. Accelerated Step-Up Infliximab Use Is Associated with Sustained Primary Response in Pediatric Crohn’s Disease. Dig Dis Sci 2018;63:1003-10. [DOI: 10.1007/s10620-018-4969-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
433 Adler J, Dong S, Eder SJ, Dombkowski KJ; ImproveCareNow Pediatric IBD Learning Health System. Perianal Crohn Disease in a Large Multicenter Pediatric Collaborative. J Pediatr Gastroenterol Nutr 2017;64:e117-24. [PMID: 27801750 DOI: 10.1097/MPG.0000000000001447] [Cited by in Crossref: 31] [Cited by in F6Publishing: 10] [Article Influence: 7.8] [Reference Citation Analysis]
434 Syed S, Kugathasan S, Kumar A, Prince J, Schoen BT, McCracken C, Ziegler TR, Suchdev PS. Use of Reticulocyte Hemoglobin Content in the Assessment of Iron Deficiency in Children With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2017;64:713-20. [PMID: 27429427 DOI: 10.1097/MPG.0000000000001335] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
435 Huang Z, Peng K, Li X, Zhao R, You J, Cheng X, Wang Z, Wang Y, Wu B, Wang H, Zeng H, Yu Z, Zheng C, Wang Y, Huang Y. Mutations in Interleukin-10 Receptor and Clinical Phenotypes in Patients with Very Early Onset Inflammatory Bowel Disease: A Chinese VEO-IBD Collaboration Group Survey. Inflamm Bowel Dis. 2017;23:578-590. [PMID: 28267044 DOI: 10.1097/mib.0000000000001058] [Cited by in Crossref: 37] [Cited by in F6Publishing: 20] [Article Influence: 9.3] [Reference Citation Analysis]
436 Diederen K, de Ridder L, van Rheenen P, Wolters VM, Mearin ML, Damen GM, de Meij TG, van Wering H, Tseng LA, Oomen MW, de Jong JR, Sloots CE, Benninga MA, Kindermann A. Complications and Disease Recurrence After Primary Ileocecal Resection in Pediatric Crohn's Disease: A Multicenter Cohort Analysis. Inflamm Bowel Dis 2017;23:272-82. [PMID: 28079626 DOI: 10.1097/MIB.0000000000000999] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 4.3] [Reference Citation Analysis]
437 Kang B, Choi SY, Choi YO, Kim M, Kim K, Lee J, Choe YH. Subtherapeutic Infliximab Trough Levels and Complete Mucosal Healing Are Associated With Sustained Clinical Remission After Infliximab Cessation in Paediatric-onset Crohn’s Disease Patients Treated With Combined Immunosuppressive Therapy. Journal of Crohn's and Colitis 2018;12:644-52. [DOI: 10.1093/ecco-jcc/jjy021] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
438 Guerrerio AL, Frischmeyer-Guerrerio PA, Huang C, Wu Y, Haritunians T, McGovern DPB, MacCarrick GL, Brant SR, Dietz HC. Increased Prevalence of Inflammatory Bowel Disease in Patients with Mutations in Genes Encoding the Receptor Subunits for TGFβ. Inflamm Bowel Dis 2016;22:2058-62. [PMID: 27508510 DOI: 10.1097/MIB.0000000000000872] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
439 Levy RL, van Tilburg MA, Langer SL, Romano JM, Walker LS, Mancl LA, Murphy TB, Claar RL, Feld SI, Christie DL, Abdullah B, DuPen MM, Swanson KS, Baker MD, Stoner SA, Whitehead WE. Effects of a Cognitive Behavioral Therapy Intervention Trial to Improve Disease Outcomes in Children with Inflammatory Bowel Disease. Inflamm Bowel Dis 2016;22:2134-48. [PMID: 27542131 DOI: 10.1097/MIB.0000000000000881] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 8.8] [Reference Citation Analysis]
440 Assa A, Butcher J, Li J, Elkadri A, Sherman PM, Muise AM, Stintzi A, Mack D. Mucosa-Associated Ileal Microbiota in New-Onset Pediatric Crohn's Disease. Inflamm Bowel Dis. 2016;22:1533-1539. [PMID: 27271491 DOI: 10.1097/mib.0000000000000776] [Cited by in Crossref: 33] [Cited by in F6Publishing: 18] [Article Influence: 8.3] [Reference Citation Analysis]
441 Connors J, Basseri S, Grant A, Giffin N, Mahdi G, Noble A, Rashid M, Otley A, Van Limbergen J. Exclusive Enteral Nutrition Therapy in Paediatric Crohn's Disease Results in Long-term Avoidance of Corticosteroids: Results of a Propensity-score Matched Cohort Analysis. J Crohns Colitis 2017;11:1063-70. [PMID: 28575325 DOI: 10.1093/ecco-jcc/jjx060] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 8.5] [Reference Citation Analysis]
442 Birimberg-Schwartz L, Zucker DM, Akriv A, Cucchiara S, Cameron FL, Wilson DC, Lazowska I, Yianni L, Paul SP, Romano C, Kolacek S, Buderus S, Pærregaard A, Russell RK, Escher JC, Turner D; Pediatric IBD Porto group of ESPGHAN. Development and Validation of Diagnostic Criteria for IBD Subtypes Including IBD-unclassified in Children: a Multicentre Study From the Pediatric IBD Porto Group of ESPGHAN. J Crohns Colitis 2017;11:1078-84. [PMID: 28430891 DOI: 10.1093/ecco-jcc/jjx053] [Cited by in Crossref: 6] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
443 Aloi M, DʼArcangelo G, Bramuzzo M, Gasparetto M, Martinelli M, Alvisi P, Illiceto MT, Valenti S, Distante M, Pellegrino S, Gatti S, Arrigo S, Civitelli F, Martelossi S; SIGENP IBD Working Group. Effect of Early Versus Late Azathioprine Therapy in Pediatric Ulcerative Colitis. Inflamm Bowel Dis 2016;22:1647-54. [PMID: 27271489 DOI: 10.1097/MIB.0000000000000828] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
444 Al-Hussaini A, El Mouzan M, Hasosah M, Al-Mehaidib A, ALSaleem K, Saadah OI, Al-Edreesi M. Clinical Pattern of Early-Onset Inflammatory Bowel Disease in Saudi Arabia: A Multicenter National Study. Inflamm Bowel Dis. 2016;22:1961-1970. [PMID: 27104817 DOI: 10.1097/mib.0000000000000796] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 5.8] [Reference Citation Analysis]
445 Birimberg-Schwartz L, Wilson DC, Kolho KL, Karolewska-Bochenek K, Afzal NA, Spray C, Romano C, Lionetti P, Hauer AC, Martinez-Vinson C, Veres G, Escher JC, Turner D; paediatric IBD Porto group of ESPGHAN. pANCA and ASCA in Children with IBD-Unclassified, Crohn's Colitis, and Ulcerative Colitis-A Longitudinal Report from the IBD Porto Group of ESPGHAN. Inflamm Bowel Dis 2016;22:1908-14. [PMID: 27135480 DOI: 10.1097/MIB.0000000000000784] [Cited by in Crossref: 29] [Cited by in F6Publishing: 10] [Article Influence: 7.3] [Reference Citation Analysis]
446 Oliva S, Bassotti G, Villanacci V. Histologic features in pediatric ileitis: Is it possible to tip the balance towards Crohn’s disease? Digestive and Liver Disease 2018;50:154-5. [DOI: 10.1016/j.dld.2017.12.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
447 Navas-lópez VM, Pujol-muncunill G, Llerena E, Navalón Rubio M, Gil-ortega D, Varea-calderón V, Sierra Salinas C, Martin-de-carpi J. A real-world study focused on the effectiveness and safety of adalimumab as first-line anti-TNF treatment for paediatric Crohn's disease. Anales de Pediatría (English Edition) 2018;88:89-99. [DOI: 10.1016/j.anpede.2017.03.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
448 Mager DR, Carroll MW, Wine E, Siminoski K, Macdonald K, Kluthe CL, Medvedev P, Chen M, Wu J, Turner JM, Huynh HQ. Vitamin D status and risk for sarcopenia in youth with inflammatory bowel diseases. Eur J Clin Nutr 2018;72:623-6. [DOI: 10.1038/s41430-018-0105-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
449 Mañosa M, Calafat M, de Francisco R, García C, Casanova MJ, Huelín P, Calvo M, Tosca J, Fernández-Salazar L, Arajol C, Zabana Y, Bastida G, Hinojosa J, Márquez L, Barreiro-de-Acosta M, Calvet X, Monfort D, Gómez-Garcia MR, Rodríguez E, Huguet JM, Rojas-Feria M, Hervias D, Atienza R, Busquets D, Zapata E, Dueñas C, Charro M, Martínez-Cerezo FJ, Plaza R, Vázquez JM, Gisbert JP, Cañete F, Cabré E, Domènech E; GETECCU. Phenotype and natural history of elderly onset inflammatory bowel disease: a multicentre, case-control study. Aliment Pharmacol Ther 2018;47:605-14. [PMID: 29369387 DOI: 10.1111/apt.14494] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 10.3] [Reference Citation Analysis]
450 Minar P, Jackson K, Tsai YT, Rosen MJ, Northcutt M, Khodoun M, Finkelman FD, Denson LA. A Low Neutrophil CD64 Index Is Associated with Sustained Remission During Infliximab Maintenance Therapy. Inflamm Bowel Dis 2016;22:2641-7. [PMID: 27749455 DOI: 10.1097/MIB.0000000000000922] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
451 Dunn KA, Moore-Connors J, MacIntyre B, Stadnyk AW, Thomas NA, Noble A, Mahdi G, Rashid M, Otley AR, Bielawski JP, Van Limbergen J. Early Changes in Microbial Community Structure Are Associated with Sustained Remission After Nutritional Treatment of Pediatric Crohn's Disease. Inflamm Bowel Dis. 2016;22:2853-2862. [PMID: 27805918 DOI: 10.1097/mib.0000000000000956] [Cited by in Crossref: 48] [Cited by in F6Publishing: 22] [Article Influence: 12.0] [Reference Citation Analysis]
452 Rinawi F, Assa A, Hartman C, Mozer Glassberg Y, Friedler VN, Rosenbach Y, Silbermintz A, Zevit N, Shamir R. Incidence of Bowel Surgery and Associated Risk Factors in Pediatric-Onset Crohn's Disease. Inflamm Bowel Dis 2016;22:2917-23. [PMID: 27755214 DOI: 10.1097/MIB.0000000000000937] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
453 Goyal A, Yeh A, Bush BR, Firek BA, Siebold LM, Rogers MB, Kufen AD, Morowitz MJ. Safety, Clinical Response, and Microbiome Findings Following Fecal Microbiota Transplant in Children With Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2018;24:410-21. [DOI: 10.1093/ibd/izx035] [Cited by in Crossref: 70] [Cited by in F6Publishing: 63] [Article Influence: 17.5] [Reference Citation Analysis]
454 Douglas GM, Hansen R, Jones CMA, Dunn KA, Comeau AM, Bielawski JP, Tayler R, El-Omar EM, Russell RK, Hold GL, Langille MGI, Van Limbergen J. Multi-omics differentially classify disease state and treatment outcome in pediatric Crohn's disease. Microbiome. 2018;6:13. [PMID: 29335008 DOI: 10.1186/s40168-018-0398-3] [Cited by in Crossref: 43] [Cited by in F6Publishing: 52] [Article Influence: 10.8] [Reference Citation Analysis]
455 Minar P, Saeed SA, Afreen M, Kim MO, Denson LA. Practical Use of Infliximab Concentration Monitoring in Pediatric Crohn Disease. J Pediatr Gastroenterol Nutr 2016;62:715-22. [PMID: 26551317 DOI: 10.1097/MPG.0000000000001029] [Cited by in Crossref: 30] [Cited by in F6Publishing: 8] [Article Influence: 7.5] [Reference Citation Analysis]
456 Bruining DH, Zimmermann EM, Loftus EV Jr, Sandborn WJ, Sauer CG, Strong SA; Society of Abdominal Radiology Crohn’s Disease-Focused Panel. Consensus Recommendations for Evaluation, Interpretation, and Utilization of Computed Tomography and Magnetic Resonance Enterography in Patients With Small Bowel Crohn's Disease. Radiology 2018;286:776-99. [PMID: 29319414 DOI: 10.1148/radiol.2018171737] [Cited by in Crossref: 90] [Cited by in F6Publishing: 97] [Article Influence: 22.5] [Reference Citation Analysis]
457 Bruining DH, Zimmermann EM, Loftus EV Jr, Sandborn WJ, Sauer CG, Strong SA; Society of Abdominal Radiology Crohn’s Disease-Focused Panel. Consensus Recommendations for Evaluation, Interpretation, and Utilization of Computed Tomography and Magnetic Resonance Enterography in Patients With Small Bowel Crohn's Disease. Gastroenterology 2018;154:1172-94. [PMID: 29329905 DOI: 10.1053/j.gastro.2017.11.274] [Cited by in Crossref: 79] [Cited by in F6Publishing: 87] [Article Influence: 19.8] [Reference Citation Analysis]
458 Jung D, Lee S, Jeong I, Oh SH, Kim KM. Short-Term Outcome of Infliximab Therapy in Pediatric Crohn's Disease: A Single-Center Experience. Pediatr Gastroenterol Hepatol Nutr 2017;20:236-43. [PMID: 29302505 DOI: 10.5223/pghn.2017.20.4.236] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
459 Assa A, Bronsky J, Kolho KL, Zarubova K, de Meij T, Ledder O, Sladek M, van Biervliet S, Strisciuglio C, Shamir R. Anti-TNFα Treatment After Surgical Resection for Crohn's Disease Is Effective Despite Previous Pharmacodynamic Failure. Inflamm Bowel Dis 2017;23:791-7. [PMID: 28426458 DOI: 10.1097/MIB.0000000000001050] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
460 Kang B, Choi SY, Chi S, Lim Y, Jeon TY, Choe YH. Baseline wall thickness is lower in mucosa-healed segments 1 year after infliximab in pediatric Crohn disease patients. J Pediatr Gastroenterol Nutr. 2017;64:279-285. [PMID: 27050057 DOI: 10.1097/mpg.0000000000001222] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
461 Turner D, Levine A, Walters TD, Focht G, Otley A, López VN, Koletzko S, Baldassano R, Mack D, Hyams J. Which PCDAI Version Best Reflects Intestinal Inflammation in Pediatric Crohn’s Disease? J Pediatr Gastroenterol Nutr. 2016; Epub ahead of print. [PMID: 27050050 DOI: 10.1097/mpg.0000000000001227] [Cited by in Crossref: 38] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
462 Ohya T, Yanagimachi M, Iwasawa K, Umetsu S, Sogo T, Inui A, Fujisawa T, Ito S. Childhood-onset inflammatory bowel diseases associated with mutation of Wiskott-Aldrich syndrome protein gene. World J Gastroenterol 2017; 23(48): 8544-8552 [PMID: 29358862 DOI: 10.3748/wjg.v23.i48.8544] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
463 Bramuzzo M, Martelossi S, Torre G, Cardile S, Arrigo S, Vignola S, Ferrari F, Zuin G, Illiceto MT, Gasparetto M, Pellegrino S, Romano C, Maggiore G, Montico M, Aloi M; SIGENP IBD Group. Clinical Features and Risk Factors of Autoimmune Liver Involvement in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2016;63:259-264. [PMID: 26756875 DOI: 10.1097/mpg.0000000000001078] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
464 De Greef E, Hoffman I, Smets F, Van Biervliet S, Bontems P, Hauser B, Paquot I, Alliet P, Arts W, Dewit O, De Vos M, Baert F, Bossuyt P, Rahier JF, Franchimont D, Vermeire S, Fontaine F, Louis E, Coche JC, Veereman G; IBD working group of BESPGHAN, BIRD. Paediatric Crohn Disease: Disease Activity and Growth in the BELCRO Cohort After 3 Years Follow-up. J Pediatr Gastroenterol Nutr 2016;63:253-8. [PMID: 26835906 DOI: 10.1097/MPG.0000000000001132] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
465 Zaidi D, Bording-Jorgensen M, Huynh HQ, Carroll MW, Turcotte JF, Sergi C, Liu J, Wine E. Increased Epithelial Gap Density in the Noninflamed Duodenum of Children With Inflammatory Bowel Diseases. J Pediatr Gastroenterol Nutr 2016;63:644-50. [PMID: 26933801 DOI: 10.1097/MPG.0000000000001182] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 2.6] [Reference Citation Analysis]
466 Kelsen JR, Sullivan KE. Inflammatory Bowel Disease in Primary Immunodeficiencies. Curr Allergy Asthma Rep 2017;17:57. [PMID: 28755025 DOI: 10.1007/s11882-017-0724-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
467 Ley D, Duhamel A, Behal H, Vasseur F, Sarter H, Michaud L, Gower-Rousseau C, Turck D. Growth Pattern in Paediatric Crohn Disease Is Related to Inflammatory Status. J Pediatr Gastroenterol Nutr 2016;63:637-43. [PMID: 26925610 DOI: 10.1097/MPG.0000000000001177] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 3.6] [Reference Citation Analysis]
468 Senhaji N, Nadifi S, Zaid Y, Serrano A, Rodriguez DAL, Serbati N, Karkouri M, Badre W, Martín J. Polymorphisms in oxidative pathway related genes and susceptibility to inflammatory bowel disease. World J Gastroenterol 2017; 23(47): 8300-8307 [PMID: 29307990 DOI: 10.3748/wjg.v23.i47.8300] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
469 Corica D, Romano C. Biological Therapy in Pediatric Inflammatory Bowel Disease: A Systematic Review. J Clin Gastroenterol. 2017;51:100-110. [PMID: 27636407 DOI: 10.1097/mcg.0000000000000696] [Cited by in Crossref: 27] [Cited by in F6Publishing: 6] [Article Influence: 5.4] [Reference Citation Analysis]
470 Özçakar ZB, Çakar N, Uncu N, Çelikel BA, Yalçinkaya F. Familial Mediterranean fever-associated diseases in children. QJM 2017;110:287-90. [PMID: 28040706 DOI: 10.1093/qjmed/hcw230] [Cited by in Crossref: 7] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
471 Girardelli M, Basaldella F, Paolera SD, Vuch J, Tommasini A, Martelossi S, Crovella S, Bianco AM. Genetic profile of patients with early onset inflammatory bowel disease. Gene. 2018;645:18-29. [PMID: 29248579 DOI: 10.1016/j.gene.2017.12.029] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
472 Lichtman Y, Sheiner E, Wainstock T, Segal I, Landau D, Walfisch A. Maternal history of recurrent pregnancy loss is associated with increased risk for long-term pediatric gastrointestinal morbidity in the offspring. Am J Reprod Immunol 2018;79:e12799. [DOI: 10.1111/aji.12799] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
473 Protásio BKPF, Barbosa CMPMM, Neufeld CB, Buck LD, Laund LSL, Toporovski MS, Visoni TC. Specificities of presentation of Crohn's disease in childhood. Einstein (Sao Paulo) 2018;16:eRC4070. [PMID: 29236792 DOI: 10.1590/S1679-45082017RC4070] [Reference Citation Analysis]
474 Wilson DC, Russell RK. Overview of paediatric IBD. Seminars in Pediatric Surgery 2017;26:344-8. [DOI: 10.1053/j.sempedsurg.2017.10.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
475 Nasiri S, Kuenzig ME, Benchimol EI. Long-term outcomes of pediatric inflammatory bowel disease. Seminars in Pediatric Surgery 2017;26:398-404. [DOI: 10.1053/j.sempedsurg.2017.10.010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
476 Krawiec P, Mroczkowska-juchkiewicz A, Pac-kożuchowska E. Serum Hepcidin in Children with Inflammatory Bowel Disease: . Inflammatory Bowel Diseases 2017;23:2165-71. [DOI: 10.1097/mib.0000000000001245] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
477 Frivolt K, Hetterich H, Schwerd T, Hajji M, Bufler P, Coppenrath E, Koletzko S. Increase of Intra-abdominal Adipose Tissue in Pediatric Crohn Disease. Journal of Pediatric Gastroenterology & Nutrition 2017;65:633-8. [DOI: 10.1097/mpg.0000000000001593] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
478 Senhaji N, Zaid Y, El Khalfi B, Fahimi M, Martin J, Badre W, Nadifi S, Soukri A. Peroxiredoxin-2 up-regulation in inflammatory bowel disease: Friend or foe? J Gastroenterol Hepatol 2017;32:1212-20. [PMID: 27869326 DOI: 10.1111/jgh.13664] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
479 Alsabban Z, Carman N, Moineddin R, Lo RT, King SK, Langer JC, Walters TD, Griffiths AM, Church PC, Greer MC. Can MR enterography screen for perianal disease in pediatric inflammatory bowel disease?: Can MRE Screen for Perianal Disease in P-IBD? J Magn Reson Imaging 2018;47:1638-45. [DOI: 10.1002/jmri.25888] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
480 Hochart A, Gower-Rousseau C, Sarter H, Fumery M, Ley D, Spyckerelle C, Peyrin-Biroulet L, Laberenne JE, Vasseur F, Savoye G, Turck D; Epimad Group. Ulcerative proctitis is a frequent location of paediatric-onset UC and not a minor disease: a population-based study. Gut 2017;66:1912-7. [PMID: 27489240 DOI: 10.1136/gutjnl-2016-311970] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
481 Schwerd T, Bryant RV, Pandey S, Capitani M, Meran L, Cazier JB, Jung J, Mondal K, Parkes M, Mathew CG, Fiedler K, McCarthy DJ, Sullivan PB, Rodrigues A, Travis SPL, Moore C, Sambrook J, Ouwehand WH, Roberts DJ, Danesh J, Russell RK, Wilson DC, Kelsen JR, Cornall R, Denson LA, Kugathasan S, Knaus UG, Serra EG, Anderson CA, Duerr RH, McGovern DP, Cho J, Powrie F, Li VS, Muise AM, Uhlig HH; WGS500 Consortium., Oxford IBD cohort study investigators., COLORS in IBD group investigators., UK IBD Genetics Consortium., INTERVAL Study. NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease. Mucosal Immunol 2018;11:562-74. [PMID: 29091079 DOI: 10.1038/mi.2017.74] [Cited by in Crossref: 49] [Cited by in F6Publishing: 37] [Article Influence: 9.8] [Reference Citation Analysis]
482 Dipasquale V, Romano C. Pharmacological treatments and infectious diseases in pediatric inflammatory bowel disease. Expert Rev Gastroenterol Hepatol 2018;12:237-47. [PMID: 28994306 DOI: 10.1080/17474124.2018.1391091] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
483 Sahn B, De Matos V, Stein R, Ruchelli E, Masur S, Klink AJ, Baldassano RN, Piccoli DA, Russo P, Mamula P. Histological features of ileitis differentiating pediatric Crohn disease from ulcerative colitis with backwash ileitis. Dig Liver Dis 2018;50:147-53. [PMID: 29089273 DOI: 10.1016/j.dld.2017.10.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
484 Sjöberg F, Barkman C, Nookaew I, Östman S, Adlerberth I, Saalman R, Wold AE. Low-complexity microbiota in the duodenum of children with newly diagnosed ulcerative colitis. PLoS One 2017;12:e0186178. [PMID: 29049404 DOI: 10.1371/journal.pone.0186178] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
485 Sag E, Demir F, Ercin ME, Kalyoncu M, Cakir M. Neonatal ulcerative colitis associated with Familial Mediterranean fever: a case report. Rheumatol Int 2018;38:137-40. [PMID: 29027576 DOI: 10.1007/s00296-017-3848-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
486 Yu YR, Rodriguez JR. Clinical presentation of Crohn's, ulcerative colitis, and indeterminate colitis: Symptoms, extraintestinal manifestations, and disease phenotypes. Semin Pediatr Surg. 2017;26:349-355. [PMID: 29126502 DOI: 10.1053/j.sempedsurg.2017.10.003] [Cited by in Crossref: 69] [Cited by in F6Publishing: 94] [Article Influence: 13.8] [Reference Citation Analysis]
487 Rinawi F, Assa A, Eliakim R, Mozer-glassberg Y, Nachmias-friedler V, Niv Y, Rosenbach Y, Silbermintz A, Zevit N, Shamir R. Risk of Colectomy in Patients With Pediatric-onset Ulcerative Colitis. Journal of Pediatric Gastroenterology & Nutrition 2017;65:410-5. [DOI: 10.1097/mpg.0000000000001545] [Cited by in Crossref: 16] [Cited by in F6Publishing: 3] [Article Influence: 3.2] [Reference Citation Analysis]
488 Cheng J, Hamilton Z, Smyth M, Barker C, Israel D, Jacobson K. Concomitant Therapy with Immunomodulator Enhances Infliximab Durability in Pediatric Inflammatory Bowel Disease: . Inflammatory Bowel Diseases 2017;23:1762-73. [DOI: 10.1097/mib.0000000000001212] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
489 Ashton JJ, Ennis S, Beattie RM. Early-onset paediatric inflammatory bowel disease. The Lancet Child & Adolescent Health 2017;1:147-58. [DOI: 10.1016/s2352-4642(17)30017-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 2.6] [Reference Citation Analysis]
490 Olén O, Askling J, Sachs MC, Frumento P, Neovius M, Smedby KE, Ekbom A, Malmborg P, Ludvigsson JF. Childhood onset inflammatory bowel disease and risk of cancer: a Swedish nationwide cohort study 1964-2014. BMJ 2017;358:j3951. [PMID: 28931512 DOI: 10.1136/bmj.j3951] [Cited by in Crossref: 67] [Cited by in F6Publishing: 74] [Article Influence: 13.4] [Reference Citation Analysis]
491 Starr AE, Deeke SA, Ning Z, Chiang CK, Zhang X, Mottawea W, Singleton R, Benchimol EI, Wen M, Mack DR, Stintzi A, Figeys D. Proteomic analysis of ascending colon biopsies from a paediatric inflammatory bowel disease inception cohort identifies protein biomarkers that differentiate Crohn's disease from UC. Gut 2017;66:1573-83. [PMID: 27216938 DOI: 10.1136/gutjnl-2015-310705] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 9.4] [Reference Citation Analysis]
492 Nir O, Rinawi F, Amarilyo G, Harel L, Shamir R, Assa A. Phenotypic Features and Longterm Outcomes of Pediatric Inflammatory Bowel Disease Patients with Arthritis and Arthralgia. J Rheumatol 2017;44:1636-43. [PMID: 28864649 DOI: 10.3899/jrheum.170168] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
493 Wahbeh GT, Ward BT, Lee DY, Giefer MJ, Suskind DL. Lack of Mucosal Healing From Modified Specific Carbohydrate Diet in Pediatric Patients With Crohn Disease. Journal of Pediatric Gastroenterology & Nutrition 2017;65:289-92. [DOI: 10.1097/mpg.0000000000001619] [Cited by in Crossref: 26] [Cited by in F6Publishing: 9] [Article Influence: 5.2] [Reference Citation Analysis]
494 Rinawi F, Assa A, Eliakim R, Mozer Glassberg Y, Nachmias Friedler V, Niv Y, Rosenbach Y, Silbermintz A, Zevit N, Shamir R. Predictors of pouchitis after ileal pouch–anal anastomosis in pediatric-onset ulcerative colitis: . European Journal of Gastroenterology & Hepatology 2017;29:1079-85. [DOI: 10.1097/meg.0000000000000914] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 2.4] [Reference Citation Analysis]
495 Monasta L, Pierobon C, Princivalle A, Martelossi S, Marcuzzi A, Pasini F, Perbellini L. Inflammatory bowel disease and patterns of volatile organic compounds in the exhaled breath of children: A case-control study using Ion Molecule Reaction-Mass Spectrometry. PLoS One 2017;12:e0184118. [PMID: 28859138 DOI: 10.1371/journal.pone.0184118] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
496 Ghione S, Sarter H, Fumery M, Armengol-Debeir L, Savoye G, Ley D, Spyckerelle C, Pariente B, Peyrin-Biroulet L, Turck D, Gower-Rousseau C; Epimad Group. Dramatic Increase in Incidence of Ulcerative Colitis and Crohn's Disease (1988-2011): A Population-Based Study of French Adolescents. Am J Gastroenterol. 2018;113:265-272. [PMID: 28809388 DOI: 10.1038/ajg.2017.228] [Cited by in Crossref: 61] [Cited by in F6Publishing: 68] [Article Influence: 12.2] [Reference Citation Analysis]
497 Marigorta UM, Denson LA, Hyams JS, Mondal K, Prince J, Walters TD, Griffiths A, Noe JD, Crandall WV, Rosh JR, Mack DR, Kellermayer R, Heyman MB, Baker SS, Stephens MC, Baldassano RN, Markowitz JF, Kim MO, Dubinsky MC, Cho J, Aronow BJ, Kugathasan S, Gibson G. Transcriptional risk scores link GWAS to eQTLs and predict complications in Crohn's disease. Nat Genet 2017;49:1517-21. [PMID: 28805827 DOI: 10.1038/ng.3936] [Cited by in Crossref: 85] [Cited by in F6Publishing: 73] [Article Influence: 17.0] [Reference Citation Analysis]
498 Ricciuto A, Fish JR, Tomalty DE, Carman N, Crowley E, Popalis C, Muise A, Walters TD, Griffiths AM, Church PC. Diagnostic delay in Canadian children with inflammatory bowel disease is more common in Crohn's disease and associated with decreased height. Arch Dis Child. 2018;103:319-326. [PMID: 28794097 DOI: 10.1136/archdischild-2017-313060] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
499 Luo Y, Yu J, Lou J, Fang Y, Chen J. Exclusive Enteral Nutrition versus Infliximab in Inducing Therapy of Pediatric Crohn's Disease. Gastroenterol Res Pract 2017;2017:6595048. [PMID: 28928769 DOI: 10.1155/2017/6595048] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
500 Santha SL, Shankar PR, Pan A, Schoen B, Kugathasan S, Sauer CG. Mucosal Healing in Clinical Practice: A Single-Center Pediatric IBD Experience. Inflammatory Bowel Diseases 2017;23:1447-53. [DOI: 10.1097/mib.0000000000001176] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
501 Watson KL, Kim SC, Boyle BM, Saps M. Prevalence and Impact of Functional Abdominal Pain Disorders in Children With Inflammatory Bowel Diseases (IBD-FAPD). Journal of Pediatric Gastroenterology & Nutrition 2017;65:212-7. [DOI: 10.1097/mpg.0000000000001479] [Cited by in Crossref: 28] [Cited by in F6Publishing: 9] [Article Influence: 5.6] [Reference Citation Analysis]
502 Lopez RN, Evans HM, Appleton L, Bishop J, Chin S, Mouat S, Gearry RB, Day AS. Point Prevalence of Pediatric Inflammatory Bowel Disease in New Zealand in 2015: Initial Results from the PINZ Study. Inflammatory Bowel Diseases 2017;23:1418-24. [DOI: 10.1097/mib.0000000000001138] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
503 Wiskin AE, Sandhu BK. Editorial: changing nature of paediatric IBD-new insights from Irish data. Aliment Pharmacol Ther 2017;46:457-8. [PMID: 28707803 DOI: 10.1111/apt.14147] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
504 Kopylov U, Koulaouzidis A, Klang E, Carter D, Ben-Horin S, Eliakim R. Monitoring of small bowel Crohn's disease. Expert Rev Gastroenterol Hepatol 2017;11:1047-58. [PMID: 28737951 DOI: 10.1080/17474124.2017.1359541] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
505 Hosoi K, Ohtsuka Y, Fujii T, Kudo T, Matsunaga N, Tomomasa T, Tajiri H, Kunisaki R, Ishige T, Yamada H, Arai K, Yoden A, Ushijima K, Aomatsu T, Nagata S, Uchida K, Takeuchi K, Shimizu T. Treatment with infliximab for pediatric Crohn's disease: Nationwide survey of Japan. J Gastroenterol Hepatol. 2017;32:114-119. [PMID: 27478130 DOI: 10.1111/jgh.13498] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
506 Duricova D, Fumery M, Annese V, Lakatos PL, Peyrin-Biroulet L, Gower-Rousseau C. The natural history of Crohn's disease in children: a review of population-based studies. Eur J Gastroenterol Hepatol. 2017;29:125-134. [PMID: 27748673 DOI: 10.1097/meg.0000000000000761] [Cited by in Crossref: 45] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
507 Veenbergen S, van Leeuwen MA, Driessen GJ, Kersseboom R, de Ruiter LF, Raatgeep R(, Lindenbergh-kortleve DJ, Simons-oosterhuis Y, Biermann K, Halley DJ, de Ridder L, Escher JC, Samsom JN. Development and Function of Immune Cells in an Adolescent Patient With a Deficiency in the Interleukin-10 Receptor. Journal of Pediatric Gastroenterology & Nutrition 2017;65:e5-e15. [DOI: 10.1097/mpg.0000000000001559] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
508 Sullivan KJ, Wei M, Chernetsova E, Hallani S, de Nanassy J, Benchimol EI, Mack DR, Nasr A, El Demellawy D. Value of upper endoscopic biopsies in predicting medical refractoriness in pediatric patients with ulcerative colitis. Hum Pathol. 2017;66:167-176. [PMID: 28652148 DOI: 10.1016/j.humpath.2017.06.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
509 Stenke E, Bourke B, Knaus U. Crohn's Strictures-Moving Away from the Knife.Front Pediatr. 2017;5:141. [PMID: 28670577 DOI: 10.3389/fped.2017.00141] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
510 Rolandsdotter H, Eberhardson M, Fagerberg UL, Finkel Y. Granulocyte and Monocyte Apheresis for Induction of Remission in Children With New-Onset Inflammatory Bowel Colitis. J Pediatr Gastroenterol Nutr 2018;66:84-9. [PMID: 28604509 DOI: 10.1097/MPG.0000000000001641] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
511 Schwerd T, Pandey S, Yang HT, Bagola K, Jameson E, Jung J, Lachmann RH, Shah N, Patel SY, Booth C, Runz H, Düker G, Bettels R, Rohrbach M, Kugathasan S, Chapel H, Keshav S, Elkadri A, Platt N, Muise AM, Koletzko S, Xavier RJ, Marquardt T, Powrie F, Wraith JE, Gyrd-Hansen M, Platt FM, Uhlig HH. Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann-Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn's disease. Gut 2017;66:1060-73. [PMID: 26953272 DOI: 10.1136/gutjnl-2015-310382] [Cited by in Crossref: 92] [Cited by in F6Publishing: 91] [Article Influence: 18.4] [Reference Citation Analysis]
512 Gerfaud A, Bridoux-henno L, Bretagne J, Siproudhis L, Bouguen G, Dabadie A. Évaluation de la transition pédiatrie-gastroentérologie d’adultes des enfants atteints de maladie inflammatoire cryptogénique intestinale. Archives de Pédiatrie 2017;24:534-41. [DOI: 10.1016/j.arcped.2017.03.008] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
513 Mansuri I, Fletcher JG, Bruining DH, Kolbe AB, Fidler JL, Samuel S, Tung J. Endoscopic Skipping of the Terminal Ileum in Pediatric Crohn Disease. American Journal of Roentgenology 2017;208:W216-24. [DOI: 10.2214/ajr.16.16575] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
514 Rinawi F, Assa A, Bashir H, Peleg S, Shamir R. Clinical and Phenotypic Differences in Inflammatory Bowel Disease Among Arab and Jewish Children in Israel. Dig Dis Sci. 2017;62:2095-2101. [PMID: 28547648 DOI: 10.1007/s10620-017-4623-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
515 Mossotto E, Ashton JJ, Coelho T, Beattie RM, MacArthur BD, Ennis S. Classification of Paediatric Inflammatory Bowel Disease using Machine Learning. Sci Rep. 2017;7:2427. [PMID: 28546534 DOI: 10.1038/s41598-017-02606-2] [Cited by in Crossref: 49] [Cited by in F6Publishing: 59] [Article Influence: 9.8] [Reference Citation Analysis]
516 Schulman JM, Pritzker L, Shaoul R. Maintenance of Remission with Partial Enteral Nutrition Therapy in Pediatric Crohn's Disease: A Retrospective Study. Can J Gastroenterol Hepatol 2017;2017:5873158. [PMID: 28567370 DOI: 10.1155/2017/5873158] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
517 Dotson JL, Cho M, Bricker J, Kappelman MD, Chisolm DJ, Tomer G, Crandall WV. Race Differences in Initial Presentation, Early Treatment, and 1-year Outcomes of Pediatric Crohnʼs Disease: Results from the ImproveCareNow Network. Inflammatory Bowel Diseases 2017;23:767-74. [DOI: 10.1097/mib.0000000000001046] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 2.4] [Reference Citation Analysis]
518 Coughlan A, Wylde R, Lafferty L, Quinn S, Broderick A, Bourke B, Hussey S; DOCHAS Study. A rising incidence and poorer male outcomes characterise early onset paediatric inflammatory bowel disease. Aliment Pharmacol Ther. 2017;45:1534-1541. [PMID: 28449214 DOI: 10.1111/apt.14070] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
519 Benchimol EI, Bernstein CN, Bitton A, Carroll MW, Singh H, Otley AR, Vutcovici M, El-Matary W, Nguyen GC, Griffiths AM, Mack DR, Jacobson K, Mojaverian N, Tanyingoh D, Cui Y, Nugent ZJ, Coulombe J, Targownik LE, Jones JL, Leddin D, Murthy SK, Kaplan GG. Trends in Epidemiology of Pediatric Inflammatory Bowel Disease in Canada: Distributed Network Analysis of Multiple Population-Based Provincial Health Administrative Databases. Am J Gastroenterol. 2017;112:1120-1134. [PMID: 28417994 DOI: 10.1038/ajg.2017.97] [Cited by in Crossref: 136] [Cited by in F6Publishing: 158] [Article Influence: 27.2] [Reference Citation Analysis]
520 Fabian O, Hradsky O, Potuznikova K, Kalfusova A, Krskova L, Hornofova L, Zamecnik J, Bronsky J. Low predictive value of histopathological scoring system for complications development in children with Crohn’s disease. Pathology - Research and Practice 2017;213:353-8. [DOI: 10.1016/j.prp.2017.01.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
521 Rothschild B, Rinawi F, Herman Y, Nir O, Shamir R, Assa A. Prognostic significance of granulomas in children with Crohn's disease. Scand J Gastroenterol. 2017;52:716-721. [PMID: 28346037 DOI: 10.1080/00365521.2017.1304571] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
522 Lee EJ, Moon JS, Ko JS, Yang HR, Jang JY, Kim JW, Lee KJ. Effect of the Baseline Vitamin D Level on Growth Outcome in Pediatric Crohn Disease. Pediatr Gastroenterol Hepatol Nutr 2017;20:41-6. [PMID: 28401055 DOI: 10.5223/pghn.2017.20.1.41] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
523 Cohen-dolev N, Sladek M, Hussey S, Turner D, Veres G, Koletzko S, Martin de Carpi J, Staiano A, Shaoul R, Lionetti P, Amil Dias J, Paerregaard A, Nuti F, Pfeffer Gik T, Ziv-baran T, Ben Avraham Shulman S, Sarbagili Shabat C, Sigall Boneh R, Russell RK, Levine A. Differences in Outcomes Over Time With Exclusive Enteral Nutrition Compared With Steroids in Children With Mild to Moderate Crohn’s Disease: Results From the GROWTH CD Study. Journal of Crohn's and Colitis 2018;12:306-12. [DOI: 10.1093/ecco-jcc/jjx150] [Cited by in Crossref: 40] [Cited by in F6Publishing: 45] [Article Influence: 8.0] [Reference Citation Analysis]
524 Kim S. Surgery in Pediatric Crohn's Disease: Indications, Timing and Post-Operative Management. Pediatr Gastroenterol Hepatol Nutr 2017;20:14-21. [PMID: 28401051 DOI: 10.5223/pghn.2017.20.1.14] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
525 Naviglio S, Parentin F, Nider S, Rassu N, Martelossi S, Ventura A. Ocular Involvement in Children with Inflammatory Bowel Disease. Inflamm Bowel Dis 2017;23:986-90. [PMID: 28328621 DOI: 10.1097/MIB.0000000000001079] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
526 Levine A, Yerushalmi B, Kori M, Broide E, Mozer-glassberg Y, Shaoul R, Kolho K, Shteyer E, Shamaly H, Ledder O, Cohen S, Peleg S, Shabat CS, Focht G, Shachmon E, Boaz M, On A, Turner D. Mesalamine Enemas for Induction of Remission in Oral Mesalamine-refractory Pediatric Ulcerative Colitis: A Prospective Cohort Study. Journal of Crohn's and Colitis 2017;11:970-4. [DOI: 10.1093/ecco-jcc/jjx042] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
527 van Haaften-Visser DY, Harakalova M, Mocholi E, van Montfrans JM, Elkadri A, Rieter E, Fiedler K, van Hasselt PM, Triffaux EMM, van Haelst MM, Nijman IJ, Kloosterman WP, Nieuwenhuis EES, Muise AM, Cuppen E, Houwen RHJ, Coffer PJ. Ankyrin repeat and zinc-finger domain-containing 1 mutations are associated with infantile-onset inflammatory bowel disease. J Biol Chem 2017;292:7904-20. [PMID: 28302725 DOI: 10.1074/jbc.M116.772038] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
528 Church PC, Greer MC, Cytter-Kuint R, Doria AS, Griffiths AM, Turner D, Walters TD, Feldman BM. Magnetic resonance enterography has good inter-rater agreement and diagnostic accuracy for detecting inflammation in pediatric Crohn disease. Pediatr Radiol 2017;47:565-75. [PMID: 28283726 DOI: 10.1007/s00247-017-3790-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
529 Cummins EP, Crean D. Hypoxia and inflammatory bowel disease. Microbes and Infection 2017;19:210-21. [DOI: 10.1016/j.micinf.2016.09.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
530 van Tilburg MAL, Claar RL, Romano JM, Langer SL, Drossman DA, Whitehead WE, Abdullah B, Levy RL. Psychological Factors May Play an Important Role in Pediatric Crohn's Disease Symptoms and Disability. J Pediatr 2017;184:94-100.e1. [PMID: 28238483 DOI: 10.1016/j.jpeds.2017.01.058] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
531 Morgenstern S, Brook E, Rinawi F, Shamir R, Assa A. Tissue and peripheral eosinophilia as predictors for disease outcome in children with ulcerative colitis. Digestive and Liver Disease 2017;49:170-4. [DOI: 10.1016/j.dld.2016.11.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 4.4] [Reference Citation Analysis]
532 Diederen K, Hoekman DR, Leek A, Wolters VM, Hummel TZ, de Meij TG, Koot BGP, Tabbers MM, Benninga MA, Kindermann A. Raised faecal calprotectin is associated with subsequent symptomatic relapse, in children and adolescents with inflammatory bowel disease in clinical remission. Aliment Pharmacol Ther 2017;45:951-60. [DOI: 10.1111/apt.13950] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
533 Rinawi F, Assa A, Eliakim R, Mozer-glassberg Y, Nachmias Friedler V, Niv Y, Rosenbach Y, Silbermintz A, Zevit N, Shamir R. The natural history of pediatric-onset IBD-unclassified and prediction of Crohn’s disease reclassification: a 27-year study. Scandinavian Journal of Gastroenterology 2017;52:558-63. [DOI: 10.1080/00365521.2017.1282008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
534 Rosen MJ, Karns R, Vallance JE, Bezold R, Waddell A, Collins MH, Haberman Y, Minar P, Baldassano RN, Hyams JS, Baker SS, Kellermayer R, Noe JD, Griffiths AM, Rosh JR, Crandall WV, Heyman MB, Mack DR, Kappelman MD, Markowitz J, Moulton DE, Leleiko NS, Walters TD, Kugathasan S, Wilson KT, Hogan SP, Denson LA. Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-Only Crohn's Disease in Treatment-Naive Pediatric Patients. Gastroenterology 2017;152:1345-1357.e7. [PMID: 28132889 DOI: 10.1053/j.gastro.2017.01.016] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 9.4] [Reference Citation Analysis]
535 El Mouzan MI, Al Mofarreh MA, Saadah OI, Al-Hussaini AA, Al-Saleem KA, Al Mehaidib AI. Impact of pediatric inflammatory bowel disease on linear growth: Data from a national cohort study in Saudi Arabia. Saudi J Gastroenterol 2016;22:106-8. [PMID: 26997215 DOI: 10.4103/1319-3767.178524] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
536 Gale G, Sigurdsson GV, Östman S, Malmborg P, Högkil K, Hasséus B, Jontell M, Saalman R. Does Crohn's Disease with Concomitant Orofacial Granulomatosis Represent a Distinctive Disease Subtype? Inflamm Bowel Dis 2016;22:1071-7. [PMID: 26829409 DOI: 10.1097/MIB.0000000000000670] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 3.4] [Reference Citation Analysis]
537 Palmieri O, Bossa F, Valvano MR, Corritore G, Latiano T, Martino G, D'Incà R, Cucchiara S, Pastore M, D'Altilia M, Scimeca D, Biscaglia G, Andriulli A, Latiano A. Crohn's Disease Localization Displays Different Predisposing Genetic Variants. PLoS One 2017;12:e0168821. [PMID: 28052082 DOI: 10.1371/journal.pone.0168821] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
538 Lee WS, Ng RT, Chan KW, Lau YL. Variable outcome in infantile-onset inflammatory bowel disease in an Asian cohort. World J Gastroenterol 2016; 22(48): 10653-10662 [PMID: 28082818 DOI: 10.3748/wjg.v22.i48.10653] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
539 Kim HJ, Kim Y, Cho JM, Oh SH, Kim KM. Therapeutic Efficacy of Oral Enteral Nutrition in Pediatric Crohn's Disease: A Single Center Non-Comparative Retrospective Study. Yonsei Med J 2016;57:1185-91. [PMID: 27401650 DOI: 10.3349/ymj.2016.57.5.1185] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
540 Seemann NM, King SK, Elkadri A, Walters T, Fish J, Langer JC. The operative management of children with complex perianal Crohn's disease. Journal of Pediatric Surgery 2016;51:1993-7. [DOI: 10.1016/j.jpedsurg.2016.09.021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
541 Kalla R, Kennedy NA, Ventham NT, Boyapati RK, Adams AT, Nimmo ER, Visconti MR, Drummond H, Ho G, Pattenden RJ, Wilson DC, Satsangi J. Serum Calprotectin: A Novel Diagnostic and Prognostic Marker in Inflammatory Bowel Diseases. American Journal of Gastroenterology 2016;111:1796-805. [DOI: 10.1038/ajg.2016.342] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 8.2] [Reference Citation Analysis]
542 Torres J, Mehandru S, Colombel JF, Peyrin-Biroulet L. Crohn's disease. Lancet. 2017;389:1741-1755. [PMID: 27914655 DOI: 10.1016/s0140-6736(16)31711-1] [Cited by in Crossref: 615] [Cited by in F6Publishing: 285] [Article Influence: 102.5] [Reference Citation Analysis]
543 Rinawi F, Assa A, Hartman C, Mozer Glassberg Y, Nachmias Friedler V, Rosenbach Y, Silbermintz A, Zevit N, Shamir R. Evolution of disease phenotype in pediatric-onset Crohn’s disease after more than 10 years follow up—Cohort study. Digestive and Liver Disease 2016;48:1444-50. [DOI: 10.1016/j.dld.2016.08.118] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
544 Olbjørn C, Cvancarova Småstuen M, Thiis-Evensen E, Nakstad B, Vatn MH, Perminow G. Serological markers in diagnosis of pediatric inflammatory bowel disease and as predictors for early tumor necrosis factor blocker therapy. Scand J Gastroenterol 2017;52:414-9. [PMID: 27887202 DOI: 10.1080/00365521.2016.1259653] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
545 Mottawea W, Chiang CK, Mühlbauer M, Starr AE, Butcher J, Abujamel T, Deeke SA, Brandel A, Zhou H, Shokralla S, Hajibabaei M, Singleton R, Benchimol EI, Jobin C, Mack DR, Figeys D, Stintzi A. Altered intestinal microbiota-host mitochondria crosstalk in new onset Crohn's disease. Nat Commun 2016;7:13419. [PMID: 27876802 DOI: 10.1038/ncomms13419] [Cited by in Crossref: 165] [Cited by in F6Publishing: 184] [Article Influence: 27.5] [Reference Citation Analysis]
546 Lafferty L, Tuohy M, Carey A, Sugrue S, Hurley M, Hussey S. Outcomes of exclusive enteral nutrition in paediatric Crohn’s disease. Eur J Clin Nutr 2017;71:185-91. [DOI: 10.1038/ejcn.2016.210] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
547 Ashton JJ, Coelho T, Ennis S, Vadgama B, Batra A, Afzal NA, Beattie RM. Endoscopic Versus Histological Disease Extent at Presentation of Paediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2016;62:246-51. [PMID: 26545202 DOI: 10.1097/MPG.0000000000001032] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 1.8] [Reference Citation Analysis]
548 Fernandes MA, Verstraete SG, Garnett EA, Heyman MB. Addition of Histology to the Paris Classification of Pediatric Crohn Disease Alters Classification of Disease Location. J Pediatr Gastroenterol Nutr 2016;62:242-5. [PMID: 26334258 DOI: 10.1097/MPG.0000000000000967] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 2.2] [Reference Citation Analysis]
549 Aydemir Y, Pınar A, Hızal G, Demir H, Saltık Temizel İN, Özen H, Akbıyık F, Yüce A. Neutrophil volume distribution width as a new marker in detecting inflammatory bowel disease activation. Int Jnl Lab Hem 2017;39:51-7. [DOI: 10.1111/ijlh.12574] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
550 Dunn KA, Moore-connors J, Macintyre B, Stadnyk A, Thomas NA, Noble A, Mahdi G, Rashid M, Otley AR, Bielawski JP, Van Limbergen J. The Gut Microbiome of Pediatric Crohnʼs Disease Patients Differs from Healthy Controls in Genes That Can Influence the Balance Between a Healthy and Dysregulated Immune Response: . Inflammatory Bowel Diseases 2016;22:2607-18. [DOI: 10.1097/mib.0000000000000949] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 4.2] [Reference Citation Analysis]
551 DeFilippis EM, Longman R, Harbus M, Dannenberg K, Scherl EJ. Crohn's Disease: Evolution, Epigenetics, and the Emerging Role of Microbiome-Targeted Therapies. Curr Gastroenterol Rep 2016;18:13. [PMID: 26908281 DOI: 10.1007/s11894-016-0487-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
552 Uhlig HH, Schwerd T. From Genes to Mechanisms: The Expanding Spectrum of Monogenic Disorders Associated with Inflammatory Bowel Disease. Inflamm Bowel Dis 2016;22:202-12. [PMID: 26512716 DOI: 10.1097/MIB.0000000000000614] [Cited by in Crossref: 49] [Cited by in F6Publishing: 30] [Article Influence: 8.2] [Reference Citation Analysis]
553 . UEG Week 2016 Poster Presentations. United European Gastroenterology Journal 2016;4:A157-720. [DOI: 10.1177/2050640616663689] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
554 Hartman C, Marderfeld L, Davidson K, Mozer-glassberg Y, Poraz I, Silbermintz A, Zevit N, Shamir R. Food Intake Adequacy in Children and Adolescents With Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology & Nutrition 2016;63:437-44. [DOI: 10.1097/mpg.0000000000001170] [Cited by in Crossref: 30] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
555 Kopylov U, Carter D, Eliakim AR. Capsule Endoscopy and Deep Enteroscopy in Inflammatory Bowel Disease. Gastrointestinal Endoscopy Clinics of North America 2016;26:611-27. [DOI: 10.1016/j.giec.2016.06.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
556 Rosenbaum DG, Conrad MA, Biko DM, Ruchelli ED, Kelsen JR, Anupindi SA. Ultrasound and MRI predictors of surgical bowel resection in pediatric Crohn disease. Pediatr Radiol 2017;47:55-64. [DOI: 10.1007/s00247-016-3704-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
557 Kim HJ, Oh SH, Kim DY, Lee H, Park SH, Yang S, Kim KM. Clinical Characteristics and Long-Term Outcomes of Paediatric Crohn’s Disease: A Single-Centre Experience. ECCOJC 2017;11:157-64. [DOI: 10.1093/ecco-jcc/jjw146] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
558 Bamberger S, Martinez Vinson C, Mohamed D, Viala J, Carel JC, Hugot JP, Simon D. Growth and Adult Height in Patients with Crohn's Disease Treated with Anti-Tumor Necrosis Factor α Antibodies. PLoS One 2016;11:e0163126. [PMID: 27636201 DOI: 10.1371/journal.pone.0163126] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
559 Heier CR, Fiorillo AA, Chaisson E, Gordish-Dressman H, Hathout Y, Damsker JM, Hoffman EP, Conklin LS. Identification of Pathway-Specific Serum Biomarkers of Response to Glucocorticoid and Infliximab Treatment in Children with Inflammatory Bowel Disease. Clin Transl Gastroenterol 2016;7:e192. [PMID: 27628422 DOI: 10.1038/ctg.2016.49] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
560 Bouzidi A, Mesbah-Amroun H, Boukercha A, Benhassine F, Belboueb R, Berkouk K, Messadi W, Touil-Boukoffa C. Association between MDR1 gene polymorphisms and the risk of Crohn's disease in a cohort of Algerian pediatric patients. Pediatr Res 2016;80:837-43. [PMID: 27603561 DOI: 10.1038/pr.2016.163] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
561 Bishop C, Simon H, Suskind D, Lee D, Wahbeh G. Ustekinumab in Pediatric Crohn Disease Patients. Journal of Pediatric Gastroenterology & Nutrition 2016;63:348-51. [DOI: 10.1097/mpg.0000000000001146] [Cited by in Crossref: 31] [Cited by in F6Publishing: 9] [Article Influence: 5.2] [Reference Citation Analysis]
562 Valério de Azevedo S, Maltez C, Lopes AI. Pediatric Crohn's disease, iron deficiency anemia and intravenous iron treatment: a follow-up study. Scandinavian Journal of Gastroenterology 2017;52:29-33. [DOI: 10.1080/00365521.2016.1224381] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
563 Hoekman DR, Diederen K, Koot BG, Tabbers MM, Kindermann A, Benninga MA. Relationship of clinical symptoms with biomarkers of inflammation in pediatric inflammatory bowel disease. Eur J Pediatr 2016;175:1335-42. [PMID: 27573259 DOI: 10.1007/s00431-016-2762-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
564 Turner D. Microscopic Assessment in Inflammatory Bowel Disease: The More the Merrier? J Pediatr Gastroenterol Nutr 2016;62:191-2. [PMID: 26628450 DOI: 10.1097/MPG.0000000000001049] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
565 Lee HA, Suk JY, Choi SY, Kim ER, Kim YH, Lee CK, Huh KC, Lee KM, Park DI. Characteristics of Pediatric Inflammatory Bowel Disease in Korea: Comparison with EUROKIDS Data. Gut Liver 2015;9:756-60. [PMID: 25963086 DOI: 10.5009/gnl14338] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
566 Szűcs D, Béres NJ, Rokonay R, Boros K, Borka K, Kiss Z, Arató A, Szabó AJ, Vannay &, Sziksz E, Bereczki C, Veres G. Increased duodenal expression of miR-146a and -155 in pediatric Crohn’s disease. World J Gastroenterol 2016; 22(26): 6027-6035 [PMID: 27468194 DOI: 10.3748/wjg.v22.i26.6027] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
567 Shaw KA, Bertha M, Hofmekler T, Chopra P, Vatanen T, Srivatsa A, Prince J, Kumar A, Sauer C, Zwick ME, Satten GA, Kostic AD, Mulle JG, Xavier RJ, Kugathasan S. Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease. Genome Med 2016;8:75. [PMID: 27412252 DOI: 10.1186/s13073-016-0331-y] [Cited by in Crossref: 124] [Cited by in F6Publishing: 142] [Article Influence: 20.7] [Reference Citation Analysis]
568 Nambu R, Hagiwara S, Kubota M, Kagimoto S. Difference between early onset and late-onset pediatric ulcerative colitis. Pediatr Int 2016;58:862-6. [PMID: 26833925 DOI: 10.1111/ped.12935] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
569 Kim DH, Carucci LR, Baker ME, Cash BD, Dillman JR, Feig BW, Fowler KJ, Gage KL, Noto RB, Smith MP, Yaghmai V, Yee J, Lalani T. ACR Appropriateness Criteria Crohn Disease. J Am Coll Radiol 2015;12:1048-57.e4. [PMID: 26435118 DOI: 10.1016/j.jacr.2015.07.005] [Cited by in Crossref: 33] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
570 Vora R, Finnamore HE, Crook K, Baillie C, Whittle E, Krishnamurthy B, Venkatesh K, Auth MK. Clinical Experience of Use of High-dose Intravenous Methylprednisolone in Children With Acute Moderate to Severe Colitis. Journal of Pediatric Gastroenterology & Nutrition 2016;63:51-7. [DOI: 10.1097/mpg.0000000000001080] [Cited by in Crossref: 6] [Article Influence: 1.0] [Reference Citation Analysis]
571 Kolho KL, Ainamo A. Progress in the treatment and outcome of pediatric inflammatory bowel disease patients. Expert Rev Clin Immunol. 2016;12:1337-1345. [PMID: 27322874 DOI: 10.1080/1744666x.2016.1201422] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
572 Xiao Y, Wang XQ, Yu Y, Guo Y, Xu X, Gong L, Zhou T, Li XQ, Xu CD. Comprehensive mutation screening for 10 genes in Chinese patients suffering very early onset inflammatory bowel disease. World J Gastroenterol 2016; 22(24): 5578-5588 [PMID: 27350736 DOI: 10.3748/wjg.v22.i24.5578] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
573 Song WJ, Kang B, Choi SY, Choe YH. Adalimumab Treatment in Pediatric-Onset Crohn's Disease Patients after Infliximab Failure: A Single Center Study. Pediatr Gastroenterol Hepatol Nutr 2016;19:116-22. [PMID: 27437188 DOI: 10.5223/pghn.2016.19.2.116] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
574 Jabeen R, Miller L, Yao W, Gupta S, Steiner S, Kaplan MH. Altered STAT4 Isoform Expression in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2015;21:2383-2392. [PMID: 26177303 DOI: 10.1097/mib.0000000000000495] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
575 Wiskin AE, Haggarty R, Afzal NA, Batra A, Wootton SA, Beattie RM. Nutritional perspectives of children with Crohn's disease: a single-centre cohort observation of disease activity, energy expenditure and dietary intake. Eur J Clin Nutr 2016;70:1132-7. [PMID: 27329610 DOI: 10.1038/ejcn.2016.107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
576 Kammermeier J, Dziubak R, Pescarin M, Drury S, Godwin H, Reeve K, Chadokufa S, Huggett B, Sider S, James C, Acton N, Cernat E, Gasparetto M, Noble-Jamieson G, Kiparissi F, Elawad M, Beales PL, Sebire NJ, Gilmour K, Uhlig HH, Bacchelli C, Shah N. Phenotypic and Genotypic Characterisation of Inflammatory Bowel Disease Presenting Before the Age of 2 years. J Crohns Colitis. 2017;11:60-69. [PMID: 27302973 DOI: 10.1093/ecco-jcc/jjw118] [Cited by in Crossref: 71] [Cited by in F6Publishing: 75] [Article Influence: 11.8] [Reference Citation Analysis]
577 Pomerri F, Al Bunni F, Zuliani M, Guariso G, Gasparetto M, Giorgi B, Cananzi M, Muzzio PC. Assessing pediatric ileocolonic Crohn's disease activity based on global MR enterography scores. Eur Radiol 2017;27:1044-51. [PMID: 27277259 DOI: 10.1007/s00330-016-4443-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
578 Liu TC, Gurram B, Baldridge MT, Head R, Lam V, Luo C, Cao Y, Simpson P, Hayward M, Holtz ML, Bousounis P, Noe J, Lerner D, Cabrera J, Biank V, Stephens M, Huttenhower C, McGovern DP, Xavier RJ, Stappenbeck TS, Salzman NH. Paneth cell defects in Crohn's disease patients promote dysbiosis. JCI Insight 2016;1:e86907. [PMID: 27699268 DOI: 10.1172/jci.insight.86907] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 5.8] [Reference Citation Analysis]
579 Aloi M, Birimberg-schwartz L, Buderus S, Hojsak I, Fell JM, Bronsky J, Veereman G, Koletzko S, Shaoul R, Miele E, Turner D, Russell RK. Treatment Options and Outcomes of Pediatric IBDU Compared with Other IBD Subtypes: A Retrospective Multicenter Study from the IBD Porto Group of ESPGHAN. Inflammatory Bowel Diseases 2016;22:1378-83. [DOI: 10.1097/mib.0000000000000767] [Cited by in Crossref: 20] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
580 Capriati T, Cardile S, Papadatou B, Romano C, Knafelz D, Bracci F, Diamanti A. Pediatric inflammatory bowel disease: specificity of very early onset. Expert Review of Clinical Immunology 2016;12:963-72. [DOI: 10.1080/1744666x.2016.1184571] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
581 Beser OF, Conde CD, Serwas NK, Cokugras FC, Kutlu T, Boztug K, Erkan T. Clinical features of interleukin 10 receptor gene mutations in children with very early-onset inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2015;60:332-338. [PMID: 25373860 DOI: 10.1097/mpg.0000000000000621] [Cited by in Crossref: 30] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
582 Larsen MD, Baldal ME, Nielsen RG, Nielsen J, Lund K, Nørgård BM. The incidence of Crohn's disease and ulcerative colitis since 1995 in Danish children and adolescents <17 years - based on nationwide registry data. Scand J Gastroenterol 2016;51:1100-5. [PMID: 27160395 DOI: 10.3109/00365521.2016.1172340] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
583 Chiaroni-clarke RC, Munro JE, Ellis JA. Sex bias in paediatric autoimmune disease – Not just about sex hormones? Journal of Autoimmunity 2016;69:12-23. [DOI: 10.1016/j.jaut.2016.02.011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
584 Scherdel P, Dunkel L, van Dommelen P, Goulet O, Salaün J, Brauner R, Heude B, Chalumeau M. Growth monitoring as an early detection tool: a systematic review. The Lancet Diabetes & Endocrinology 2016;4:447-56. [DOI: 10.1016/s2213-8587(15)00392-7] [Cited by in Crossref: 46] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
585 Diederen K, Hoekman DR, Hummel TZ, de Meij TG, Koot BG, Tabbers MM, Vlieger AM, Kindermann A, Benninga MA. The prevalence of irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease, and the relationship with biochemical markers of disease activity. Aliment Pharmacol Ther 2016;44:181-8. [PMID: 27110920 DOI: 10.1111/apt.13636] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
586 Kang B, Choi SY, Kim HS, Kim K, Lee YM, Choe YH. Mucosal Healing in Paediatric Patients with Moderate-to-Severe Luminal Crohn’s Disease Under Combined Immunosuppression: Escalation versus Early Treatment. ECCOJC 2016;10:1279-86. [DOI: 10.1093/ecco-jcc/jjw086] [Cited by in Crossref: 38] [Cited by in F6Publishing: 45] [Article Influence: 6.3] [Reference Citation Analysis]
587 Hasdemir B, Mhaske P, Paruthiyil S, Garnett EA, Heyman MB, Matloubian M, Bhargava A. Sex- and corticotropin-releasing factor receptor 2- dependent actions of urocortin 1 during inflammation. Am J Physiol Regul Integr Comp Physiol 2016;310:R1244-57. [PMID: 27053649 DOI: 10.1152/ajpregu.00445.2015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
588 Moran CJ, Kaplan JL, Winter HS, Masiakos PT. Occult Blood and Perianal Examination: Value Added in Pediatric Inflammatory Bowel Disease Screening. J Pediatr Gastroenterol Nutr 2015;61:52-5. [PMID: 25651490 DOI: 10.1097/MPG.0000000000000754] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
589 Gasparetto M, Guariso G, Pozza LV, Ross A, Heuschkel R, Zilbauer M. Clinical course and outcomes of diagnosing Inflammatory Bowel Disease in children 10 years and under: retrospective cohort study from two tertiary centres in the United Kingdom and in Italy. BMC Gastroenterol 2016;16:35. [PMID: 26976427 DOI: 10.1186/s12876-016-0455-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
590 Pusateri AJ, Kim SC, Dotson JL, Balint JP, Potter CJ, Boyle BM, Crandall WV. Incidence, pattern, and etiology of elevated liver enzymes in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2015;60:592-7. [PMID: 25493346 DOI: 10.1097/MPG.0000000000000672] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
591 Louis E. When it is not inflammatory bowel disease: differential diagnosis. Curr Opin Gastroenterol 2015;31:283-9. [PMID: 26039719 DOI: 10.1097/MOG.0000000000000183] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
592 Andreoletti G, Ashton JJ, Coelho T, Willis C, Haggarty R, Gibson J, Holloway J, Batra A, Afzal NA, Beattie RM, Ennis S. Exome analysis of patients with concurrent pediatric inflammatory bowel disease and autoimmune disease. Inflamm Bowel Dis 2015;21:1229-36. [PMID: 25895113 DOI: 10.1097/MIB.0000000000000381] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
593 El Mouzan MI, Al Edreesi MH, Al-Hussaini AA, Saadah OI, Al Qourain AA, Al Mofarreh MA, Al Saleem KA. Nutritional status of children with inflammatory bowel disease in Saudi Arabia. World J Gastroenterol 2016; 22(5): 1854-1858 [PMID: 26855544 DOI: 10.3748/wjg.v22.i5.1854] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
594 Lee MN, Kang B, Choi SY, Kim MJ, Woo SY, Kim JW, Choe YH, Lee SY. Relationship between azathioprine dosage, 6-thioguanine nucleotide levels, and therapeutic response in pediatric patients with IBD treated with azathioprine. Inflamm Bowel Dis 2015;21:1054-62. [PMID: 25851563 DOI: 10.1097/MIB.0000000000000347] [Cited by in Crossref: 38] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
595 Moran CJ, Klein C, Muise AM, Snapper SB. Very early-onset inflammatory bowel disease: gaining insight through focused discovery. Inflamm Bowel Dis. 2015;21:1166-1175. [PMID: 25895007 DOI: 10.1097/mib.0000000000000329] [Cited by in Crossref: 44] [Cited by in F6Publishing: 16] [Article Influence: 7.3] [Reference Citation Analysis]
596 Ognibene NM, Basile M, Di Maurizio M, Petrillo G, De Filippi C. Features and perspectives of MR enterography for pediatric Crohn disease assessment. Radiol Med 2016;121:362-77. [PMID: 26838591 DOI: 10.1007/s11547-015-0613-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
597 Carroll MW, Hamilton Z, Gill H, Simkin J, Smyth M, Espinosa V, Bressler B, Jacobson K. Pediatric Inflammatory Bowel Disease Among South Asians Living in British Columbia, Canada: A Distinct Clinical Phenotype. Inflammatory Bowel Diseases 2016;22:387-96. [DOI: 10.1097/mib.0000000000000651] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
598 Gurram B, Salzman NH, Kaldunski ML, Jia S, Li BU, Stephens M, Sood MR, Hessner MJ. Plasma-induced signatures reveal an extracellular milieu possessing an immunoregulatory bias in treatment-naive paediatric inflammatory bowel disease. Clin Exp Immunol 2016;184:36-49. [PMID: 26660358 DOI: 10.1111/cei.12753] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
599 Pugmire BS, Gee MS, Kaplan JL, Hahn PF, Doody DP, Winter HS, Gervais DA. Role of percutaneous abscess drainage in the management of young patients with Crohn disease. Pediatr Radiol 2016;46:653-9. [DOI: 10.1007/s00247-015-3533-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
600 Dupont-Lucas C, Sternszus R, Ezri J, Leibovitch S, Gervais F, Amre D, Deslandres C. Identifying Patients at High Risk of Loss of Response to Infliximab Maintenance Therapy in Paediatric Crohn's Disease. J Crohns Colitis 2016;10:795-804. [PMID: 26822611 DOI: 10.1093/ecco-jcc/jjw038] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
601 Buderus S, Scholz D, Behrens R, Classen M, De Laffolie J, Keller KM, Zimmer KP, Koletzko S; CEDATA-GPGE Study Group. Inflammatory bowel disease in pediatric patients: Characteristics of newly diagnosed patients from the CEDATA-GPGE Registry. Dtsch Arztebl Int 2015;112:121-7. [PMID: 25759978 DOI: 10.3238/arztebl.2015.0121] [Cited by in Crossref: 4] [Cited by in F6Publishing: 24] [Article Influence: 0.7] [Reference Citation Analysis]
602 Larsen MD, Qvist N, Nielsen J, Kjeldsen J, Nielsen RG, Nørgård BM. Use of Anti-TNFα Agents and Time to First-time Surgery in Paediatric Patients with Ulcerative Colitis and Crohn’s Disease. ECCOJC 2016;10:650-6. [DOI: 10.1093/ecco-jcc/jjw017] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
603 Shannon A, Eng K, Kay M, Blanchard S, Wyllie R, Mahajan L, Worley S, Lavery I, Fazio V. Long-term follow up of ileal pouch anal anastomosis in a large cohort of pediatric and young adult patients with ulcerative colitis. J Pediatr Surg. 2016;51:1181-1186. [PMID: 26876089 DOI: 10.1016/j.jpedsurg.2015.12.012] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
604 Greener T, Klang E, Yablecovitch D, Lahat A, Neuman S, Levhar N, Avidan B, Yanai H, Dotan I, Chowers Y, Weiss B, Saibil F, Amitai MM, Ben-Horin S, Kopylov U, Eliakim R; Israeli IBD Research Nucleus (IIRN). The Impact of Magnetic Resonance Enterography and Capsule Endoscopy on the Re-classification of Disease in Patients with Known Crohn's Disease: A Prospective Israeli IBD Research Nucleus (IIRN) Study. J Crohns Colitis. 2016;10:525-531. [PMID: 26748404 DOI: 10.1093/ecco-jcc/jjw006] [Cited by in Crossref: 40] [Cited by in F6Publishing: 54] [Article Influence: 6.7] [Reference Citation Analysis]
605 Martinelli M, Strisciuglio C, Alessandrella A, Rossi F, Auricchio R, Campostrini N, Girelli D, Nobili B, Staiano A, Perrotta S, Miele E. Serum Hepcidin and Iron Absorption in Paediatric Inflammatory Bowel Disease. J Crohns Colitis 2016;10:566-74. [PMID: 26733407 DOI: 10.1093/ecco-jcc/jjv242] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 4.2] [Reference Citation Analysis]
606 Müller KE, Lakatos PL, Kovacs JB, Arato A, Varkonyi A, Nemes E, Tarnok A, Toth G, Papp M, Solyom E, Horvath A, Guthy I, Kovacs M, Veres G. Baseline Characteristics and Disease Phenotype in Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology & Nutrition 2016;62:50-5. [DOI: 10.1097/mpg.0000000000000885] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
607 Saadah OI, El Mouzan M, Al Mofarreh M, Al Mehaidib A, Al Edreesi M, Hasosah M, Al-Hussaini A, AlSaleem K. Characteristics of Pediatric Crohn's Disease in Saudi Children: A Multicenter National Study. Gastroenterol Res Pract 2016;2016:7403129. [PMID: 26858752 DOI: 10.1155/2016/7403129] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
608 Yoon J, Oh SH, Kim HJ, Park SH, Ye BD, Yang SK, Kim KM. Primary Sclerosing Cholangitis with Inflammatory Bowel Disease in Korean Children. Pediatr Gastroenterol Hepatol Nutr. 2015;18:268-275. [PMID: 26770902 DOI: 10.5223/pghn.2015.18.4.268] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
609 Henderson P, Kennedy NA, Van Limbergen JE, Cameron FL, Satsangi J, Russell RK, Wilson DC. Serum C-reactive protein and CRP genotype in pediatric inflammatory bowel disease: influence on phenotype, natural history, and response to therapy. Inflamm Bowel Dis 2015;21:596-605. [PMID: 25636121 DOI: 10.1097/MIB.0000000000000296] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
610 Desai D. Disease Behaviour in Patients with Crohn’s Disease: A Review. GHOA 2015;3. [DOI: 10.15406/ghoa.2015.03.00076] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
611 Alipour M, Zaidi D, Valcheva R, Jovel J, Martínez I, Sergi C, Walter J, Mason AL, Wong GK, Dieleman LA, Carroll MW, Huynh HQ, Wine E. Mucosal Barrier Depletion and Loss of Bacterial Diversity are Primary Abnormalities in Paediatric Ulcerative Colitis. J Crohns Colitis 2016;10:462-71. [PMID: 26660940 DOI: 10.1093/ecco-jcc/jjv223] [Cited by in Crossref: 98] [Cited by in F6Publishing: 118] [Article Influence: 14.0] [Reference Citation Analysis]
612 Moon CM, Jung SA, Kim SE, Song HJ, Jung Y, Ye BD, Cheon JH, Kim YS, Kim YH, Kim JS, Han DS; CONNECT study group. Clinical Factors and Disease Course Related to Diagnostic Delay in Korean Crohn's Disease Patients: Results from the CONNECT Study. PLoS One. 2015;10:e0144390. [PMID: 26647084 DOI: 10.1371/journal.pone.0144390] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
613 Costa CO, Carrilho FJ, Nunes VS, Sipahi AM, Rodrigues M. A snapshot of the nutritional status of Crohn's disease among adolescents in Brazil: a prospective cross-sectional study. BMC Gastroenterol 2015;15:172. [PMID: 26642931 DOI: 10.1186/s12876-015-0403-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
614 Elshal MF, Aldahlawi AM, Saadah OI, McCoy JP. Reduced Dendritic Cells Expressing CD200R1 in Children with Inflammatory Bowel Disease: Correlation with Th17 and Regulatory T Cells. Int J Mol Sci 2015;16:28998-9010. [PMID: 26690123 DOI: 10.3390/ijms161226143] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
615 Senhaji N, Serrano A, Badre W, Serbati N, Karkouri M, Zaid Y, Nadifi S, Martin J. Association of inflammatory cytokine gene polymorphisms with inflammatory bowel disease in a Moroccan cohort. Genes Immun. 2016;17:60-65. [PMID: 26632999 DOI: 10.1038/gene.2015.52] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
616 Zeissig S, Petersen BS, Tomczak M, Melum E, Huc-Claustre E, Dougan SK, Laerdahl JK, Stade B, Forster M, Schreiber S, Weir D, Leichtner AM, Franke A, Blumberg RS. Early-onset Crohn's disease and autoimmunity associated with a variant in CTLA-4. Gut 2015;64:1889-97. [PMID: 25367873 DOI: 10.1136/gutjnl-2014-308541] [Cited by in Crossref: 86] [Cited by in F6Publishing: 81] [Article Influence: 12.3] [Reference Citation Analysis]
617 Obih C, Wahbeh G, Lee D, Braly K, Giefer M, Shaffer ML, Nielson H, Suskind DL. Specific carbohydrate diet for pediatric inflammatory bowel disease in clinical practice within an academic IBD center. Nutrition. 2016;32:418-425. [PMID: 26655069 DOI: 10.1016/j.nut.2015.08.025] [Cited by in Crossref: 80] [Cited by in F6Publishing: 72] [Article Influence: 11.4] [Reference Citation Analysis]
618 Urlep D, Blagus R, Orel R. Incidence Trends and Geographical Variability of Pediatric Inflammatory Bowel Disease in Slovenia: A Nationwide Study. Biomed Res Int. 2015;2015:921730. [PMID: 26688822 DOI: 10.1155/2015/921730] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
619 Fumery M, Duricova D, Gower-Rousseau C, Annese V, Peyrin-Biroulet L, Lakatos PL. Review article: the natural history of paediatric-onset ulcerative colitis in population-based studies. Aliment Pharmacol Ther 2016;43:346-55. [PMID: 26582737 DOI: 10.1111/apt.13478] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 6.4] [Reference Citation Analysis]
620 Michielan A, D’Incà R. Host-microbiome interaction in Crohn’s disease: A familiar or familial issue? World J Gastrointest Pathophysiol 2015; 6(4): 159-168 [PMID: 26600974 DOI: 10.4291/wjgp.v6.i4.159] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
621 Dotson JL, Crandall WV, Zhang P, Forrest CB, Bailey LC, Colletti RB, Kappelman MD. Feasibility and validity of the pediatric ulcerative colitis activity index in routine clinical practice. J Pediatr Gastroenterol Nutr. 2015;60:200-204. [PMID: 25221935 DOI: 10.1097/mpg.0000000000000568] [Cited by in Crossref: 20] [Cited by in F6Publishing: 5] [Article Influence: 2.9] [Reference Citation Analysis]
622 Kalaria R, Desai D, Abraham P, Joshi A, Gupta T, Shah S. Temporal Change in Phenotypic Behaviour in Patients with Crohn's Disease: Do Indian Patients Behave Differently from Western and Other Asian Patients? J Crohns Colitis. 2016;10:255-261. [PMID: 26519461 DOI: 10.1093/ecco-jcc/jjv202] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
623 Kim S, Koh H. Nutritional aspect of pediatric inflammatory bowel disease: its clinical importance. Korean J Pediatr. 2015;58:363-368. [PMID: 26576179 DOI: 10.3345/kjp.2015.58.10.363] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
624 Zitomersky NL, Atkinson BJ, Fournier K, Mitchell PD, Stern JB, Butler MC, Ashworth L, Hauenstein S, Heiner L, Chuang E, Singh S, Bousvaros A. Antibodies to infliximab are associated with lower infliximab levels and increased likelihood of surgery in pediatric IBD. Inflamm Bowel Dis 2015;21:307-14. [PMID: 25569737 DOI: 10.1097/MIB.0000000000000284] [Cited by in Crossref: 37] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
625 Torres J, Colombel JF. Genetics and phenotypes in inflammatory bowel disease. Lancet. 2016;387:98-100. [PMID: 26490194 DOI: 10.1016/s0140-6736(15)00464-x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 9] [Article Influence: 3.4] [Reference Citation Analysis]
626 Cakir M, Unal F, Dinler G, Baran M, Yuksekkaya HA, Tumgor G, Kasirga E, Kalayci AG, Aydogdu S. Inflammatory bowel disease in Turkish children. World J Pediatr 2015;11:331-7. [DOI: 10.1007/s12519-015-0042-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
627 Wiernicka A, Szymanska S, Cielecka-Kuszyk J, Dadalski M, Kierkus J. Histological healing after infliximab induction therapy in children with ulcerative colitis. World J Gastroenterol 2015; 21(37): 10654-10661 [PMID: 26457025 DOI: 10.3748/wjg.v21.i37.10654] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
628 Hojsak I, Kolacek S, Hansen LF, Bronsky J, Piekkala M, Lionetti P, Skaba R, Kolho K. Long-term outcomes after elective ileocecal resection in children with active localized Crohn's disease—a multicenter European study. Journal of Pediatric Surgery 2015;50:1630-5. [DOI: 10.1016/j.jpedsurg.2015.03.054] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
629 Bryant RV, Brain O, Travis SP. Conventional drug therapy for inflammatory bowel disease. Scand J Gastroenterol. 2015;50:90-112. [PMID: 25523560 DOI: 10.3109/00365521.2014.968864] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 5.7] [Reference Citation Analysis]
630 Serwas NK, Kansu A, Santos-Valente E, Kuloğlu Z, Demir A, Yaman A, Gamez Diaz LY, Artan R, Sayar E, Ensari A, Grimbacher B, Boztug K. Atypical manifestation of LRBA deficiency with predominant IBD-like phenotype. Inflamm Bowel Dis 2015;21:40-7. [PMID: 25479458 DOI: 10.1097/MIB.0000000000000266] [Cited by in Crossref: 60] [Cited by in F6Publishing: 34] [Article Influence: 8.6] [Reference Citation Analysis]
631 Malmborg P, Hildebrand H. The emerging global epidemic of paediatric inflammatory bowel disease--causes and consequences. J Intern Med. 2016;279:241-258. [PMID: 26355194 DOI: 10.1111/joim.12413] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
632 Winter DA, Karolewska-bochenek K, Lazowska-przeorek I, Lionetti P, Mearin ML, Chong SK, Roma-giannikou E, Maly J, Kolho K, Shaoul R, Staiano A, Damen GM, de Meij T, Hendriks D, George EK, Turner D, Escher JC. Pediatric IBD-unclassified Is Less Common than Previously Reported; Results of an 8-Year Audit of the EUROKIDS Registry: . Inflammatory Bowel Diseases 2015;21:2145-53. [DOI: 10.1097/mib.0000000000000483] [Cited by in Crossref: 27] [Cited by in F6Publishing: 9] [Article Influence: 3.9] [Reference Citation Analysis]
633 Schreiber-Dietrich D, Chiorean L, Cui XW, Braden B, Kucharzik T, Jüngert J, Kosiak W, Stenzel M, Dietrich CF. Particularities of Crohn's disease in pediatric patients: current status and perspectives regarding imaging modalities. Expert Rev Gastroenterol Hepatol 2015;9:1313-25. [PMID: 26377445 DOI: 10.1586/17474124.2015.1083420] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
634 Suskind DL, Singh N, Nielson H, Wahbeh G. Fecal microbial transplant via nasogastric tube for active pediatric ulcerative colitis. J Pediatr Gastroenterol Nutr. 2015;60:27-29. [PMID: 25162366 DOI: 10.1097/mpg.0000000000000544] [Cited by in Crossref: 63] [Cited by in F6Publishing: 32] [Article Influence: 9.0] [Reference Citation Analysis]
635 Chhaya V, Pollok RCG, Cecil E, Subramanian V, Curcin V, Majeed A, Saxena S. Impact of early thiopurines on surgery in 2770 children and young people diagnosed with inflammatory bowel disease: a national population-based study. Aliment Pharmacol Ther 2015;42:990-9. [DOI: 10.1111/apt.13361] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
636 El-Matary W, Dupuis K, Sokoro A. Anti-Saccharomyces cerevisiae antibody titres correlate well with disease activity in children with Crohn's disease. Acta Paediatr 2015;104:827-30. [PMID: 25877674 DOI: 10.1111/apa.13026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
637 Kelsen JR, Dawany N, Moran CJ, Petersen BS, Sarmady M, Sasson A, Pauly-Hubbard H, Martinez A, Maurer K, Soong J, Rappaport E, Franke A, Keller A, Winter HS, Mamula P, Piccoli D, Artis D, Sonnenberg GF, Daly M, Sullivan KE, Baldassano RN, Devoto M. Exome sequencing analysis reveals variants in primary immunodeficiency genes in patients with very early onset inflammatory bowel disease. Gastroenterology 2015;149:1415-24. [PMID: 26193622 DOI: 10.1053/j.gastro.2015.07.006] [Cited by in Crossref: 55] [Cited by in F6Publishing: 64] [Article Influence: 7.9] [Reference Citation Analysis]
638 Martinelli M, Strisciuglio C, Veres G, Paerregaard A, Pavic AM, Aloi M, Martín-de-Carpi J, Levine A, Turner D, Del Pezzo M, Staiano A, Miele E; Porto IBD Working Group of European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN). Clostridium difficile and pediatric inflammatory bowel disease: a prospective, comparative, multicenter, ESPGHAN study. Inflamm Bowel Dis 2014;20:2219-25. [PMID: 25268634 DOI: 10.1097/MIB.0000000000000219] [Cited by in Crossref: 42] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
639 Mann ER, Bernardo D, Ng SC, Rigby RJ, Al-Hassi HO, Landy J, Peake ST, Spranger H, English NR, Thomas LV, Stagg AJ, Knight SC, Hart AL. Human gut dendritic cells drive aberrant gut-specific t-cell responses in ulcerative colitis, characterized by increased IL-4 production and loss of IL-22 and IFNγ. Inflamm Bowel Dis 2014;20:2299-307. [PMID: 25397892 DOI: 10.1097/MIB.0000000000000223] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
640 Strisciuglio C, Miele E, Giugliano FP, Vitale S, Andreozzi M, Vitale A, Catania MR, Staiano A, Troncone R, Gianfrani C. Bifidobacteria Enhance Antigen Sampling and Processing by Dendritic Cells in Pediatric Inflammatory Bowel Disease: . Inflammatory Bowel Diseases 2015;21:1491-8. [DOI: 10.1097/mib.0000000000000389] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
641 Levine A, Koletzko S, Turner D, Escher JC, Cucchiara S, de Ridder L, Kolho KL, Veres G, Russell RK, Paerregaard A, Buderus S, Greer ML, Dias JA, Veereman-Wauters G, Lionetti P, Sladek M, Martin de Carpi J, Staiano A, Ruemmele FM, Wilson DC;  European Society of Pediatric Gastroenterology; Hepatology, and Nutrition. ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr. 2014;58:795-806. [PMID: 24231644 DOI: 10.1097/mpg.0000000000000239] [Cited by in Crossref: 306] [Cited by in F6Publishing: 195] [Article Influence: 43.7] [Reference Citation Analysis]
642 Szymańska E, Szymańska S, Szczepański M, Landowski P, Czaja-Bulsa G, Jarocka-Cyrta E, Korczowski B, Krzesiek E, Kierkuś J. Demographic characteristics of children with early clinical manifestation of inflammatory bowel disease. Prz Gastroenterol 2016;11:14-7. [PMID: 27110305 DOI: 10.5114/pg.2015.52495] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
643 Cutler DJ, Zwick ME, Okou DT, Prahalad S, Walters T, Guthery SL, Dubinsky M, Baldassano R, Crandall WV, Rosh J, Markowitz J, Stephens M, Kellermayer R, Pfefferkorn M, Heyman MB, LeLeiko N, Mack D, Moulton D, Kappelman MD, Kumar A, Prince J, Bose P, Mondal K, Ramachandran D, Bohnsack JF, Griffiths AM, Haberman Y, Essers J, Thompson SD, Aronow B, Keljo DJ, Hyams JS, Denson LA, Kugathasan S; PRO-KIIDS Research Group. Dissecting Allele Architecture of Early Onset IBD Using High-Density Genotyping. PLoS One 2015;10:e0128074. [PMID: 26098103 DOI: 10.1371/journal.pone.0128074] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
644 Clarke T, Lusher J. Transitioning patients with inflammatory bowel disease (IBD) from adolescent to adult services: a systematic review. Frontline Gastroenterol 2016;7:264-70. [PMID: 28839867 DOI: 10.1136/flgastro-2015-100575] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
645 Okou DT, Kugathasan S. Role of genetics in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2014;20:1878-84. [PMID: 25118609 DOI: 10.1097/MIB.0000000000000085] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
646 Pichler J, Huber WD, Aufricht C, Bidmon-Fliegenschnee B. Growth and bone health in paediatric patients with Crohn's disease receiving subcutaneous tumor necrosis factor antibody. World J Gastroenterol 2015; 21(21): 6613-6620 [PMID: 26074699 DOI: 10.3748/wjg.v21.i21.6613] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
647 Thangarajah D, Hyde MJ, Konteti VK, Santhakumaran S, Frost G, Fell JM. Systematic review: Body composition in children with inflammatory bowel disease. Aliment Pharmacol Ther. 2015;42:142-157. [PMID: 26043941 DOI: 10.1111/apt.13218] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
648 Grover Z, Lewindon P. Two-Year Outcomes After Exclusive Enteral Nutrition Induction Are Superior to Corticosteroids in Pediatric Crohn's Disease Treated Early with Thiopurines. Dig Dis Sci 2015;60:3069-74. [PMID: 26038093 DOI: 10.1007/s10620-015-3722-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 4.7] [Reference Citation Analysis]
649 Herzog D, Fournier N, Buehr P, Koller R, Rueger V, Heyland K, Nydegger A, Spalinger J, Schibli S, Braegger C. Early-onset Crohn's disease is a risk factor for smaller final height. Eur J Gastroenterol Hepatol. 2014;26:1234-1239. [PMID: 25089544 DOI: 10.1097/MEG.0000000000000169] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
650 Aloi M, D’arcangelo G, Capponi M, Nuti F, Vassallo F, Civitelli F, Oliva S, Pagliaro G, Cucchiara S. Managing paediatric acute severe ulcerative colitis according to the 2011 ECCO-ESPGHAN guidelines: Efficacy of infliximab as a rescue therapy. Digestive and Liver Disease 2015;47:455-9. [DOI: 10.1016/j.dld.2015.01.156] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
651 Luo Y, Yu J, Zhao H, Lou J, Chen F, Peng K, Chen J. Short-Term Efficacy of Exclusive Enteral Nutrition in Pediatric Crohn's Disease: Practice in China. Gastroenterol Res Pract 2015;2015:428354. [PMID: 26106412 DOI: 10.1155/2015/428354] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
652 Baillie CT, Smith JA. Surgical strategies in paediatric inflammatory bowel disease. World J Gastroenterol 2015; 21(20): 6101-6116 [PMID: 26034347 DOI: 10.3748/wjg.v21.i20.6101] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
653 Buderus S, Boone JH, Lentze MJ. Fecal Lactoferrin: Reliable Biomarker for Intestinal Inflammation in Pediatric IBD. Gastroenterol Res Pract. 2015;2015:578527. [PMID: 26089872 DOI: 10.1155/2015/578527] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
654 Oliva-Hemker M, Hutfless S, Al Kazzi ES, Lerer T, Mack D, LeLeiko N, Griffiths A, Cabrera J, Otley A, Rick J. Clinical Presentation and Five-Year Therapeutic Management of Very Early-Onset Inflammatory Bowel Disease in a Large North American Cohort. J Pediatr. 2015;167:527-532.e1-3. [PMID: 25982142 DOI: 10.1016/j.jpeds.2015.04.045] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 7.3] [Reference Citation Analysis]
655 Gallego-Gutiérrez S, Navas-López VM, Kolorz M, Bartosova L, Lukac K, Luque-Pérez S, Núñez-Caro L, García-Galán P, Fernández-Crehuet FG, Blasco-Alonso J, Serrano-Nieto MJ, Sierra-Salinas C. Successful Mercaptopurine Usage despite Azathioprine-Induced Pancreatitis in Paediatric Crohn's Disease. J Crohns Colitis 2015;9:676-9. [PMID: 25968582 DOI: 10.1093/ecco-jcc/jjv086] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
656 Korolkova OY, Myers JN, Pellom ST, Wang L, M'Koma AE. Characterization of Serum Cytokine Profile in Predominantly Colonic Inflammatory Bowel Disease to Delineate Ulcerative and Crohn's Colitides. Clin Med Insights Gastroenterol. 2015;8:29-44. [PMID: 26078592 DOI: 10.4137/cgast.s20612] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 7.3] [Reference Citation Analysis]
657 Malmborg P, Grahnquist L, Ideström M, Lindholm J, Befrits R, Björk J, Montgomery S, Hildebrand H. Presentation and Progression of Childhood-Onset Inflammatory Bowel Disease in Northern Stockholm County: . Inflammatory Bowel Diseases 2015;21:1098-108. [DOI: 10.1097/mib.0000000000000356] [Cited by in Crossref: 36] [Cited by in F6Publishing: 8] [Article Influence: 5.1] [Reference Citation Analysis]
658 Martinelli M, Strisciuglio C, Illiceto MT, Cardile S, Guariso G, Vignola S, Aloi M, D’altilia MR, Alvisi P, Salvatore S, Staiano A, Cucchiara S, Miele E. Natural history of pancreatic involvement in paediatric inflammatory bowel disease. Digestive and Liver Disease 2015;47:384-9. [DOI: 10.1016/j.dld.2015.01.155] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
659 Hojsak I, Mišak Z, Jadrešin O, Močić Pavić A, Kolaček S. Methotrexate is an efficient therapeutic alternative in children with thiopurine-resistant Crohn's disease. Scand J Gastroenterol 2015;50:1208-13. [PMID: 25877164 DOI: 10.3109/00365521.2015.1031166] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
660 Schechter A, Griffiths C, Gana JC, Shaoul R, Shamir R, Shteyer E, Bdolah-Abram T, Ledder O, Turner D. Early endoscopic, laboratory and clinical predictors of poor disease course in paediatric ulcerative colitis. Gut 2015;64:580-8. [PMID: 24848266 DOI: 10.1136/gutjnl-2014-306999] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 6.1] [Reference Citation Analysis]
661 Arcos-machancoses J, Donat-aliaga E, Polo-miquel B, Masip-simó E, Ribes-koninckx C, Pereda-pérez A. Retraso diagnóstico en la enfermedad inflamatoria intestinal pediátrica. Descripción y estudio de los factores de riesgo. Anales de Pediatría 2015;82:247-54. [DOI: 10.1016/j.anpedi.2014.05.024] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
662 Inoue K, Aomatsu T, Yoden A, Okuhira T, Kaji E, Tamai H. Usefulness of a novel and rapid assay system for fecal calprotectin in pediatric patients with inflammatory bowel diseases. J Gastroenterol Hepatol. 2014;29:1406-1412. [PMID: 24635100 DOI: 10.1111/jgh.12578] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
663 Sigall-Boneh R, Pfeffer-Gik T, Segal I, Zangen T, Boaz M, Levine A. Partial enteral nutrition with a Crohn's disease exclusion diet is effective for induction of remission in children and young adults with Crohn's disease. Inflamm Bowel Dis. 2014;20:1353-1360. [PMID: 24983973 DOI: 10.1097/mib.0000000000000110] [Cited by in Crossref: 151] [Cited by in F6Publishing: 75] [Article Influence: 21.6] [Reference Citation Analysis]
664 Maignant S, Pélatan C, Breton E, Cagnard B, Chaillou E, Giniès JL, Le Hénaff G, Ségura JF, Willot S, Bridoux L, Jobert A, Darviot E, Delaperrière N, Lapeyre D, Carré E, Grimal I, Hankard R, Wagner AC, Balençon M, Caldari D, Tourtelier Y, Dabadie A. [Knowledge of adolescents with inflammatory bowel disease: Results of a multicenter cross-sectional survey]. Arch Pediatr 2015;22:468-75. [PMID: 25725972 DOI: 10.1016/j.arcped.2015.01.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
665 Weidlich S, Bulau AM, Schwerd T, Althans J, Kappler R, Koletzko S, Mayr D, Bufler P. Intestinal expression of the anti-inflammatory interleukin-1 homologue IL-37 in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2014;59:e18-26. [PMID: 24732025 DOI: 10.1097/MPG.0000000000000387] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 4.7] [Reference Citation Analysis]
666 Church PC, Guan J, Walters TD, Frost K, Assa A, Muise AM, Griffiths AM. Infliximab maintains durable response and facilitates catch-up growth in luminal pediatric Crohn's disease. Inflamm Bowel Dis 2014;20:1177-86. [PMID: 24865777 DOI: 10.1097/MIB.0000000000000083] [Cited by in Crossref: 65] [Cited by in F6Publishing: 28] [Article Influence: 9.3] [Reference Citation Analysis]
667 Haisma SM, Lijftogt T, Kindermann A, Damen G, de Ridder L, Escher JC, Mearin ML, de Meij T, Hendriks D, George E, Hummel T, Norbruis O, van Rheenen P. Methotrexate for maintaining remission in paediatric Crohn's patients with prior failure or intolerance to thiopurines: a multicenter cohort study. J Crohns Colitis 2015;9:305-11. [PMID: 25656249 DOI: 10.1093/ecco-jcc/jjv031] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
668 Cozijnsen M, Duif V, Kokke F, Kindermann A, van Rheenen P, de Meij T, Schaart M, Damen G, Norbruis O, Pelleboer R, Van den Neucker A, van Wering H, Hummel T, Oudshoorn J, Escher J, de Ridder L. Adalimumab Therapy in Children With Crohn Disease Previously Treated With Infliximab. Journal of Pediatric Gastroenterology & Nutrition 2015;60:205-10. [DOI: 10.1097/mpg.0000000000000589] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 2.4] [Reference Citation Analysis]
669 Levine A, Turner D, Pfeffer Gik T, Amil Dias J, Veres G, Shaoul R, Staiano A, Escher J, Kolho KL, Paerregaard A, Martin de Carpi J, Veereman Wauters G, Koletzko S, Shevah O, Finnby L, Sladek M. Comparison of outcomes parameters for induction of remission in new onset pediatric Crohn's disease: evaluation of the porto IBD group "growth relapse and outcomes with therapy" (GROWTH CD) study. Inflamm Bowel Dis 2014;20:278-85. [PMID: 24390062 DOI: 10.1097/01.MIB.0000437735.11953.68] [Cited by in Crossref: 58] [Cited by in F6Publishing: 31] [Article Influence: 8.3] [Reference Citation Analysis]
670 Zeissig Y, Petersen BS, Milutinovic S, Bosse E, Mayr G, Peuker K, Hartwig J, Keller A, Kohl M, Laass MW, Billmann-Born S, Brandau H, Feller AC, Röcken C, Schrappe M, Rosenstiel P, Reed JC, Schreiber S, Franke A, Zeissig S. XIAP variants in male Crohn's disease. Gut 2015;64:66-76. [PMID: 24572142 DOI: 10.1136/gutjnl-2013-306520] [Cited by in Crossref: 107] [Cited by in F6Publishing: 101] [Article Influence: 15.3] [Reference Citation Analysis]
671 Giraldo Escobar L, Crespo Madrid N, Vila Miravet V, Pujol Muncunill G, Varea Calderón V, Martín de Carpi J. Colitis ulcerosa asociada a hepatitis autoinmune: ¿una forma diferencial de enfermedad inflamatoria intestinal? Anales de Pediatría 2015;82:e78-81. [DOI: 10.1016/j.anpedi.2013.11.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
672 Zimmerman LA, Shamberger RC, Valim C, Bousvaros A. The effect of immunomodulators and biologics on indication for surgical bowel resection in children with Crohn's disease. Inflamm Bowel Dis 2014;20:1015-20. [PMID: 24788215 DOI: 10.1097/MIB.0000000000000042] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
673 Minar P, Haberman Y, Jurickova I, Wen T, Rothenberg ME, Kim MO, Saeed SA, Baldassano RN, Stephens M, Markowitz J, Rosh J, Crandall WV, Heyman MB, Mack DR, Griffiths AM, Baker SS, Hyams JS, Kugathasan S, Denson LA. Utility of neutrophil Fcγ receptor I (CD64) index as a biomarker for mucosal inflammation in pediatric Crohn's disease. Inflamm Bowel Dis 2014;20:1037-48. [PMID: 24788216 DOI: 10.1097/MIB.0000000000000049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 0.3] [Reference Citation Analysis]
674 Athanasakos A, Mazioti A, Economopoulos N, Kontopoulou C, Stathis G, Filippiadis D, Spyridopoulos T, Alexopoulou E. Inflammatory bowel disease-the role of cross-sectional imaging techniques in the investigation of the small bowel. Insights Imaging. 2015;6:73-83. [PMID: 25537967 DOI: 10.1007/s13244-014-0377-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
675 Clark JG, Srinath AI, Youk AO, Kirshner MA, McCarthy FN, Keljo DJ, Bousvaros A, DeMaso DR, Szigethy EM. Predictors of depression in youth with Crohn disease. J Pediatr Gastroenterol Nutr. 2014;58:569-573. [PMID: 24343281 DOI: 10.1097/mpg.0000000000000277] [Cited by in Crossref: 37] [Cited by in F6Publishing: 14] [Article Influence: 4.6] [